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TÍTULO DA TESE:    Transtirretina e o transporte das hormonas tiróides em peixes e o 
efeito dos disruptores endócrinos neste processo  
 
RESUMO 
 
Nos vertebrados, a transtirretina (TTR) é uma proteína responsável pelo transporte sanguíneo 
das hormonas tiróides (HT), tiroxina (T4) e triiodotironina (T3). A evolução estrutural e 
funcional da TTR nos vertebrados, a sua capacidade de formar fibras amilóides causando 
doenças humanas e a sua afinidade para disruptores endócrinos (DEs) são questões 
importantes pouco exploradas em peixes. Neste estudo produziu-se TTR recombinante de 
dourada (sbrTTR), antisoro específico anti-sbrTTR e dois mutantes sbrTTR no N-terminal. 
Ensaios competitivos de ligação demonstraram que sbrTTR liga-se com afinidade semelhante 
à T3 (Kd=10.6nM) e T4 (Kd=9.8nM) e que o N-terminal influencia a ligação à sbrTTR e a 
produção de fibras amilóides. Níveis plasmáticos de TTR (3.8µg/ml) aumentaram após 
administração de HT apesar da expressão génica hepática não ser alterada, sugerindo que as 
HT regulam a secreção da TTR mas não a síntese. Os DEs competiram significativamente na 
ligação sbrTTR-HT in vitro, indicando a utilidade deste ensaio na avaliação da disrupção do 
eixo da tiróide em peixes. In vivo, os ligandos da TTR, ioxynil e diethylstilbestrol, alteram o 
eixo da tiróide em dourada; a expressão de TSH e deiodinases no cérebro diminuiu apesar dos 
níveis plasmáticos das HT e a expressão hepática da TTR não sofrerem quaisquer alterações. 
 
 
Palavras chave: Transtirretina, proteínas de ligação às hormonas tiróides, hormonas tiróides, 
peixes teleósteos, sistema da tiróide, disruptores endócrinos. 
 
 
 THESIS TITLE:       Transthyretin and thyroid hormone transport in fish and the effect           
of endocrine disruptors on this process 
 
 
 
ABSTRACT 
 
 
Transthyretin (TTR) is a homotetrameric protein that transports thyroid hormones (THs) 
thyroxine (T4) and triiodothyronine (T3) in vertebrate’s blood. TTR features raise important 
questions: understanding its structural/functional evolution in vertebrates; its ability to form 
amyloid fibrils causing human disease and TTR’s high affinity for endocrine disruptor 
chemicals (EDCs). In fish, TTR features are poorly explored. In this study, sea bream 
recombinant TTR (sbrTTR), specific anti-sbrTTR antisera and two sbrTTR N-terminal 
mutants were produced. A [125I-T3] competitive binding assay demonstrated that sbrTTR 
binds T3 (Kd=10.6nM) and T4 (Kd=9.8nM) with a similar affinity and the N-terminus was 
found to influence binding to sbrTTR but also the formation of fibrils. TTR plasma levels, 
measured (3.8µg/ml) for the first time in fish using a specific ELISA, increased upon 
administration of THs, although hepatic gene expression was not modified suggesting THs 
regulate TTR secretion but not synthesis. Putative EDCs strongly displace in vitro sbrTTR-
THs binding indicating the sbrTTR binding assay could be a useful risk assessment tool for 
thyroid axis disruption in fish. In vivo, TTR-binders ioxynil and diethylstilbestrol altered the 
thyroid axis in sea bream; brain TSH and deiodinases expression was downregulated although 
TH plasma levels and TTR hepatic expression remained unaltered. 
 
 
 
Key-words: Transthyretin, thyroid hormone binding proteins, thyroid hormones, teleost fish, 
thyroid system, endocrine disrupting chemicals. 
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1.1 Thesis context 
The present manuscript describes research work developed within the aim of the thesis 
to give an overview of the thyroid hormone axis and the thyroid hormone binding 
proteins. It is focused on a quite specific aspect of the vast field of Biology, although 
many tools and sub-fields of this multidisciplinary area were obviously involved. The 
research field addressed by the thesis and in particular the introduction would fall within 
the realms of Fish Thyroidology. This, in its turn, can be included in Comparative 
Endocrinology, a branch of Endocrinology, and an important sub-discipline of Animal 
Physiology. 
Humankind has been dealing with aspects of endocrine physiology and pathology for 
thousands of years (e.g., domestic castration of dogs to modify behaviour). For instance, 
description of dysfunctional thyroid gland symptoms and respective treatment with the 
iodide rich sea water date back over 3.500 years (Medvei, 1982). However, the concepts 
of “endocrine” and “hormone” were only established at the beginning of the twentieth 
century (Bayliss and Starling, 1901/1902; Bayliss and Starling, 1902) and since then the 
field of Endocrinology has been evolving rapidly. The progress in science and 
technology allowed hormone identification, characterization and provided means of 
quantification. It also permitted great advances in the understanding of endocrine glands 
secretory mechanisms, hormone and receptor structures and interactions and signal 
transduction. Most of these achievements however, have been mainly focused on 
mammalian systems and in particular the human endocrine system due to its interest for 
human medicine. Studies focused on non-mammalian animals have been grouped 
together and classified as “Comparative Endocrinology”. This new field was initially 
based upon comparisons of “lower-vertebrates” with the better known mammalian 
model. However, the limited value of such extrapolations is clear when considered in 
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the context of the entirely different physiological challenges faced by mammals and 
lower vertebrates in their environments. Today, the concept of comparative 
endocrinology mostly relies in the search of “commonalities in the endocrine 
physiology of different vertebrate and invertebrate organisms with a view to 
establishing underlying principles and evolutionary relationships of the groups” 
(Leatherland, 1993). 
Over the past 20 years Comparative Endocrinology started to devote increasing 
attention to a specific taxon such as fish in which the endocrine system regulates many 
fundamental processes (e.g. growth, development, metabolism and reproduction). This 
phenomenon is also probably explained by the key position of fish in evolution and the 
fact that they represent the most abundant vertebrates on the planet (over 25,000, 
Helfman et al.(1997)). Moreover, the perceived health benefits of consuming fish have 
made them of increasing commercial importance as a food resource, but there is also a 
buoyant sport fishing and aquarium hobbyist industry. 
The present work is focused on a very specific aspect of fish endocrinology or more 
precisely fish thyroidology: thyroid hormone transport. All the studies herein described 
concern Transthyretin (TTR), one of several thyroid hormone binding proteins which 
have been described and characterised in vertebrates. Human TTR is especially well 
characterised and is an important subject of study due to its role in severe 
neurodegenerative diseases (e.g. familial amyloidotic polyneurpathy (FAP), senile 
systemic amyloidosis (SSA)). In fish, however, relatively little is known about this 
binding protein. Only recently TTR was identified in teleost fish (Funkenstein, 2001; 
Kawakami et al., 2006; Santos and Power, 1999; Yamauchi et al., 1999). When the 
present thesis project was conceived and planned, studies concerning fish TTR were 
very scarce or almost inexistent although there was evidence (mostly from other 
CHAPTER 1  General Introduction 
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vertebrates) of many interesting aspects to explore: TTR binding to thyroid hormones 
(THs) and the molecular basis of this process; its role in the thyroid axis and 
involvement in TH regulation; TTR misfolding and stability a causative factor in human 
diseases and also the ability of TTR to bind endocrine disrupting chemicals (EDC). 
Furthermore, the sequence of TTR from a teleost fish, the sea bream, had recently been 
cloned and preliminary studies of its structure were ongoing which made it the perfect 
tool. In light of the scarcity of information about fish TTR and taking into consideration 
its potential importance in a number of important aspects of vertebrate thyroidology the 
present project was undertaken. In the present thesis a number of tools with which to 
study fish TTR were developed and applied in structural, biochemical and physiological 
studies. They have responded to some questions about fish TTR but mostly they have 
raised many new interesting ones about this proteins evolution and function.  
 
1.2 The Endocrine system 
As life evolved in its complexity, multicellularity and differentiation gave rise to the 
extremely organised forms of life presently found in nature. Such multicellular 
organisms are in the end no more than an orchestra of cells performing different 
functions as an integrated whole and for this reason coordination is a key factor. 
Efficient organization and coordination requires an effective communication network 
and cells in close connection communicate directly by electrical and chemical 
interactions. However, as animals became larger networks were required to sense and 
bring about rapid responses to specific stimulus, two important networks which evolved 
were the nervous and the endocrine system. In the latter system, information is 
integrated in a set of chemical messengers known as “hormones” (from the Greek 
hormao = to excite) which are produced by a number of endocrine glands widely spread 
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throughout the body. In general, endocrine integration controls long-term processes like 
growth, development, metabolism, reproduction, etc. 
The term hormone was introduced for the first time by Bayliss and Starling in 1902. 
They demonstrated unequivocally, when trying to identify the factors responsible for 
pancreatic secretion, that this vital process is regulated by a hormone, secretin, and 
defined in their study the concept of “endocrine”. The definition of an endocrine 
hormone is a “factor secreted from a gland into the blood stream which acts at distant 
targets”. However, with the advance of the field of endocrinology a number of new 
concepts have been introduced. Currently, it is established that hormones may circulate 
in the blood, other body fluids or by diffusion between cells and their action can be 
endocrine (if the target is a distant organ) but also autocrine (when acting on the same 
cell type that secreted them or paracrine (if acting on neighbouring cells of different 
type). In 1989, (Bolander, 1989) defined a hormone as a “chemical, non-nutrient, 
intercellular messenger carrying information between two or more cells”.  
Different chemical compounds can act as hormones. They can be peptides and proteins, 
steroids or amino acid derivatives. The structural and chemical properties of each 
hormone greatly determine their mode of action. These chemical messengers are 
synthesized by the metabolic machinery of the gland cells, stored in vesicles or granules 
and released, on appropriate stimulation, by exocytosis directly into the blood or other 
body fluids. The stimulus for release is usually a consequence of alterations in the 
external environment (e.g. temperature) or in vivo (e.g. nutritional status) and can be 
transmitted as an electrical or chemical signal like a neurotransmitter, nutrient or other 
hormone. Once in the circulation (or in the extracellular space) the released hormone 
travels to its effector sites. Most water-soluble hormones, like peptides, are carried in 
physical solution while hydrophobic and lipid soluble hormones (like steroid or some 
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peptide derivatives) are carried bound to plasma proteins. When reaching the target cell 
the hormone is recognized by specific receptors in the plasma membrane, cytoplasm or 
nucleus. Hormone-receptor binding gives rise to a cascade of intracellular events that 
ultimately lead to the hormone´s physiological effect (e.g., changes in enzyme activity, 
ion levels, transcription of responsive genes, etc). In general, small lipophilic hormones 
like steroid or thyroid hormones pass through the lipid plasma membrane of receptor 
cells and bind a cytoplasmic or nuclear receptor. The complex formed binds to acceptor 
sites on the chromosome regulating the transcription of specific genes, the products of 
which are usually enzymes. In contrast, peptide or protein hormones which are water-
soluble do not cross the plasma membrane and act by binding to transmembrane 
receptors on the cell surface. The hormone-receptor complex activates an enzyme inside 
the membrane, which in turn leads to the formation of a second intracellular messenger 
(e.g. cyclic adenosine monophosphate (cAMP), cyclic guanosine monophosphate 
(cGMP), diacylglycerol (DAG), inositol triphosphate (IP3) and Ca2+ (Bentley, 1998; 
Lodish et al., 2000). The secondary messengers trigger a cascade of intracellular 
responses, generally involving activation of ion channels or enzymes such as protein 
kinases that give rise to the hormone’s physiological effect. The response is of a rapid 
non-genomic kind unlike that generally provoked by hormones binding to nuclear 
receptors. However, recently membrane receptors have also been shown to control 
transcription of specific genes through transcription factor activation (Lodish et al., 
2000; Neves et al., 2002) and nuclear receptors located in the cytoplasm and cell 
membrane appear to interact with intracellular signalling factors mediating non-
genomic actions (Aranda and Pascual, 2001). 
Hormone concentrations in the blood stream are usually very low but cause profound 
effects as a consequence of their amplification by the cascade of events they activate. 
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However the triggering of such events is highly dependent on circulating hormone 
concentrations which are mainly determined by their rate of secretion and clearance. 
The balance of circulating hormone levels is crucial and is generally regulated by a 
feedback system. In this way, negative feedback loops, often involving two or more 
glands, act inducing a gland to raise/decrease hormone secretion in response to lower or 
higher circulating hormone concentrations. One well established example of this 
mechanism is the hypothalamus – pituitary - thyroid axis which will now be described 
as it provides the background for the present thesis. 
 
 
1.3 Thyroid axis and hormones 
 
The presence of a thyroid gland in mammals has been recognised for several thousand 
years (Leatherland, 1993); in humans it consists of a small bilobed structure that 
develops embryonically as an outgrowth from the front of the pharynx and migrates in a 
posterior direction to the ventral surface of the neck surrounding the trachea (Dorit et 
al., 1991). This position is generally comparable in all vertebrates. Structurally, the 
thyroid gland consists of a follicle formed by a single layer of epithelial cells 
surrounding a central cavity filled with colloid. In an active thyroid gland the epithelial 
cells of the follicle are columnar and the colloid contains numerous vacuoles while in an 
inactive gland the epithelial cells are flattened and follicles are distended with colloid 
(Bentley, 1998). The thyroid appears to have the longest phylogenetic history of any 
endocrine gland and its basic follicular unit has been conserved in all vertebrates and 
homologous tissues have been identified in protochordates, including amphioxus 
(Cephalochordata) and ascidians (Urochordata) (Barrington, 1962). 
The thyroid gland exerts its action through the synthesis of two biologically active 
hormones, Thyroxine (T4) and Triiodothyronine (T3) the production of which is 
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regulated by a feedback inhibition mechanism operating at the level of the 
hypothalamus - pituitary gland - thyroid gland axis. Thyroid follicles have the 
remarkable ability to extract iodine from the blood which is essential for thyroid 
hormone synthesis. Iodine uptake is a critical step for hormone production and by 
regulating this step the thyroid gland regulates its own activity. Thyroid hormone levels 
in the blood are primarily controlled by negative feedback at the hypothalamus (fig.1). 
This system-wide regulatory centre located in the brain, synthesizes and releases 
thyrotropin-releasing-hormone (TRH) which in turn stimulates the secretion of 
thyrotropin-stimulating-hormone (TSH) by the pituitary gland. TSH is secreted into the 
blood by the pituitary gland and acts on the thyroid stimulating the synthesis and release 
of biologically active TH molecules. Synthesis of TRH by the hypothalamus is 
regulated by both the concentration of THs and TSH in the blood. A reduction in the 
concentration of circulating THs is also directly sensed by the pituitary thyrotrophs and 
stimulates TSH release.  
 
1.3.1 Thyroid hormones  
Thyroid hormones have been identified throughout the vertebrates including basal 
groups such as, cyclostomes, teleosts, amphibians and reptiles (Chiu et al., 1975; Higgs 
and Eales, 1973; Packard et al., 1976) and iodothyronine active compounds were also 
found to be present in a number of protochordates (Bentley, 1998). The thyroid 
hormones are probably the most pluripotent hormones found in vertebrates as they can 
influence virtually every metabolic activity of an organism (e.g., concentration and 
function of numerous enzymes; metabolism of fats, carbohydrate, vitamins, proteins; 
heart rate; stimulation of erythropoiesis or regulation of bone synthesis, etc.).  
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Figure 1 Hypothalamic - pituitary gland - thyroid gland axis. Thyroid hormone levels are regulated by 
a feedback inhibition mechanism which operates along the hypothalamic-pituitary-thyroid axis. The 
hypothalamus secretes thyrotropin releasing hormone (TRH) which stimulates the pituitary to secrete 
thyroid stimulating hormone (TSH). TSH, in turn, stimulates the thyroid gland to produce and secrete 
thyroid hormones (T4 and T3) into the circulation where they bind thyroid binding proteins. The system 
attempts to maintain constant the free TH fraction through a negative feedback loop. Alterations on free 
hormone concentrations are sensed at the level of the hypothalamus and pituitary and TSH production is  
stimulated/inhibited in order to re-establish adequate TH levels.  
Adapted from: http://www.dpcweb.com/medical/thyroid/thyroid_function.html 
 
 
Physiologically, THs act through two major mechanisms: by increasing protein 
synthesis and oxygen consumption. Ultimately, their action influences basic life cycle 
events such as growth, differentiation, metamorphosis, reproduction, hibernation and 
thermogenesis (Bentley, 1998). Normal thyroid function is essential for both mental and 
physical development of young mammals. Inadequate production or overproduction of 
thyroid hormones is strongly associated with two types of thyroid disease states in 
humans, hypothyroidism and hyperthyroidism, respectively. In children, low levels of 
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THs (hypothyroidism) can compromise normal physical and mental development, a 
conditions known as cretinism. The same condition in adults results in low metabolism 
and several associated complication like weight increase, low body temperatures, etc  
(Dorit et al., 1991). Usually hypothyroidism can be readily treated by oral 
administration of synthetic THs. Abnormally high TH levels (hyperthyroidism) causes 
an elevation of the metabolic rate, weight loss, excessive perspiration, nervousness and 
other complications (Dorit et al., 1991) Hyperthyroidism is commonly treated by 
administering anti-thyroid drugs (e.g. propylthiourea, methimazole), which suppress 
synthesis of thyroid hormones primarily by interfering with iodination of thyroglobulin.  
In other vertebrates the function of THs is still not fully understood. For example they 
are essential for moulting in amphibians and reptiles, and their essential role in 
amphibian methamorphosis is widely recognised (Leloup and Buscaglia, 1977). Recent 
reports also highlight their importance in fish development, growth and metamorphosis 
(Power et al., 2001; Yamano, 2005). In fact, many vertebrates have a characteristic rise 
in THs during crucial stages of development (Hulbert, 2000; Leloup and Buscaglia, 
1977).   
Functional THs are small amino acid derivatives (fig. 2) consisting of a hydrophobic 
thyronine nucleus, which accounts for their poor water solubility, a hydrophilic 
hydroxyl group attached to the phenolic ring and four or three iodines at positions 3, 5, 
3’, and 5’ in thyroxine (T4) or 3, 5, 3’ in  triiodo L-thyronine (T3) (Power et al., 2000a). 
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Figure 2 The chemical structure of thyroid hormones T4 (left) and T3 (right) (Lundberg, 2006) 
 
 
1.3.2 THs biosynthesis   
The general principals of thyroid hormonogenesis as presently accepted were first 
outlined by Gorbman and Bern (1962) and are essentially similar throughout vertebrates 
(Leatherland, 1993). TH synthesis takes place in the follicular cells of the thyroid and 
starts with the uptake of extracellular iodide. See fig. 3 for a schematic representation of 
TH biosynthesis. The thyroid utilizes I-, the elemental form in the blood, which is 
ultimately derived from the environment. Terrestrial vertebrates obtain I- mostly from 
food while fish take up iodine from the water via the gills and gut. Iodide is pumped 
into thyrocytes in an ATP dependent manner by means of a sodium/iodide co-tranporter 
(symporter, NIS) protein in the plasma membrane. Once inside the follicular cell it is 
converted by thyroid peroxidase (TPO), most likely at the luminal surface of the cell, to 
an oxidized species of iodine which is incorporated into tyrosyl groups of thyroglobulin 
(TG) a very large glycoprotein. Iodination occurs at specific tyrosine sites within 
thyroglobulin giving rise to diiodotyrosine (DIT) and monoiodeotyrosine (MIT). TPO 
activity facilitates the intramolecular coupling of either two DIT residues, giving rise to 
tetraiodothyronine (T4), or a MIT with a DIT residue resulting in the formation of 
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triiodothyronine (T3). At this stage, iodinated thyronine compounds are an integral part 
of thyroglobulin and represent a reserve of THs stored in the lumen of the thyroid 
follicles. Enzymatic degradation of the thyroglobulin, stimulated by TSH, releases THs 
into the intracellular compartment. Free T4 and smaller amounts of free T3 are then 
secreted into the blood. While T4 is formed exclusively in the thyroid, 80% of T3 found 
in circulation is thought to derive from T4 conversion in peripheral non-thyroidal tissues 
(especially liver and kidney). The difference between the source of T3 and T4 is 
probably related to their mode of action. T4 is considered to be a prohormone as in order 
to act it has to be converted to its derivative, T3, the biologically more potent TH 
because of its greater affinity for thyroid hormone receptors (TRs) (McNabb, 1992).  
 
 
Figure 3. Thyroid hormones biosynthesis pathway in a thyroid follicle cell. The first step to hormone 
synthesis is the import of iodide into the follicular cells, an active transport process (an ATP-pump pumps 
K+ in and Na+ out of the cell) that occurs through a sodium/iodide "symporter" (transporting iodide in). 
Once in the follicular cell, iodide is converted into iodine by the enzyme thyroid peroxidase (TPO), which 
uses hydrogen peroxide (H2O2) as a cofactor. Thyroid peroxidase catalyzes the incorporation of iodide 
molecule onto both the 3 and/or 5 positions of the phenol rings of tyrosines present in the large protein 
thyroglobulin (TG) originating diiodotyrosine (DIT) and monoiodeotyrosine (MIT). Thyroglobulin 
contains 140 tyrosines but only two to five of these are converted into either T4 or T3 through TPO 
activity. TSH stimulates enzymatic degradation of thyroglobulin releasing the THs into the intracellular 
compartment which are further secreted into the blood plasma. Original picture from Boas, et al (2006). 
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1.3.3 TH mode of action and metabolism 
Once released into the circulation, a major part of THs reversibly binds to plasma 
transport proteins and only a minor fraction (approximately 0.03% for T4 and 0.3% for 
T3) remains in the free form (fig.1). According to the “free hormone hypothesis” 
formulated by Robbins and Rall in 1960 and further supported by Mendel and 
colleagues (Mendel, 1989), thyroid hormones enter target cells by diffusion and it is the 
free hormone and not the protein-bound one that is available to enter cells. Therefore, 
the free extracellular TH concentration constitutes the driving force that determines the 
rate at which THs reach their targets eliciting physiological responses.  However, an 
alternative proposal (Beraud et al., 1958 and Ingbar and Freinkel, 1960) suggests that 
transmembrane diffusion of THs is governed by intra and extra-cellular thyroid-
hormone binding proteins. More recently several studies have demonstrated the 
existence of a cellular uptake mechanism for THs in which binding proteins mediate 
cell entry through protein receptors on the membrane of the target cell (Benvenga and 
Robbins, 1990; Divino and Schussler, 1990; Kuchler-Bopp et al., 1998; Vieira et al., 
1995). Although this membrane translocation mechanism is not completely clarified it 
is presently accepted that cellular uptake of THs is a carrier-mediated process important 
for overall regulation of their bioactivity (for review see Hennemann et al., 2001). 
TH actions after cellular uptake are mediated by nuclear thyroid hormone receptors 
(TRs) that can bind T3 with high affinity (for reviews see Wu and Koenig, 2000; Zhang 
and Lazar, 2000). TRs belong to the nuclear receptor superfamily that also includes 
receptors for other small lipophylic hormones (e.g. steroids, retinoids and vitamin D). 
Two distinct genes (TRα and TRβ) located in different chromosomes (17 and 3, 
respectively in humans) generate multiple TRs isoforms including TRα1, TRα2, TRα3 
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and TRβ1, TRβ2 (Lazar, 1993) which have distinct functional roles. TRs act as 
transcription factors regulating gene expression. They bind to specific regulatory DNA 
sequences of the target genes known as TH response elements (TREs). Although TR 
can bind TREs as monomers or homodimers, they preferentially bind many TREs as 
heterodimers with the retinoid X receptor (RXR), another member of the nuclear 
receptor superfamily. Binding of unliganded TR generally represses basal transcription 
while ligand (T3) binding triggers a conformational change in the TR activating 
transcription of a target gene. Inhibition and enhancement of gene expression can 
depend on the nature of the TREs, hormonal status and the cellular environment.  
TRs like other nuclear receptors exhibit a modular structure with a variable N-terminal 
region, a central DNA-binding domain containing two zinc fingers and a large highly 
conserved ligand-dependent activation domain located towards the C-terminus of the 
protein (Lazar, 1993). The intracellular T3 concentration largely determines the degree 
of occupancy of nuclear receptors thus regulating biological responses to THs (Brent, 
1994). The intracellular T3 concentration in its turn is directly influenced by factors such 
as, T3 and T4 uptake rates from the extracellular fluid or TH inactivation. The latter can 
be achieved by glucuronide or sulphate conjugation, deamination or decarboxylation, 
but the major metabolic pathway is deiodination which takes place mainly in liver and 
kidney. T4 can lose iodine atoms in a stepwise manner to create an array of 
iodothyronines. The most important deiodination pathway is T4 conversion to T3 which 
occurs by removal of one iodide unit from the outer ring of T4 (5’-monodeiodination or 
outer-ring deiodination, ORD). Monodeiodination of the inner ring (5-
monodeiodination or inner-ring deiodination, IRD) can also take place giving rise to 
3,3’,5’-T3 (reverse T3 or rT3). Although, rT3 has no biological activity this alternative 
pathway allows control of peripheral hormone levels by converting excess T4 into non-
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active rT3 which can be further deiodinated to T2, T1 and thyronine (T0). Elevated 
plasma T3 levels can also reduce 5’-monodeiodination activity (MacLatchy, 1993; 
Scott-Thomas et al., 1992) suggesting an autoregulation of T3 production. This dual 
control mechanism allows independent regulation of the prohormone T4 and of the 
biologically active T3 blood levels (Leatherland, 1993). Deiodination is carried out by a 
family of selenoprotein enzymes, the deiodinases. At least three different deiodinases 
are known in homeotherms, type I (DI), type II (DII) and type III (DIII) (Berry et al., 
1991; Croteau et al., 1996; Croteau et al., 1995), which vary in tissue location, substrate 
preference and affinity (fig. 4B). DI, which can deiodinate both inner and outer ring is 
commonly found in the liver, kidney, muscle, pituitary and thyroid gland. DII can only 
deiodinate the outer ring and being the major activating enzyme. It is mostly present in 
the brain but also in the testis, thyroid, muscle, heart and pituitary. DIII can only 
deoidinate catalyze inner ring deoidination being the major inactivating enzyme. It is 
found in the brain and skin and also the placenta and fetal tissue.  
 
 
 
 
 
 
 
 
 
 
 
Figure 4. A- Structure of L-thyroxine indicating the main pathways of metabolism. Deiodination of T4 
occurs through removal of one iodide unit form the inner (left) or outer (right) ring of the molecule. B- 
Representation of the main deiodination pathways: Outer-ring deiodination (ORD,       ) and inner-ring 
deiodination (IRD,     ). Active T3 is formed from T4 outer ring deiodination (T4ORD) through the action 
of deiodinases DI or DII. Inner-ring deiodination of T4 (T4IRD) by DI or DIII results in the formation of 
the inactive reverse T3 (rT3). T3 itself can be degraded by removal of one of a inner (T3IRD) by DI or DIII 
or outer-ring iodine (T3ORD) by DI or DII originating the presumed inactive 3, 3’-T2. Adapted from 
Brown et al (2004). 
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These enzymes act as a complex and coordinated system which enables hormonal 
activation or inactivation\degradation to playing an important role in modulating TH 
levels in specific tissues and overall THs homeostasis and economy. 
 
1.3.4 Thyroid axis in fish 
In higher vertebrates THs have a widespread and diverse action and are essential from 
early stages of life. Since in lower vertebrates the best known feature of THs is its 
crucial role in amphibian metamorphosis (Shi et al., 1996), THs are expected to greatly 
influence embryonic and larval stages of development. In fact, due to its pluripotent 
action, fish thyroid systems inevitably attract the interest of many fields like fish 
physiology, biochemistry or aquaculture. The TH axis has also become of considerable 
concern in environmental toxicology as a number of toxic chemicals may strongly 
interfere with normal thyroid function, mostly due to their structural resemblance to 
THs. Throughout the past two decades knowledge about the role of THs in fish has 
improved and reports mostly relate to their role in regulation of development, growth 
and aspects of reproduction (for review see Leatherland, 1994; Power et al., 2001; 
Yamano, 2005) while regulation of basal metabolism, so evident in endotherms, is not 
so well documented in teleosts. 
The existence of a thyroid gland in mammals has been accepted for thousands of years 
but the recognition of a comparable tissue in fishes only occurred in the mid-late 19th 
century (Maurer, 1886; Simon, 1844). Unlike tetrapods, which possess a single discrete 
gland, in fish, thyroid follicles may not be encapsulated by connective tissue. Most 
orders of teleost fish lack a “glandular” structure and instead thyroid follicles are found 
scattered throughout the connective tissue of the lower jaw (pharyngeal region) usually 
aggregated around the ventral aorta (Bentley, 1998; Leatherland, 1994). The essential 
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components making up the thyroid axis have, however, been largely conserved across 
vertebrates as has the basic structure and function of fish thyroid tissue. Nevertheless, 
many aspects of the teleost thyroid axis certainly meet fish physiological adaptations 
with particular mechanisms of action, some of which are still not completely clarified.  
The basic steps involved in fish thyroid function from TH biosynthesis to TH action 
seem to fit the current model. TSH stimulates secretion from the thyroid which secretes 
mainly T4 which is converted in the periphery to T3 by deiodination. TH transport to 
target cells involves carrier proteins and T3 is the active TH form that predominantly 
binds TRs.  
TH biosynthesis depends on an adequate supply of iodide and fish have the capacity to 
take up iodide from water across the extensive gill surface (Hunn and Fromm, 1966). In 
teleosts an adequate plasma iodide level is partly determined by dietary and branchial 
uptake suggesting different strategies in iodide economy. Owing to the greater iodide 
availability teleosts may have less efficient mechanisms of recovery and retention of 
hormonal iodide than homeotherms. TH biosynthesis, thyroglobulin properties and 
intrathyroidal secretion have received limited attention in teleosts. The few studies 
which exist report that negligible amounts of T3 (Eales and Brown, 1993) are 
synthesized or secreted by thyrocytes in teleost species. Although the TH biosynthesis 
in fish is assumed to fit the mammalian model there are still many gaps in knowledge to 
be filled. Regulation of thyroid function seems to occur through the hypothalamus-
pituitary-thyroid axis, although the identities of the hypothalamic substances 
influencing teleost thyrotropes are still not known. However, in contrasts to the situation 
in mammals, T3 does not appear to influence the activity of the teleost hypothalamus-
pituitary-thyroid axis (Eales and Brown, 1993). This fact suggests a loose linkage 
between the control of T4 and T3 metabolism pointing to fundamental differences in 
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control of thyroid status in teleosts. In contrast to mammals, where plasma T4 largely 
exceeds T3 levels (50-100:1), plasma T3 levels in teleosts may exceed that of T4, 
suggesting a strong 5’-monodeiodination activity (T4-ORD) and peripheral deiodination 
seems to be the primary control of teleost thyroid function (Eales and Brown, 1993; 
Power et al., 2001). It is the regulated conversion of T4 to T3 in tissues which may 
largely determine the T4 secretion rate from the thyroid. In homeotherms primary 
control of T4 and T3 is largely central through the hypothalamic-pituitary axis. As THs 
are involved in regulation of basal metabolism rates in homeotherms, this mechanism 
may have arisen as an advantageous adaptation leading to central control by the 
hypothalamus, the brain centre associated with thermoregulation. 
TH degradation seems to occur mainly through deiodination pathways (Eales and 
Brown, 1993) but oxidative deamination and decarboxylation also take place. The liver 
is the pivotal organ in T4 metabolism and is mainly involved in deiodination and it is the 
site where TH conjugation and biliary excretion also occur (Power et al., 2001). T3 is 
mainly degraded by T3 IRD in brain, liver and possibly other tissues (Eales et al., 
1993b; MacLatchy, 1993). Excretion of TH metabolites was found to occur through the 
urine and the bile (Eales et al., 1971; Sinclair and Eales, 1972) and other possible routes 
may be gills, gut or skin.  
As in mammals three deiodinase isotypes are expressed in piscine species including 
agnathans, chondrichthyes and teleosts (Orozco and Valverde-R, 2005). Fish 
deiodinases share properties with their corresponding counterparts in higher vertebrates. 
However in fish, these enzymes exhibit distinct features and their physiological role in 
functions regulated by THs is not completely clear. 
Putative nuclear T3-binding receptors have been described in teleosts in a number of 
different tissues (e.g., liver, gills, brain, kidney, pituitary and ovary) (Eales and Brown, 
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1993; Power et al., 2001). Only relatively recently, cloning and characterisation of TRs 
in fish was carried out (Power et al., 2001; Yamano et al., 1994; Yamano and Inui, 
1995)  and revealed two principal receptor types, TRα and TRβ. The properties, binding 
profile and molecular structure of such receptors closely resemble those described in 
high vertebrates. Therefore they can also be expected to function as transcription factors 
probably binding similar response elements (Power et al., 2001). 
In common with mammals, in teleosts more than 99% of THs do not circulate in the 
free form (Eales and Shostak, 1985; Weirich et al., 1987) but are covalently bound to 
plasma proteins (Falkner and Eales, 1973) including lipoproteins (Babin, 1992). In fish 
thyroid hormone transport by plasma proteins is poorly explored but evidence points to 
a different general profile. Only two of the three thyroid hormone binding proteins 
(THBP) present in the blood of larger mammals have been found, albumin (Richardson 
et al., 1994) and transthyretin (TTR) (Kawakami et al., 2006; Santos and Power, 1999; 
Yamauchi et al., 1999). The latter protein appears to be the main TH carrier in fish and 
shows a great ability to bind T3 (Morgado et al., 2006; Yamauchi et al., 1999) unlike 
mammalian TTR which
 
preferentially binds T4 (Chang et al., 1999). The biological 
significance and adaptive advantage of this transport system is largely unexplored in 
fish or even in higher vertebrates. As THBP is a major issue of the present work this 
matter will be further developed in the following section.  
 
1.3.5 Thyroid Hormones Binding Proteins (THBP) 
THs exert their action at a cellular level to bring about important physiological 
processes and therefore the delivery of THs from their site of synthesis to their site of 
action (target tissues) is a crucial process in vertebrates. Plasma is the immediate major 
compartment into which the thyroid secretes THs (mostly T4) and the ultimate source of 
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THs for all target tissues. As previously mentioned, in vertebrate’s less than 1% of THs 
are present in blood as the free form (physiologically active fraction) as the majority is 
bound to THBP. These proteins are synthesized by the liver and secreted into the 
bloodstream where they bind and transport THs. In the serum of larger mammals, the 
major THBPs are thyroxine-binding globulin (TBG), Albumin (ALB) and Transthyretin 
(prealbumin,TTR) (Larsson et al., 1985). In humans, serum albumin is present at 
approximately 100-fold the molar concentration of TTR and 2000 fold that of TBG. 
Although present in much lower concentration, TBG shows the highest affinity for THs 
(50 fold higher than TTR and 7000 fold higher than ALB) and carries about 75% of all 
plasma T4 while TTR and ALB transport 20% and 5% respectively. Table 1 shows the 
main characteristics of these three THBPs. TBG is a 54KDa acidic glycoprotein 
(apparent molecular weight 60KDa in SDS-PAGE) which in addition to binding T4 also 
binds T3 but with slightly less affinity. It was first recognised as a major THBP in 1952 
(Robbins, 1992) and its primary structure deduced in 1989 (Flink et al., 1986). The 
mature molecule without the 20 amino acids signal peptide is composed of 395 residues 
(44KDa) and four heterosaccharide groups. It has a single iodothyronine binding site 
and loses affinity for THs above 55ºC although association with T4 increases its 
stability. Alteration of TBG synthesis or degradation processes leads to acquired TBG 
abnormalities (Refetoff et al., 1976). Human serum albumin (HSA) is a 66.5 KDa 
protein composed of 585 amino acids with no carbohydrates and forming three main 
domains. It is the main protein present in serum where it constitutes half of the total 
protein content. Albumin binds a wide variety of molecules (hormones, drugs, etc.) and 
thus the association with THs can be considered as non-specific. In spite of containing 
several iodothyronine binding sites only one has higher affinity for THs but even so it is 
considerably lower than TH binding to TBG and for the reason the contribution of 
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albumin to TH transport is relatively minor. TTR is an unglycosylated 55 KDa tetramer 
which is highly acidic. Despite being present in serum at much higher levels than TBG 
it plays a lesser role in TH transport and only 0.5 % of circulating TTR is occupied by 
T4. Its normal concentration in serum (250 mg/l) corresponds to a maximal binding 
capacity of approximately 300 µg T4/dl. TTR also binds a great variety of non-
iodothyronine ligands like for example salicylates, penicillin or flavonoid compounds 
which shown particularly high affinity for the protein. TTR will be characterized in 
detail in section 1.4 where its features, functions and structural/functional evolution are 
described. 
Although the biological advantage of transporting a high percentage of hormone in a 
bound, non-active form has not been extensively explored, the existing evidence 
suggests it has several important functions. THBPs are probably responsible for the 
maintenance of a large extrathyroidal thyroid hormone pool counteracting permeation of 
strongly lipophilic hormones into cells (Ekins et al., 1982; Mendel, 1989; Mendel and 
Weisiger, 1990; Mendel et al., 1987). The latter effect allows an even distribution of 
hormones to tissues and safeguards the body from the effects of abrupt fluctuations in 
hormone secretion. THBP can also serve as an additional protection against iodine 
wastage by imparting macromolecular properties to small iodothyronine molecules 
limiting their urinary loss (Chan et al., 1972). Furthermore, THBP may promote 
hormone cellular uptake by interaction with cell membranes and prevent the undue loss 
of hormones through metabolism and excretion (they prevent glomerular filtration due 
to the large size of the hormone-protein complex).  
The relative abundance and hormone binding properties of THBPs are not conserved in 
vertebrates. In a series of studies, reviewed by Richardson (2002), serum samples from 
individuals representative of different vertebrate classes (mammals, birds, reptiles, 
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amphibians and also fish (Richardson et al., 2005)) were analysed for the presence of 
THBPs. Albumin was the only THBP present in all species studied, suggesting it may 
be the evolutionarily oldest TH carrier protein. In addition to albumin, TTR was also 
present in the blood of several homeotherms (birds and eutherian mammals), a 
condition controlled by THs. The simultaneous presence of the three THBPs seems to 
occur only in some eutherian species where TBG was also found in addition to TTR and 
albumin. The same studies suggest an apparent absence of TTR in the plasma of adult 
amphibians, reptiles and fishes, however its presence is well established for the early 
stages of development (Funkenstein et al., 1999; Kawakami et al., 2006; Richardson et 
al., 2005; Santos and Power, 1999; Yamauchi et al., 1993; Yamauchi et al., 1999; 
Yamauchi et al., 1998) which are characterised by surging TH blood levels (Hulbert, 
2000). The previous findings strongly suggest a straight relationship may exist between 
the increase in THBP distribution capacity and TH requirements. Such capacity, which 
obviously increased during the evolution of vertebrates, could be related with the 
developmentally regulated expression of a gene coding for a new THBP with higher 
affinity than those already present in blood (Richardson et al., 2005). The presence of 
three THBP with different T3 and T4 binding capacities may result in a very robust 
buffering system enabling a highly effective homeostatic control of free hormone levels. 
This could also offer some explanation to observations that THBP are not essential for 
normal thyroid function and questions about their adaptive value. Clinical studies in 
humans show that wide fluctuations in THBP concentrations or its complete absence do 
not alter the hormonal economy or metabolic status of the subject (Lissitzky, 1990; 
Refetoff, 1989). Mutations that lead to the absence of albumin in humans (Kallee and 
Ott, 1992) and rats (Mendel et al., 1989) or TTR in mice (Palha et al., 1994) are 
associated with normal phenotypes and the organisms remain eutheroid (with normal 
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TH levels). These findings are highly suggestive that the THBP system may involve 
several functionally redundant components. However, the adaptive advantage acquired 
throughout evolution could rely on such redundancy. One deficient component of the 
system could be compensated by the others: under conditions of TH stress a buffering 
system with three carrier proteins would provide a strong selection advantage over a 
single protein system (Richardson, 2002; Schreiber, 2002a).  
The efficiency of the hormone transport and delivery system is certainly crucial for 
thyroid hormone-dependent processes to take place. Nevertheless, many aspects of the 
activity of such physiologically important TH transporters and mechanisms by which 
they regulate TH bioavailability remain unclear and call for further investigation.  
 
Table 1. Properties and metabolic parameters of the three main THBPs in human serum.  
From  http://www.thyroidmanager.org/Chapter3/3a-frame.htm.  
 
 
 
TBG TTR ALB 
Molecular weight (KDa)  54* 55 66.5 
Structure  Monomer Tetramer  Monomer 
Isoelectric point (pH)  4.2-4.6 5.35 4.7-5.2 
Number of binding sites 
for T4 and T3 
 
 
1 2 Several 
T4 1x1010 
 
2x108 
 
1.5x106 
 Association constant  
         Ka (M-1) 
T3 1x109 
 
1x106 
 
2x105 
 
Concentration in serum 
(mean normal,mg/l) 
 16 250 40 000 
T4 75 20 5 Relative distribution of T4 
and T3 in serum (%)  T3 75 <5 20 
In-Vivo Survival Half-life 
(days) 
 5 2 15 
Degradation rate (mg/day) 
 
16 650 17000 
  * Apparent molecular weight by SDS-PAGE is 60KDa 
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1.4 Transthyretin (TTR) 
 
Transthyretin was identified for the first time in 1942 in human serum and cerebrospinal 
fluid (Kabat and Moore, 1942; Kabat et al., 1942; Seibert and Nelson, 1942) and was 
originally called prealbumin due to its greater electrophoretic mobility at pH 8.6 than 
albumin. In 1958, TTR was first recognized to bind thyroxine (Ingbar, 1958) and 
designated thyroxine-binding prealbumin (TBPA). Determination of the primary 
structure by Goodman et al in 1974 (Kanda et al., 1974), led to proposal of a new name 
transthyretin (TTR) which was adopted in 1981 (Robbins, 1976) and reflects its ability 
to transport thyroid hormones and retinol.  
TTR research has developed over several decades and has been reviewed by different 
authors (Benson and Uemichi, 1996; Schreiber, 2001; Power et al., 2000a; Schreiber, 
2002a; Schreiber and Richardson, 1997). In common with most plasma proteins TTR is 
synthesized and secreted by the liver (Dickson et al., 1982) and released into the blood 
stream. It is produced as a single polypeptide chain and folds into a globular protein 
being is present in plasma as a tetramer of four identical monomers (Blake et al., 1971; 
Gonzalez and Offord, 1971; Rask et al., 1971) that bind and transport THs. TTR’s role 
as one of the THBP in the plasma is probably its best characterised function and the 
biological meaning of the transport network to which it belongs has been discussed in 
section 1.3.5. However, a number of other characteristics for this protein have also been 
observed and are now considered.  
 
1.4.1 RBP transport 
Another major function attributed to TTR is its ability to bind retinol-binding protein 
(RBP), the 21 KDa specific carrier of all-trans retinol (Blaner, 1989; Goodman, 1984) 
from liver storage sites to target cells and is important in vision and bone growth. The 
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presence of retinol bound to RBP is essential for the formation of a stable complex with 
TTR and crystallographic studies have established that two RBP molecules can bind 
one TTR tetramer (Monaco et al., 1995) and do not interfere with TH binding (van 
Jaarsveld et al., 1973). In mammals holo-RBP (retinol-RBP complex unbound to TTR) 
circulates almost entirely bound to TTR. It has been proposed that this binding serves to 
prevent filtration of the relatively small RBP molecule through kidney glomeruli (Kanai 
et al., 1968; Peterson, 1971). In TTR null mice the levels of plasma RBP and retinol 
were found to decrease (Episkopou et al., 1993). Surprisingly though, the mice 
remained healthy showing normal retinol levels in tissues, their embryos develop 
normally and relatively little RBP was detected in their urine (Wei et al., 1995). In light 
of these findings, the current understanding of retinol transport is not complete and the 
participation of TTR in it still requires clarification. Previous studies regarding the 
evolutionary onset of TTR synthesis suggested it may not be absolutely required for 
retinol transport (Richardson et al., 1994; Schreiber and Richardson, 1997). Moreover, 
RBP is known to be present in the blood of fish but it could only be isolated in the 
uncomplexed form (Berni et al., 1992; Shidoji and Muto, 1977). Although piscine holo-
RBP shows binding ability to human TTR it displays an extremely low or inexistent 
affinity to piscine TTR (Folli et al., 2003). Structural studies show a high degree of 
conservation in TTR’s TH binding sites but in contrast a few amino acid differences 
may be responsible for an apparent lack of TTR-RBP binding in fish. This suggests 
conservation of TTR-TH binding in all vertebrates whereas TTR-RBP binding ability 
may have been acquired later in evolution. 
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1.4.2 TTR as a stress and nutritional marker 
In mammals TTR is produced by the liver and is a typical negative acute phase protein 
as its levels strongly decrease in response to injury. The liver plays a crucial role in the 
adaptive alterations accompanying any stressful condition and is extremely sensitive to 
nutritional insults. In malnutrition TTR and also ALB and TBG are significantly 
reduced due to depressed liver synthesis (Ingenbleek, 1985). Moreover, TTR and RBP 
are the first plasma proteins to decline in parallel as a result of early nutritional 
deprivation (Ingenbleek, 1985; Ingenbleek et al., 1975). According to the free hormone 
theory ((Mendel, 1989; Robbins and Rall, 1960), see section 1.3.3) the suppression of 
TTR and RBP synthesis releases increased amounts of free ligands readily available to 
target cells. This negative acute phase feature of TTR is commonly used by clinicians to 
monitor the nutritional status of their patients. In fact TTR has been extensively 
characterised as a marker of malnutrition or stress (Brugler et al., 2002; Ingenbleek and 
Bernstein, 1999; Ingenbleek et al., 1972; Ingenbleek and Young, 1994; Ingenbleek and 
Young, 2002). Food restriction in fish has also been found to cause a dramatic reduction 
in TTR transcripts (Power et al., 2000b) as previously observed in rats (de Jong and 
Schreiber, 1987; Le Moullac et al., 1992). However, it is still not resolved if down-
regulation of TTR in liver is directly caused by malnutrition or is also a consequence of 
reduced TH levels in plasma. The factors behind regulation of TTR production are still 
unclear but it seems likely that in common with other hormonal homeostatic processes 
the concentration of THs have a role, although studies are still required to clarify this 
matter.   
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1.4.3 TTR synthesis in the choroid  plexus 
In addition to being produced in the liver, high levels of TTR expression have also been 
reported in the choroid plexus (Dickson et al., 1985; Soprano et al., 1985), where 
cerebrospinal fluid (CSF) is produced. In fact, evidence shows that abundance of both 
chicken and rat TTR transcripts in the choroids plexus are far higher than that in the 
liver (Duan et al., 1991; Schreiber et al., 1990). TTR is the most abundant of all proteins 
(Dickson et al., 1986) synthesized by the choroids plexus and it is secreted exclusively 
towards the brain (Schreiber et al., 1990) and is the only THBP produced in the brain 
(Schreiber and Richardson, 1997; Schreiber et al., 2001) .  
Most of the cerebrospinal fluid surrounding the brain is produced in the choroid plexus 
(Cserr, 1971) and its epithelial cells, where TTR is synthesized, constitute the blood-
cerebrospinal fluid barrier. The functional significance of TTR in the brain is probably 
related to its TH binding capacity and it is proposed to be the brain THBP responsible 
for hormone distribution (Dickson et al., 1987a; Schreiber et al., 1990). A model for 
TTR and T4 distribution within the blood-brain barrier was proposed by Southwell et al 
(1993). In contrast to the situation in the liver, TTR synthesis in the choroid plexus is 
constitutive and does not change during the acute phase response which also suggests 
different regulatory and functional requirements for TTR produced in the brain and in 
the rest of the body (Dickson et al., 1986).  
 
1.4.4 Molecular Structure  
Human TTR is a 55KDa homotetramer composed of four identical subunits, each 
containing 127 amino acids. The overall shape of the tetramer forms a narrow central 
channel which buries two identical thyroid hormone binding sites (Blake et al., 1974). 
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However, under physiological conditions only one of the binding sites is filled at one 
time due to negative cooperative effect of hormone binding (Neumann et al., 2001). 
The three-dimensional structure of human TTR (fig. 5) was determined by X-ray 
crystallography (Blake, et al., 1978; 1974) at 2.5 Å resolution and has subsequently 
been refined by other authors (Hamilton et al., 1993; Hornberg et al., 2000; Wojtczak et 
al., 1992). In the first models the N-terminal region of the monomers could not be 
resolved but in 1993, in the structural model conceived by Hamilton et al. the first 10 N-
terminal amino acids were observed as curve structures placed near the opening of the 
central thyroid hormone binding channel.  
Presently, TTR X-ray structures from several mutant variants of human TTR (for 
review see Hornberg et al., 2000) and also from chicken, rat and fish are also available 
(Eneqvist et al., 2004; Folli et al., 2003; Sunde et al., 1996; Wojtczak, 1997). The 
models show little variation between structures pointing to an overall conservation of 
TTR three-dimensional structure during vertebrate evolution. X-ray diffraction indicates 
that the dominant secondary structure is the β-sheet. Each monomer (A, B, C and D) has 
two 4-stranded β-sheets and a short α-helix. Anti-parallel β-sheet interactions link 
monomers into dimers and a short loop from each monomer forms the main dimer-
dimer interaction resulting in the formation of the central hydrophobic channel (fig. 5). 
The two TH binding sites situated between monomers A, C and B, D can be divided 
into three symmetry-related pairs of halogen binding pockets (HBP) comprised of an 
inner and outer cavity: HBP1 (HBP1’), HBP2 (HBP2’), HBP3 (HBP3’). The main 
difference between species is the lack of α-helix structures in the chicken TTR subunits. 
The TH binding site seems to be highly conserved with only one amino acid 
substitution in the sea bream sequence (Ser117 in the human sequence is substituted by 
a Thr). However, studies carried out by Eneqvist, et al (2004) point to differences in the 
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shape of the binding channel between sea bream and human TTR. In sea bream TTR the 
channel is wider at its entrance and has a narrower inner and outer cavity. Homology 
models based on the known X-ray crystal structure coordinates have been constructed 
for Lizard (Achen et al., 1993) and bullfrog (Yamauchi et al., 1998) TTRs and also for 
fish TTR (Power et al., 2000a) and subsequently X-ray crystallography was carried out. 
These models showed little variation from the known TTR structures. Despite the high 
conservation of the structures, comparisons of the electrostatic properties between the 
piscine homology model and X-ray structures from chicken, human and rat revealed 
that the surface potential, particularly in the TH binding site is noticeable more negative 
in chicken and even more-so in the sea bream structure than in human or rat (Power et 
al., 2000a). 
 
 
 
 
 
 
 
 
 
Figure. 5. Diagram of human tetrameric TTR crystal structure with each monomer colored differently 
(subunit A, yellow; subunit B, red; subunit C, green; subunit D, blue). TTR structure is predominantly β-
sheet; each monomer has a two 4-stranded β-sheets and a short α-helix. A short loop from each monomer 
forms the main dimer-dimer interaction resulting in the formation of the tetramer. Left panel represents a 
view (perpendicular to the binding site, Z-axis) of the co-crystal structure of TTR in complex with T4 
(shown in stick representation) showing the two TH binding sites. Right panel presents a view (down the 
Z-axis) rotated by 90° about the Y-axis (relative to the view on left) to display the central channel where 
TH and other ligands bind. Original diagrams taken from Johnson et al. (2005). 
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1.4.5 Genomic structure and transcriptional regulation 
The genomic structures of TTR have been described for human (Sakaki et al., 1989) rat 
(Fung et al., 1988) and mouse (Costa et al., 1986). Human TTR is encoded by a single 
copy gene located on human chromosome region 18q11.2-q12.1 (Sparkes et al., 1987). 
The gene spans 6.9 Kb with 4 exons, 3 introns and a TATA box like sequence and 
binding sites for HNF-1, 3 and 4 are located within 150bp from the transcription start 
site (Sasaki et al., 1985; Tsuzuki et al., 1985). The first exon codes for the 5’ 
untranslated region, the 18 amino acid signal peptide and the first 3 residues of the 
mature protein. The second exon encodes residues 4-47 whilst exons 3 and 4 code for 
residues 47-92 and 93-127, respectively. A similar TTR gene organisation is found in 
both rat and mouse genomes.  
TTR gene expression in the liver is under typical negative acute phase regulation. An 
extremely well conserved DNA-segment (CTGGGAA) in the 5’-flanking region (Fung 
et al., 1988) of the gene is thought to be important for such response during 
inflammation and trauma which causes TTR mRNA in liver to decrease dramatically. 
Further regulatory elements can be found at least 2000 bp upstream the gene that may 
be involved in regulation of expression via cis and trans-acting factors (Costa et al., 
1989; Yan et al., 1990).  
In contrast to the liver, in choroids plexus TTR gene expression does not respond to 
inflammation or trauma (Dickson et al., 1986; Dickson et al., 1987b). Thyroid hormone 
status also doesn’t seem to influence TTR expression levels in the choroid plexus (Blay 
et al., 1993). Very little is known about the regulatory mechanisms of TTR gene 
expression in that region of the brain. In fish and amphibians where TTR expression 
seems to be mainly restricted to the liver, the genomic organisation has not yet been 
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determined. Its clarification would provide an important means for identification of 5’ 
regions important for regulation of TTR expression in the brain. 
 
1.4.6 TTR Evolution 
Over the last two decades TTR synthesis and gene expression has been studied in many 
species. Also, the amino acid sequence of TTRs from different species has been 
determined directly or derived indirectly from the DNA sequence (see fig. 6). These 
findings have been important in defining changes in TTR which accompanied evolution 
of vertebrates. The changes identified encompass a number of different aspects such as, 
tissue expression patterns, TTR gene structure and TH binding properties. 
 
1.4.6.1 Evolution of TTR gene expression 
TTR has been identified in a large number of vertebrates, including eutherian mammals, 
marsupial mammals, birds, reptiles, amphibia and fish. As in humans, TTR gene 
expression in other eutherian mammals, marsupials and birds (for review see Power et 
al., 2000a; Schreiber, 2002a; Schreiber and Richardson, 1997) is mainly restricted to 
liver and choroids plexus. However, TTR synthesis was also found in the retina of 
cattle, rats and sheep, in lower levels in rat and human pancreas visceral yolk sack 
during fetal rat development and in developing chicken heart (for review see Power et 
al., 2000a; Schreiber et al., 2001). The ontogeny, tissue specific expression and function 
of TTR during development is poorly described. In reptiles TTR was found to be 
strongly expressed in the choroids plexus of lizards, turtles and young crocodiles but not 
at all in their livers (Achen et al., 1993; Schreiber, 2002a). In amphibians TTR mRNA 
was observed in the liver of premetamorphic tadpoles of frog (Rana catesbiana) and 
African clawed frog (Xenopus laevis) but no traces of TTR expression were detected in 
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the choroids plexus. Instead, lipocalin, a protein known to bind small hydrophobic 
ligands was found to be the main protein synthesized in that region of the brain (Achen 
et al., 1993; Yamauchi et al., 1998). In fish although small amounts of TTR mRNA 
were present in other tissues than liver (Funkenstein et al., 1999; Manzon et al., 2007; 
Power et al., 2000a; Santos and Power, 1999) synthesis in the choroid plexus was not 
found.  
The evidence so far available appear to suggest that TTR expression in the choroid 
plexus first arose at the stage of stem reptiles but expression in the liver probably 
appeared in or prior to ancient fish. It has been hypothesised that the expression and 
synthesis of TTR in the choroid plexus of reptilians may be associated with the 
appearance of a neocortex (Kent, 1987). This idea has been further developed 
(Schreiber, 2002b) and the rapid increase in brain relative to body size and complexity 
during evolution has been proposed to exert a selection pressure for the appearance of 
TTR synthesis in the choroid plexus. As the blood-brain barrier restricts the access of 
THBP to the brain, a THBP produced within the brain would ensure an efficient 
distribution of THs essential for brain development and differentiation.  
A number of hypotheses have been proposed for the onset of TTR synthesis in the liver 
(Richardson, 2002) and the consequent provision of an additional THBP in blood 
plasma. A first theory proposes that the selection pressure for hepatic TTR production 
was the increase in size of internal organs and consequently larger lipid pools. The 
appearance of a THBP with higher affinity for THs than albumin would help counteract 
their partitioning into tissues. Another hypothesis relates the evolution of TTR 
expression in the liver with homeothermy as THs are strongly involved with control of 
basal metabolic rate. This theory is supported by the production of TTR in the liver of 
birds, diprotodont marsupials and eutherians which are better homeotherms than 
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polyprotodont marsupials, monotremes, reptiles, amphibians and fish in which the 
capacity to synthesize hepatic TTR in adults has not been demonstrated (Richardson, 
2002; Richardson et al., 2005). In both fish and amphibians TTR hepatic synthesis is 
proposed to be developmentally regulated and a consequence of the characteristic 
upsurge of TH levels in the blood during early development stages. However, recent 
studies in fish clearly demonstrate transcripts of TTR in adult fish liver (Power et al., 
2000a), countering the “homeothermy” proposal. 
 
1.4.6.2 Evolution of TTR binding properties 
In addition to evolution of differential tissue expression of TTR a change in TTR 
binding affinity to T3 and T4 appears to have occurred during evolution. Such binding 
affinities have been measured for a number of different vertebrate species (Chang et al., 
1999; Prapunpoj et al., 2002; Prapunpoj et al., 2000) revealing that in birds, reptiles and 
amphibians TTR seem to bind more strongly to T3 than T4 in contrast to the situation in 
mammals (see Table 2 for Kd values). These observations might suggest that during 
vertebrate evolution there was a change in TTR function from a T3 transporter to a T4 
transporter. Also in fish few reports exist of TTR binding to both T3 and T4 but showing 
higher affinity for T3 (Kawakami et al., 2006; Santos and Power, 1999; Yamauchi et al., 
1999). The hormone binding affinity of piscine TTR is explored in chapter 3 of the 
present thesis and is a key goal of the present work (see chapter 3).  
The implications of the changes in TH binding properties of TTR during vertebrate 
evolution are unclear but may be related to differences in TH balance and metabolism. 
For example, in fish there are several reports of higher blood levels of T3 than T4 
(Bjornsson et al., 1998; Eales and Shostak, 1987; Pavlidis et al., 1997; Power et al., 
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2000b) in contrast to the situation in mammals where T4 is more abundant than T3 
(McNabb, 1992). 
 
Table 2. Dissociation constants (Kd values) for TTR-TH binding from several species 
representatives of different vertebrates groups. Table source: Schreiber (2002b) and original values 
compiled from Chang et al. (1999), Prapunpoj et al. (2002; 2000).  TTR from eutherians, marsupials 
and birds were purified from serum while crocodile and xenopus TTRs were produced by 
recombinant methods in the yeast Pichi pastories.  
 
 
Source of TTR Kd T3 (nM) Kd T4 (nM) Kd T3/ Kd T4 
Eutherians    
    Humans 56.6 13.6 4.2 
    Sheep 63.5 11.3 3.2 
    Rats 67.2 8.0 8.4 
Marsupials    
    Wombat 97.8 21.8            4.5 
    Possum        206.1 15.9          12.9 
    Wallaby 65.3 13.8            4.7 
Birds    
    Emu 18.9 37.4 0.51 
    Chicken 12.3 28.8 0.43 
    Pigeon 16.1 25.3 0.64 
Reptiles    
    Saltwater crocodile          7.56 36.7 0.21 
Amphibians    
    Xenopus laevis          248       508 0.49 
 
This leads to the question of the evolution of T4 as a pro-hormone in mammals and the 
associated evolution of deiodinases in TH target cells. The generation of T3 from T4 by 
deiodinase activity allows tissues specific regulation of TH action. Evolution of TTR 
expression and TH preferences may be correlated to the evolution of deiodinases and 
may represent an adaptation to the special needs in each species. Of particular interest is 
the brain-specific 5’-deiodinase (Type II deiodinase) in mammals which converts T4 
into T3. A similar enzyme is present in other tissues but not in the brain of fish, 
amphibians or reptiles (for review see Schreiber, 2002b) and it has been suggested 
(Schreiber, 2002b) that the emergence of an efficient brain-specific deiodinase in 
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mammals could be related to the increase in TTR T4 affinity. In fact, in mammals TTR 
only transports T4 but not T3 into the brain through the blood-cerebrospinal fluid barrier 
(Dickson et al., 1987a). The presence in birds and reptiles of TTR which preferentially 
binds T3 suggests it may be the main hormone transported into the brain and may 
explain the absence of a type II deiodinase. The development in mammals of a brain-
specific deiodinase system would provide an important adaptive advantage for control 
of cerebral TH homeostasis responding to the increase in relative brain size during 
evolution (Schreiber, 2002b; Schreiber et al., 2001). 
 
1.4.6.3 Evolution of TTR structure 
TTR genes have been cloned and sequenced in vertebrates from fish to mammals and in 
all cases only a single mRNA transcript has been found.  The general cDNA structure 
consists of a 5’untranslated region (14-30 nucleotides), a coding region (127-130 amino 
acids) and a 3’untranslated region  (115-181 nucleotides) preceding the poly(A) tail.  
As the primary structures of TTR from different species became available attempts have 
been made to understand the relationship between structure, function and evolution. The 
determination of the three-dimensional structure of TTR tetramer allowed the 
establishment of correlations between the monomers polypeptide chain with their 
position on the tetrameric molecule leading to several conclusions. High primary 
structure homology is found at the interfaces of the subunits and the surface of the 
molecule seems to be less conserved than the interior region. The length of the mature 
monomer polypeptide chain varies from 127 amino acid residues in human TTR to 130 
in teleost fish and 136 in agnatha fish (lamprey) (see fig. 6) and comparison between the 
sequences reveals 36 to 85% sequences identities (Manzon et al., 2007; Power et al., 
2000a). TTR sequence in fish share the lowest identities and between teleost and 
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agnatha only 47% identity is found. However, there is an intriguingly high percentage 
amino acids identity throughout the polypeptide chain within classes and in fact  
 
 
 
Figure 6. Multiple sequence alignment of TTR monomer amino acid sequence from representative 
species of all vertebrate groups with the following accession numbers: Homo sapiens, AAA73473; Pan 
troglodytes, Q5U7I5; Macaca fascicularis, Q8HXW1; Mus musculus, P07309; Rattus norvegicus, 
P02767; Sus scrofa, P50390; Ovis aries, P12303; Bos taurus, O46375; Sorex araneus, O46654; 
Macropus giganteus, Q29616; Macropus eugenii, P42204; Petaurus breviceps, P49142; Sminthopsis 
macroura, P49143; Monodelphis domestica, P49141; Trachydosaurus rugosus, P30623; Gallus gallus, 
P27731; Anas platyrhynchos, ABC65926; Xenopus laevis, BAA77579; Rana catesbeiana, P31779; 
Crocodylus porosus, O55245; Sparus aurata, AAC26108; Cyprinus carpio, CAD66520; Petromyzon 
marinus, DQ855960.; Lampetra appendix, DQ855961. The first amino acid of the mature TTR subunit is 
indicated with an arrow. Residues identical to the human TTR sequence in other species are represented 
by dots and features of secondary structure of the human TTR (Blake et al., 1978) subunit are given 
above the sequences. Amino acids located in the central channel and that are thought to be involved in 
hormone binding are shaded. The region where amino acids have been lost at the 5’ end of exon 2 during 
the evolution of the TTR subunit is marked with a rectangle. Positive numbering of the amino acid 
residues denoted below the alignment refer to the mature human TTR sequence; negative numbers are 
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used to denote the signal peptide and greek letters represent the positions of residues absent in eutherians 
TTR sequence.(Manzon et al., 2007) 
  
 
between all vertebrate sequences described so far. In particular the amino acids located 
in the TH binding channel region are almost 100% identical between different species. 
This high homology points to a strong selection pressure to maintain this structure 
counteracting variability due to mutations or genetic drift between populations and also 
seems to highlight the importance of TTR as a TH carrier during evolution. 
Nevertheless, evolution-related mutation can be found in the molecule and are quite 
unevenly distributed throughout the polypeptide chain. By far, the greatest frequency of 
amino acid changes is found at the N-terminal section of the subunits. This region 
stands out by its systematic change during evolution of both length and properties. It is 
shortest in eutherians, of intermediate length in the marsupials (with two additional 
residues) and longest in birds, reptiles, amphibians and fishes with three additional 
residues: Val-Ser-His in chicken and lizard; Gly-Thr-His in frog and Asp-Lys-His in sea 
bream (see fig. 6). Very recently the cDNA structure has been determined for TTR from 
the Lamprey which has an even longer N-terminus with 9 extra amino-acids Asp-His-
Lys-Ser-His-Glu-Ser-His-Glu. The shortening of this section seems to lead to an 
increase in the hydrophilicity of its character. In the TTR gene, such loss of residues 
occurred at the border between exon1 and 2 and appears to results from a stepwise shift 
of the splice site at the 5’ end of exon 2 by a series of single base mutations converting 
codons into splice recognition sites (Aldred et al., 1997). It seems therefore that a 
sequence of small steps led to the shorter more hydrophilic N-terminal segment of the 
TTR subunit. Such an event likely fits in Darwin’s postulates of positive environmental 
adaptations (Aldred et al., 1997) in which slight functional improvements transmitted 
throughout generations give a selective advantage.  
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The functional adaptation arising from these N-terminal alterations is not completely 
clear, however, since changes in TTR binding strength to T4 follow a similar 
unidirectional way in evolution these two features have been correlated. The hypothesis 
was that changes in the N-terminus were responsible for changes in binding affinity to 
THs (Schreiber and Richardson, 1997): a longer and more hydrophobic N-termini leads 
to preference for T3 while a shorter more hydrophilic N-termini correlates to T4 binding.  
The X-ray models predicted for TTR revealed that the four N-terminal regions are 
unstructured, protrude from the tetramer and are located near the entrance of the binding 
channel that harbours the TH binding sites. It could be possible that changes in the 
hydrophobicity of this regions influence their flexibility and therefore the access of T4 
to the binding site (Chang et al., 1999). To test these hypothesis previous studies 
involving the production of recombinant chimeric TTRs were carried out. A first study 
reported changes in TH affinity when an N-terminal section of crocodile (C. porosus) 
TTR was replaced by Xenopus laevis N-terminus (Prapunpoj et al., 2002). Recently 
binding to THs was tested using a human TTR chimera with the N-terminal region of 
crocodile (C. porosus) TTR and to a truncated crocodile (C. porosus) TTR lacking the 
N-terminus (Prapunpoj et al., 2006). It was proposed that binding to THs is in fact 
influenced by the character the N-terminus. Furthermore it was suggested that this 
region could influence T4 binding preference whereas T3 affinity would be mainly 
determined by the core of the molecule although further studies are required to clarify 
this matter. The precise contribution of the molecular electrostatic potential or the 
nature of the N-terminal section to TTR binding properties remains quite unclear and 
confused. Nevertheless, the evidence so far seems to point towards a coherent 
hypothesis of evolution of a TTR with a shorter hydrophilic N-terminal, preferentially 
binding T4. This would provide an adaptive advantageous probably related to a more 
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efficient TH distribution system when integrated with the evolution of deiodinases (a 
matter previously developed in section 1.4.6.2). 
In contrast to the uneven distribution of amino acid changes related to evolutionary 
adaptations another type of TTR gene mutation can be distinguished where amino acid 
substitutions randomly occur in TTR´s polypetide chain. About 100 of such mutations 
have been described in human TTR contributing to considerable sequence 
heterogeneity. Such mutation may be non-pathogenic but most of them are implicated in 
human pathologies associated with TTR amyloid fibril formation.  
 
1.4.7 TTR amyloidosis  
In common with other proteins with a high β-structure content, TTR is implicated in 
different forms of amyloidosis. Amyloid diseases are “late-onset, degenerative disorders 
characterised by the aberrant aggregation and extracellular deposition of proteins or 
peptide fragments” (Huff et al., 2003). Amyloid plaques contain fibrillar protein 
aggregates that results from misfolding and subsequent degradation of such proteins.  
A number of human diseases are associated with this kind of processes like cystic 
fibrosis, Type II diabetes, Alzheimer’s disease, Prion diseases (e.g. Creutzfeldt-Jakob), 
etc. (for review see (Dobson, 2003; Huff et al., 2003; Kirkitadze et al., 2002). 
Transthyretin amyloidosis are the most prevalent type of hereditary systemic 
amyloidosis. This form of the disease was firstly recognized by Andrade (1952) in a 
report of atypical peripheral neuropathy in Portuguese families. The syndrome was 
named familial amyloidotic polyneuropathy (FAP) and it is mainly characterised by the 
systemic deposition of TTR amyloidogenic variants in the peripheral nervous system 
causing a progressive sensory and motor dysfunction. The disease is invariably fatal 
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about 10 years after onset unless liver transplantation is performed during early stages 
(Ando et al., 1993; de Carvalho et al., 2002).  
Since the first report of FAP many different kindreds with TTR amyloidosis have been 
identified (Benson and Uemichi, 1996). The most common clinical manifestations of 
TTR amyloidosis are familial amyloidotic polyneuroathy (FAP), senile systemic 
amyloidosis (SSA), familial amyloid cardiomyopathy (FAC) and the recently 
discovered central nervous system selective amyloidosis (CNSA) (see refs in Johnson et 
al. (2005)). SSA is an age-dependent sporadic disease resulting from misfolded of 
native TTR deposits in the heart (Westermark et al., 1990) whereas the familial diseases 
(FAP, FAC and CNSA) have been associated with tissue selective deposition 
(peripheral nervous system, visceral organs, autonomic nervous system, gastrointestinal 
tract, ocular tissues (Andrade, 1952)) of mutant TTR variants. In human TTR there has 
considerable sequence heterogeneity as a consequence of mutations resulting in single 
amino acids substitutions. There are over 100 identified TTR variants due to point 
mutations and more than 80 of them are pathogenic (for review see Benson and 
Uemichi, 1996; Connors et al., 2000; Eneqvist and Sauer-Eriksson, 2001; Sipe, 1992 
and references in Johnson et al., 2005). One of the most clinically significant and 
frequent mutations is the substitution of methionine for valine at position 30 (ATTR 
V30M). While the site mutations do not seem to significantly change the native 
structure of the protein they appear to destabilize the tetramer in favour of fibril 
formation. The mechanism of TTR disassociation, misfolding and aggregation is not 
completely clarified but it is thought that tetramer disassociation is the rate-limiting step 
to amyloid fibril formation and that this process may be accelerated under acidic 
conditions (Colon and Kelly, 1992; Hurshman et al., 2004; Lai et al., 1996; Liu et al., 
2000).  
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The current approach to prevent fibril formation mostly relies on stabilization of the 
native tetrameric conformation as a way to prevent the process of amyloidogenesis to 
commence (Hammarstrom et al., 2003; Klabunde et al., 2000; Miroy et al., 1996). In 
vitro studies have shown that binding of the natural ligand T4 stabilized the tetramer 
reducing fibril formation (Miroy et al., 1996). During the past few years effort has been 
directed to developing TTR tetramer kinetic stabilization strategies (for review see 
Johnson et al., 2005a). Such studies relate tetramer stability to the TH binding site and 
involve identification of small molecules with high affinity for this region. This also 
highlights the importance of identifying the structural and physicochemical properties 
that influence TTR stability.  
In spite of the high degree of identity between TTR sequences in vertebrates, TTR 
amyloidosis has not yet been described in non-human species. Even more intriguing is 
the fact that some of the pathogenic mutations in human TTR are normal features of the 
protein in other species. Sequence comparisons between pathogenic human TTR 
variants and other species reveal that 15 of the substituted amino acids have been 100% 
conserved in all other species with no pathogenic consequences (Power et al., 2000a). 
The high conservation of such residues suggests they might be of structural or 
functional importance. The fact that these mutations have no obvious effect in other 
species might indicate they arisen as a normal consequence of evolution. The reasons 
for these differences may be of great interest and remain unexplored. However the 
overall effect of any single amino acid mutation may depend on several structural, 
physicochemical and physiological factors that also differ between species. Thus, many 
variables would have to be taken into consideration making such analysis clearly 
complex.    
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1.4.8 TTR in fish 
The first indications of the presence of TTR in fish came from the isolation of a protein 
in salmon (Salmo salar) (Larsson et al.) in 1985 on the binding of serum proteins to 
[125I]T4. However, subsequent attempts using serum binding assays to identify TTR in 
fish failed (Richardson et al., 1994) and its existence was only definitely confirmed in 
1999 when TTR was isolated from masu salmon smolt serum (Yamauchi et al., 1999) 
and its cDNA (AAC26108) was cloned from sea bream (Sparus aurata) (Santos and 
Power, 1999). In 2003, the cDNA sequence for the common Carp (Cyprinus carpio) 
was also deposited in the sequence data bank (CAD66520) and in 2006 TTR was 
identified and its cDNA cloned from the Pacific Bluefin Tuna (Thunnus orientalis) 
(Kawakami et al., 2006). Very recently TTR was cloned and sequenced in two 
Lamprey, Petromyzon marinus (DQ855960) and Lampetra appendix (DQ855961) 
(Manzon et al., 2007). 
The best characterized piscine transthyretin is sea bream TTR and the cDNA for sbTTR 
monomer contains an open reading frame of 630 bp encoding for a 130 amino acid 
preceded by a leader peptide of 20 residues (Santos and Power, 1999). The monomer 
and tetramer molecular weight are of approximately 14KDa and 55KDa respectively, as 
predicted for other vertebrates. sbTTR amino acid sequence shares 40-55% identity and 
64-70% similarity with the sequences determined for other vertebrates (Power et al., 
2000a). The X-ray structure of sbTTR has been determined (Eneqvist et al., 2004; Folli 
et al., 2003) revealing that there is very high overall structural homology and the TH 
binding region is conserved and a single amino acid substitution exists in this region 
(Ser117 in human to Thr in sea bream). Also, like in the human model, the N-terminal 
amino acids of sbTTR monomers formed disordered structures and could not be 
modelled. X-ray models of sbTTR in complex with T3 and T4 were also generated 
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(Eneqvist et al., 2004) and indicate that T4 binds sbTTR in a similar mode to its binding 
to human TTR but the molecule doesn’t reach so deep in the binding pocket. Also T3 
seems to bind the protein in a novel “reversed” binding mode. This study predicts that 
the sbTTR TH binding channel is similar but not identical to the human TTR showing a 
different shape and a significantly wider entrance. It is suggested that this small 
structural changes may explain the differences in T3 and T4 binding affinities proposed 
to exist between human and sbTTR.  
Studies that characterise piscine TTR-TH binding affinities are very scarce. Yamauchi 
et al (1999) report after competition binding assays with [125I]T3 that masu salmon TTR 
binds T3 with three times more affinity than T4. A solid phase qualitative assay using 
non-denaturing PAGE and [125I]T3 [125I]T4 shows a strong signal for sbTTR T3 binding 
(Santos and Power, 1999). sbTTR was also shown have high affinity for T4 in 
fluorescence binding studies (Folli et al., 2003) but no quantitative values were 
provided. Recently, Kawakami et al. (2006) also report that the Pacific Blue Tuna TTR 
binds both T3 and T4, although no quantitative data was provided and the suggestion 
that piscine TTR has higher affinity for T3 than T4 has yet to be substantiated.  
Another major function attributed to TTR is RBP binding. The RBP molecule has been 
cloned for several fish (Santos et al., 2002) and the amino acids known to be involved in 
the formation of RBP-TTR complex in higher vertebrates are partially conserved in fish 
(Folli et al., 2003; Santos et al., 2002). Also, binding affinity has been found between 
fish TTR and mammalian RBP (Berni et al., 1992; Folli et al., 2003).  However, in fish 
no TTR-RBP complex has been found in the plasma so far (Berni et al., 1992; Zapponi 
et al., 1992) and binding studies found quite low affinity for both carp and sea bream 
TTR binding to RBP (Folli et al., 2003). The existence and importance of RBP transport 
by TTR in fish remains to be established. 
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Studies concerning TTR tissue distribution in fish suggest that in this group, in contrast 
to the situation in mammals, the presence of TTR transcripts is not restricted to the liver 
and choroids plexus. In juvenile sea bream, TTR is highly expressed in the liver but it 
seems to be absent in the choroids plexus (Santos and Power, 1999). Additionally TTR 
expression in juveniles was detected in smaller but significant amounts in other tissues 
like brain, intestine, kidney, testis and pituitary. In adult sea bream tissues, apart from 
the liver, significant TTR expression was also detected by Northern and Southern blot 
in intestine, heart, skin and muscle and in several other tissues (e.g. eye, gills, brain, 
pituitary, spleen, etc) in lower levels (Funkenstein et al., 1999; Power et al., 2000a). In 
bluefin adult tissues TTR transcripts were only found in liver and ovary (Kawakami et 
al., 2006) and in Lamprey TTR was again found in higher levels in the liver but also 
detected by RT-PCR in a wide variety of tissues as found in sea bream (Manzon et al., 
2007). The physiological function of TTR in these tissues remains to be established but 
the coincident presence of TR in such tissues (except pituitary) suggests it may be 
related to TH transport system efficiency. Other functions may be involved but the 
widespread location of TTR expression clearly suggests evolutionary changes and 
adaptations.  
In fish, very little is known about physiological conditions affecting TTR expression. 
The studies which exist are on sea bream and report downregulation of hepatic TTR 
expression by estradiol (Funkenstein et al., 2000) and in response to food restriction 
(Power et al., 2000b). In both cases decreased hepatic TTR transcripts seem to be 
coincident with lower circulating TH levels. High concentrations of estradiol in fish 
during the reproductive cycle have been associated with a reduction in TH levels 
(Norberg et al., 1989) and fasting is known to downregulate the hypothalamus-pituitary-
thyroid axis in fish. In mammals TTR reduction in response to food restriction is well 
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established and TTR production in the liver is known to have a typical acute phase 
response regulation. It remains to be established if a similar process takes place in fish 
and the role of THs. 
Studies about fish TTR are still very scarce and certainly merit more attention as the 
success, diversity and vastly differing life histories of fishes make them a very 
interesting group for studying the evolution of TTR function. 
 
1.4.9 TTR binding to Endocrine Disruptors 
Over the past years there has been increasing concern about the effect of synthetic 
chemicals on the endocrine system. A great number of chemicals are constantly released 
into the environment from industrial, medical or agricultural sources and are known to 
disrupt endocrine homeostasis in humans and animals (Colborn and Clement, 1992). 
Until recently most studies focussed on the reproductive system but evidence indicates 
that the thyroid axis is also vulnerable to endocrine-disrupting effects (Boas et al., 
2006). Although little is known about their mode of action, disruption of thyroid 
homeostasis may take place at different levels, thyroid hormone synthesis, alteration in 
TH metabolism, cellular uptake, receptor binding and also by binding to THBP. In 
particular, interference with TH transport system may affect free hormone 
concentrations in plasma and therefore TH cellular uptake and physiological action (see 
section 1.3.5). In addition, binding of endocrine disruptor chemicals (EDCs) to THBP in 
plasma may also affect the free concentrations of such compounds modulating their 
access to cells.  
In particular, TTR has been investigated as a target site for EDCs since it is able to bind 
exogenous compounds that structurally resemble THs. For example, binding to 
mammalian TTR has been shown for polychlorinated biphenyls (PCBs), hydroxylated 
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PCBs, dibenzo-p-dioxins, dibenzofurans or brominated flame retardants like 
polibrominated diphenyl ethers (PBDE) or tetrabromobisphenol A (TBBPA) (Brouwer, 
1989a; Brouwer et al., 1989b; Brouwer et al., 1999; Brouwer et al., 1998; Brouwer and 
van den Berg, 1986; Cheek et al., 1999; Hamers et al., 2006; Lans et al., 1993; Meerts et 
al., 2000) in both in vitro and in vivo experiments. In such studies, TTR binding 
potencies to EDCs are comparable to, or higher than T4. Furthermore, in vivo 
experiments suggest that the interaction of TTR with EDCs led to an increase in plasma 
clearance rates of T4 resulting in decreased serum concentrations and causing 
hypothyroxinemia in rat, seal and humans. Also, evidence from animal models report 
disruption of TH homeostasis after exposure to PBDEs (for review see Darnerud et al., 
2001) and such chemicals show an even closer structural relationship to T4 than PCBs. 
The structural characteristics of EDCs greatly influence their affinity for TTR and it has 
been suggested that hydroxylation in meta and para positions would favour TTR 
binding (Lans et al., 1993). However, X-ray crystallography studies of TTR binding 
indicates that non-hydroxylated compounds can also bind strongly to the protein (Ghosh 
et al., 2000). 
Until recently, most studies on the interaction of EDCs with THBP have been carried 
out with mammals. However, differences in the composition and binding properties of 
THBP among vertebrates (see sections 1.3.5 and 1.4.6.2) suggest different binding 
preferences for the chemicals and diverse impacts for thyroid system may occur. For 
instances, in larger eutherians the major THBP is TBG, which has no binding ability to 
EDCs (Lans et al., 1993; Rickenbacher et al., 1986; van den Berg, 1990). In rodents and 
lower vertebrates like birds, amphibians and fish, TTR is the major THBP (Richardson 
et al., 1994; Yamauchi et al., 1993; Yamauchi et al., 1999) and therefore binding to 
EDCs would likely have greater impact in this species. In recent studies, the effect of 
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EDCs binding to plasma THBP of chiken, bullfrog and masu salmon, pure plasma 
Japanese quail TTR and also recombinant TTRs from chicken, bullfrog was evaluated 
(Ishihara et al., 2003a; Ishihara et al., 2003b; Yamauchi et al., 2003). A great number of 
chemicals from different sources were potent competitors for T3 (the natural TTR binder 
in such species) binding to TTR like for example, diethylstilbestrol, ioxynil, 
pentachlorophenol, bisphenol A, etc. Such in vitro competition assays may be useful 
tools for detection of EDCs in environmental samples in a species-specific manner 
(Yamauchi et al., 2003). This would be of particular interest for fish which are 
frequently used as sentinel species in aquatic environments which act as a sink for many 
pollutants.  
In fish the binding ability of TTR to exogenous compounds is virtually unexplored, 
although numerous environmental contaminants have been reported to exert acute or 
chronic effects in vivo in teleosts (for review see Brown et al., 2004). The specific 
contribution of EDC interfering with TH transport for thyroid axis disruption in fish is 
difficult to determine as other thyroid endpoints would certainly be involved. 
Nevertheless, assessing the in vivo consequences of strong TTR binding in vitro would 
certainly be of great interest in fish, especially since thyroid disruption can severely 
compromise reproduction, development, growth and ultimately survival. 
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1.5. Aims and Outline 
The general aim of the present thesis was to explore the structure/function 
characteristics of piscine transthyretin (TTR) and analyse its physiological role as a 
thyroid hormone binding protein (THBP). This was achieved by the following studies:   
1. The molecular basis of TTR binding to thyroid hormones (THs) in fish and its 
structure/function evolution in vertebrates as a THBP.  
2. TTR stability and fibril formation in fish. 
3. TTR role and regulation, in particular in relation to THs in a fish model, the sea 
bream (Sparus auratus).  
4. The affinity of fish TTR for xenobiotic compounds in vitro and its usefulness as a 
risk assessment tool in aquatic ecosystems 
5. Fish thyroid axis disruption in vivo by binding of TTR to putative endocrine 
disruptors  
In order to explore these topics it was first necessary to develop a number of different 
tools and methods. The experimental model used during this thesis was a teleost fish, 
the gilthead sea bream (Sparus auratus) which is from the Sparidae family. The sea 
bream has a high commercial value and has been extensively used as an experimental 
model to study growth, reproduction, physiology and endocrine regulation. 
Furthermore, characterisation of the thyroid system and potential endocrine disruption 
has mostly been conducted with teleosts. The cDNA sequence for sea bream TTR was 
available “in house” and the first tool developed was a sea bream recombinant TTR 
(sbrTTR) and several mutants in order to identify the role of the N-terminus in hormone 
binding. Other tools included the production of sbrTTR specific antisera, the 
establishment of a sbTTR specific ELISA and a sbrTTR binding assay. A none-
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invasive, low stress and efficient method for administration of hormones and endocrine 
disruptors to fish was also established. 
 
The results obtained in trying to achieve the proposed aims are herein described and 
were organized in different chapters as follows: 
Chapter 3. Piscine Transthyretin hormone affinity and fibril formation: the role of the 
N-terminal. This chapter describes the production of sbrTTR and the characterisation of 
its binding affinity to T3 and T4. It also explores the putative role of sbrTTR N-terminal 
region on TTR binding affinity to THs and fibril formation through the production of 
two sbrTTR mutants were the N-terminus was truncated.    
Chapter 4. Regulation of transthyretin by thyroid hormones in fish. In this chapter TTR 
plasma levels were measured for the first time in fish using a specific sbTTR developed 
ELISA. Furthermore, control of sbTTR expression and secretion by the THs was 
investigated upon in vivo treatment with T3, T4 and an antithyroid drug, methimazole.   
Chapter 5. Disruption of thyroid hormone binding to sea bream recombinant 
transthyretin by ioxynil and polybrominated diphenyl ethers. In this chapter as specific 
sbrTTR in vitro competition binding assay was used to assess sbrTTR binding ability to 
a panel of putative endocrine disruptors. 
Chapter 6. Disruption of the thyroid system by DES, Ioxynil in the sea bream (sparus 
aurata). In this chapter the in vivo consequences for thyroid system homeostasis by two 
chemicals found to bind TTR in vitro were investigated. Several endpoints of the 
thyroid cascade were addressed including TTR levels.   
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This section gives a detailed description of the general laboratory techniques and materials 
used throughout the thesis. Many of the techniques described herein are common to several 
different chapters so to avoid repetition they are described in the present chapter. The methods 
section of each of the specific chapter gives an overview of the approach taken and also gives 
details of specific tasks.  
 
Animal maintenance 
Sea bream were obtained from TIMAR (Tavira, Portugal) and maintained at the experimental 
station Ramalhete Marine Experimental Station (University of Algarve, Faro, Portugal) in 
through-flow seawater tanks at natural annual conditions of water temperature, photoperiod 
and salinity. Maintenance and manipulation of fish were conducted in accordance with the 
recommendations of the Association of Animal Behaviour (ASAB, 2003) and the Guidelines 
of the European Union Council (86/609/EU). 
 
Polymerase-chain reaction (PCR) 
The polymerase chain reaction which uses a thermostable DNA polymerase from E.coli PVG-
A1 is typically used to amplify DNA. In the present thesis it was used to amplify plasmid 
DNA and also cDNA prepared from mRNA extracted from tissue. A typical PCR reaction 
consisted of 1 µl of plasmid DNA dilution or cDNA (approximately 0.1ug), 15 pmol of each 
primer, forward and reverse, 20 µM each dNTP, 1.5-3 mM MgCl2, 1U of Taq DNA 
polymerase (Promega, VWR, Portugal), 1x PCR buffer and molecular biology grade water 
(Sigma-Aldrich) to a final volume of 25 µl. Thermocycling conditions consisted of an initial 
denaturing step of 94 ºC for 3 min, followed by 15-40 cycles of 94 ºC for 45 s (denaturing), 
59-69 ºC for 30-60 s (annealing) and 72 ºC for 50-180 s (usually 60 s/Kb expected, 
extension). A final elongation step was performed at 72 ºC for 5 min and PCR products were 
analysed by agarose gel electrophoresis (see appendix). 
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Cloning of PCR products  
PCR products were purified directly from the PCR reaction mixture if a single product was 
detectable after electrophoresis. When multiple reaction products were detected upon 
electrophoresis the target product was excised from the agarose gel and purified using the 
GFX PCR DNA and Gel Band Purification kit (Amersham Biosciences). Purified DNA was 
eluted in 20-50 µl of sterile water (stH2O) and 1 µl analysed on an agarose gel before cloning. 
 
Cloning into pGEM-T Easy vector 
The purified DNAs were cloned into pGEM-T Easy vector (Promega, VWR, Portugal) which 
is  supplied linearized and has a single 3’ thymidine (T) residue at both ends, which facilitates 
ligation to the 3’single deoxyadenosine (A) residues added to the PCR product by the 5´→3´ 
exonuclease activity of some DNA polymerases, including Taq polymerase (T/A cloning). 
Ligations were performed overnight at 4ºC using 15ng of vector, 10-200 ng of purified PCR 
product, 5 µl of 2x rapid ligation buffer, 1.5U of T4 DNA ligase (Promega, VWR, Portugal, 
supplied with the vector) and stH2O to a final volume of 10 µl.  For transformation, 5 µl of the 
ligation reaction was mixed with a 100µl aliquot of E. coli XL1B competent cells, incubated 
on ice for 30 min and heat-shocked for 2 min at 42 ºC followed by 2 min on ice. Transformed 
cells were plated on LB agar plates containing ampicillin (75µg/ml) and 
isopropylthiogalactoside (IPTG, Sigma-Aldrich, Madrid, Spain 0.5mM) and 5-bromo-4-
chloro-3-indolyl-beta-D-galactopyranoside (X-Gal, Merk Bioscience, Germany, 80 µg/ml) 
(see Appendix) for “blue/white selection” and grown overnight at 37ºC. The cloning vectors 
utilised contain the IPTG-inducible lac operon promoter followed by the multiple cloning site 
(MCS) located inside the coding region for the enzyme β-galactosidase. Recombinant bacteria 
are grown on plates with IPTG/X-Gal, and those containing a plasmid without an insert turn 
blue, as ligation results in an active β-galactosidase which degrades X-Gal and produces a 
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blue colour. Positive transformants with a DNA insert in the MCS of the vector will remain 
white, due to the interruption of the enzyme coding sequence which means that the active 
enzyme is not produced.  
 
Cloning into pET 24b(+) expression vector   
pET expression vectors (Novagen, Germany) are not supplied in a linearized form so 
preliminary steps of  digestion and dephosphorylation are necessary. Digestion of the vector 
was performed, according to suppliers instructions (pET manual instructions), using 3 µg of 
pET vector, 3 µl of 10 x restriction enzyme buffer, 10-20 U of restriction enzymes (chosen to 
be compatible with insert restriction sites) and 3 µl of 1 mg/ml acetylated BSA in a final 
volume of 30 µl in stH2O. Dephosphorylation was performed in a final reaction volume of 50 
µl in stH2O using 5 µl of 10 x alkaline phosphatase buffer and the right proportion of digested 
plasmid and enzyme: 0.05 U of shrimp Alkaline phosphatase per 1pmol of DNA ends 
(assuming that 3 µg of vector correspond to 4 pmol of DNA ends). The mixture was incubated 
at 37 ºC for 30 min followed by 15 min at 85 ºC for enzyme inactivation. Linearized vector 
was then separated from undigested circular vector by agarose gel electrophoresis and 
purified using the GFX PCR DNA and Gel Band Purification kit (Amersham Biosciences). 
Insert ligation was performed using 50-100 ng (0.015-0.03 pmol) of pET vector and 
approximately 30 ng (0.2 pmol) of insert, 1 µl of 10mM ATP, 2 µl of bovine serum albumin 
(BSA) 250 µg/ml, 2 µl of 10 x ligase buffer, 1 µl of T4 DNA ligase (0.2-0.4 weiss U/µl) and 
stH2O to a final volume of 20 µl. The reaction mix was then incubated at 16 ºC overnight.  
Expression vector pET 24 was firstly transformed in XL1B E. coli cells. The purified DNA 
was sequenced using the dideoxy-terminator method (Seif et al., 1980) and an automated 
sequencer (Macrogen, Korea) in order to confirm the presence of the correct insert and the 
reading frame. Appropriate recombinant pET 24 expression vector constructs were used to 
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transform the host cells E. coli BL21DE3pLysS (Novagen). Transformation of E. coli 
BL21DE3pLysS with the expression vector was performed with recovery using the following 
protocol: 5 µl of ligation reaction was mixed with a 100 µl aliquot of E. coli competent cells 
(XL1B or BL21DE3pLysS), incubated on ice for 30 min and heat-shocked for 45 s at 42 ºC 
followed by 2 min on ice. Subsequently, 500 µl of LB broth (see appendix) was added and 
bacteria were grown for 30 min at 37 ºC with slow agitation (~1500 rpm). 100 µl of the 
culture was plated on LB agar plates containing the appropriate antibiotics for the plasmid 
(kanamycin) and the host strain (chloramphenicol) (see appendix) and grown overnight at 37 
ºC. The pET vectors do not contain a lac operon promoter for “blue/white colour selection” so 
X-Gal and IPTG were not added to the plates.   
 
Small-scale plasmid purification 
In order to characterize positive transformants, plasmid DNA was isolated using the alkaline-
lysis method (Sambrook et al. (1989). Single colonies were inoculated into 2 ml of LB broth 
containing 80 µg/ml ampicillin (see appendix) and grown overnight at 37ºC with vigorous 
shaking. 1.5 ml of culture was spun for 1 min in a microcentrifuge at maximum speed and the 
pellet resuspended in 100 µl of ice-cold GTE buffer (see appendix). To induce cell lysis, 200 
µl of a freshly prepared solution of 0.2 N NaOH / 1 % SDS were added, mixed by inversion 
and incubated 5 min on ice. 150 µl of ice-cold 3M KAc (see appendix) were added to 
neutralize the lysate, mixed by inversion and incubated on ice for 5 min. Cellular debris were 
spun down for 10 min at maximum speed and the supernatant transferred to a fresh tube. 
RNase A was added to a final concentration of 20 µg/ml and incubated for 20 min at 37 ºC. 
An equal volume of phenol pH 8.0: chloroform (v/v 1:1) was added, mixed by vortexing and 
then centrifuged for 2 min at 7500 g at room temperature. The supernatant was precipitated 
with ethanol and resuspended in 50 µl of stH2O. When a DNA preparation of higher quality 
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was required (e.g. for sequencing reactions) the Wizard Plus Miniprep DNA Purification 
System (Promega, VWR, Portugal) was used according to the manufacturer’s instructions.  
 
Restriction digest  
The success of a range of different DNA manipulations carried out in the context of the thesis 
was assessed using restriction digest. This permitted the appropriateness of plasmid constructs 
and sequence insertions to be assessed based upon the restriction pattern obtained. A typical 
restriction digest included 1µl of purified plasmid, 0.5 µl of each enzyme (approximately 5U), 
2 µl of 10 x compatible enzyme buffer (Promega, VWR, Portugal) and stH20 to a final 
volume of 20 µl. The reaction products from restriction digest were analysed on 1% agarose 
gels (appendix). 
 
Production of pure recombinant sbTTR  
This procedure was thoroughly developed and optimized as it has never previously been 
carried out with fish TTR and was the basis of several techniques developed and utilised in 
the context of the thesis. The methodology was initially developed and applied to the wild 
type protein and was then scaled up and further used to produce mutant TTRs which lacked a 
differing number of amino acids. The process of recombinant protein production comprised a 
number of different steps: 
 
Protein expression in E.coli 
Recombinant protein expression was carried out using competent E. coli strain 
BL21DE3pLysS (Chloramphenicol resistant) transformed with the appropriate expression 
vector construct: pET24d(+)/sbTTRWT, pET24b(+)/sbTTRM6 or pET24b(+)/sbTTRM12. 
Transformation was performed using the heat-shock method and bacteria were plated on LB 
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agar plates containing 30 µg ml-1 kanamycin and 34 µg ml-1 chloramphenicol. For protein 
expression a pre-culture was prepared by placing a single colony in 10 ml LB broth with the 
appropriate antibiotic and growing overnight at 37 ºC. The pre-culture was then diluted in LB 
broth to a final optical density (OD600nm) of 0.05 in a large scale culture  (500 mL of LB 
broth) and grown at 37 ºC with vigorous agitation (250 rpm) until the OD600nm reached 0.6-1.0 
(approximately 2 h). At this stage protein expression was induced by adding IPTG (0.2 mM) 
to the culture and incubating it for a further 3 h under the same conditions. Bacteria were 
harvested by centrifugation at 4500 g for 20 min and the pellet frozen at -80 ºC before 
inducing cell lysis. Frozen bacteria were thawed and resuspended in 10 mL double distilled 
water containing phenylmethylsulphonylfluoride (PMSF) 1mM (Sigma-Aldrich). Lysis was 
induced by adding approximately 1 mg lysozyme (Sigma-Aldrich) plus 1mM magnesium 
chloride (MgCl2) and incubating on ice for a further 10 min. DNase I (5U/µL, Amersham 
Biosciences) was subsequently added followed by incubation for another 10 min. Supernatant 
and cell membranes were separated by centrifugation at 25 000 g for 15 min at 4 ºC. The 
supernatant, containing the desired protein, was collected and stored at –80º C until required.   
 
Protein purification by preparative electrophoresis (Prep cell 491 system) 
Purification of the wild type and mutant proteins was achieved using a preparative 
continuous-elution electrophoresis system (Model 491Prep Cell, Bio-Rad laboratories). 
Optimization of this process was primarily carried out under reducing conditions (SDS-
PAGE) in which a first pure sample of sbTTRWT was obtained and used for antibody 
production. However, when the goal was binding affinity studies, proteins were always 
purified under native scaled-up conditions to generate a higher concentration of proteins 
which bound the thyroid hormone (THs). Initial experiments revealed that production of TTR 
under denaturing conditions generated abundant protein but they lacked the capacity to bind 
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THs. In both cases preparative electrophoresis was carried our following the supplier’s 
instruction manual for correct gel casting, assembly and operation (see appendix).  
The general procedure for electrophoresis was as follows: the supernatant containing the 
recombinant protein was loaded onto a cylindrical preparative native Ornstein-Davis  
polyacrylamide gel (Davis, 1964; Ornstein, 1964) after mixing with the proper sample buffer 
(appendix). Electrophoresis was carried out at a constant power of 12 W over several hours 
(depending on gel size and running conditions) in running buffer (appendix) maintaining a 
constant temperature (18 ºC). Proteins fractionated on the polyacrylamide gel were allowed to 
migrate off the end of the gel, passed into an elution chamber and collected as individual 2.5 
ml fractions in elution buffer (same as running buffer) at 8 oC  (Valkonen et al., 2001) using a 
fraction collector (LKB 1, Pharmacia Biosciences). Initially the approximate volume at which 
TTR should elute was determined using analytical SDS-PAGE (15% polyacrylamide). In 
subsequent purifications fractions were collected which were expected to contain TTR and 
alternate fractions were analyzed by analytical SDS-PAGE (15% polyacrylamide) and silver 
stained in order to identify those containing the purified sbTTR. Fractions containing pure sea 
bream TTR were pooled, concentrated by centrifugation and dialysed against 50 mM Tris, pH 
7.5. If the final sample was found to still contain contaminants it was subjected to a second 
round of purification using the 491 Prep cell.  
 
Protein concentration  
Protein fractions were concentrated using filtration columns Ultrafree 15, Biomax 5 MWCO 
(Millipore, UK) by centrifugation at 1900 g at 4 ºC. Before each centrifugation step the 
columns were filled/refilled with TTR containing fractions and in the final step the desired 
value was recovered. Finally, protein samples before and after concentration were analyzed 
by SDS-PAGE to confirm that this step was effective. Samples of filtrate were also included 
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in the final analysis as a control to ensure that significant amounts of protein were not lost in 
the filtration/concentration process. 
 
Protein dialysis  
The final purified protein sample was then dialysed at 4 oC in different fractions against Tris 
buffer 50mM pH 7.5 prepared with double distilled water. The use of native conditions and 
this dialysis step was essential to ensure that the protein retained its native tetramer 
conformation and therefore its ability to bind the hormone. Dialyses membranes (Sigma-
Aldrich) with a molecular cut off (12 KDa) slightly under TTR’s monomeric molecular 
weight (14 KDa) were chosen to ensure retention of the protein and to permit removal of 
contaminating small molecules like glycine (present in 491 Prep cell elution buffer) that 
might interfere with the protein binding ability in binding assays. Prior to dialysis membranes 
were prepared by first boiling for 30 min in a 100 mM NaHCO3 + 1 mM EDTA solution, 
followed by thoroughly washing with distilled water. The prepared dialysis membranes were 
then stored at 4 ºC in EDTA (1mM) for several months and utilised as required. Dialysis 
tubing containing the sample were immersed in over 1000 x excess buffer with slow agitation 
at 4 ºC during approximately 24 h. The dialysis buffer (50 mM Tris) was changed at least 
three times every three hours and then left overnight. Samples were recovered after dialysis 
and analysed by SDS-PAGE to ensure TTR was not lost during this process. 
 
Protein quantification   
The concentration of the purified protein was determined using a modification of the Lowry 
method (Lowry et al., 1951) and the molar extinction coefficient of the recombinant protein at 
280 nm ([ε (280nm) (M-1 cm-1) = (number of Trp) (5500) + (number of Tyr) (1490) + 
(number of Cys) (125)] (Pace et al., 1995). 
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Gel electrophoresis  
SDS-PAGE  
Protein analytical electrophoresis was carried out as described in the literature (Sambrook, 
1989). Based upon the molecular weight of monomeric TTR optimisation of electrophoresis 
was carried out by varying the concentration of polyacrylamide between 12-15%; it was 
found that a resolving gel of 15 % polyacrylamide and a stacking gel of 5 % were the most 
appropriate for good resolution (see appendix for gel preparation reagents and volumes). 
Minigels of 1,5 mm thickness were prepared in a dual gel vertical caster system (Mighty 
SmallTM SE245, Hoefer, San Francisco) with 10 well combs. After polymerization of 
polyacrylamide gels they were transferred to the electrophoresis unit (Mighty Small II 
SE250/260, Hoefer) and samples were loaded and run in a Tris-Glycine running buffer (see 
appendix) at constant power of 40 mA. Prior to electrophoresis samples were prepared in 2x 
loading buffer containing DTT (see appendix) and boiled for 5 min at 100ºC to ensure protein 
denaturing. A prestained protein ladder (#SM0671, Fermentas) was always included in 
electrophoresis to give an estimate of the molecular weight of the proteins analysed. When the 
sample front reached the bottom of the gel during electrophoresis, the power was stopped and 
the apparatus disassembled and gels removed and stained. The stacking gel was removed 
using a scalpel blade and the resolving gel was carefully transferred to a glass or plastic box 
for staining. 
 
Native PAGE 
The proteins were also analysed by native PAGE to compare electrophoretic patterns with 
human plasma albumin. For native PAGE, polyacrylamide gels were assembled in a similar 
fashion but this time a 12.5% native glycine-acetate resolving gel (see appendix) was 
prepared and no stacking gel was added. Electrophoresis was carried out with a constant 
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current of 60 mA in glycine-acetate 1 x running buffer (see appendix). Detection in native 
gels was always done by silver staining. 
 
Coomassie brilliant blue gel staining  
Coomassie brilliant blue R is a sensitive protein stain which is used to locate protein bands 
after electrophoresis in polyacrylamide gel. The use of Coomassie blue staining was based 
upon the expected concentration of protein in the samples analysed. When a concentration 
greater than 0.5 µg/band was expected gels were immersed in a solution of Coomassie 
brilliant blue (0.25%) in a staining vessel for at least one hour at room temperature with slow 
agitation. The gels were then rinsed to remove excess coomassie blue and destaining solution 
(see appendix) was added and gels gently agitated for 4 hours to overnight with several 
changes of solution to remove excess coomassie dye from the gel.  
 
Silver nitrate staining 
Silver staining is a much more sensitive method than Coomassie brilliant blue and relies on 
the production of silver atoms from silver salts by groups present on the protein. The main 
problem with this method is that it is prone to artefacts and all the procedure must be carried 
out with clean and dedicated equipment. For this procedure clean glass material was always 
used and reagents prepared with deionised water to avoid silver nitrate precipitation. Gels 
were previously placed for several hours or overnight in a 50% methanol solution in a glass 
tank and then rehydrated in deionised water. A staining solution (see appendix) was prepared 
with silver nitrate and the washed polyacrylamide gel was incubated with vigorous agitation 
for 15 min. The gel was washed 3 to 4 times in deionised water and then transferred to 
developing solution (see appendix) and incubated with agitation until protein bands with the 
desired intensity were detected. The reaction was stopped in a 1% acetic acid solution.  
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Gel Drying and storage 
Upon appropriate staining and analysis, polyacrylamide gels were carefully transferred to 
absorbent filter paper (Whatman paper), covered with cling film and dried using a gel dryer 
apparatus (Drygel.jr se540, Hoeffer Scientific Instruments, UK) under vacuum for one hour at 
60-80 ºC. When a gel image was necessary, prior to drying gels were scanned and a digital 
file generated for storage. 
 
Antibody Production 
The production of polyclonal sbTTR antibodies was carried out by a commercial company, 
Agrisera, (Sweden). Purified recombinant sbTTR (~ 1mg in water) was sent on ice to 
Agrisera and was used to immunize a female rabbit using the standard protocol 
(www.agrisera.com). In brief, the rabbit was immunized 4 times with recombinant protein 
(~250µg per immunization) in 10mM Tris solution pH 7.5, over 14 weeks. After the third 
immunization a small blood sample was collected and serum was tested together with a 
sample of pre-immune serum (as a negative control) by Western blot to assess the titer and 
specificity of the antisera for seabream TTR. As the serum sample contained a high titre of 
antibodies immunoreactive with sbTTR the rabbit was bled and a larger volume of serum was 
collected. 
 
Western blot: colorimetric and chemiluminescence analysis   
Protein samples were fractionated in duplicate by SDS-PAGE as described above. One of the 
gels was stained with Commassie blue and the other was used for immunoblotting after 
transferring the fractionated proteins to hydrophobic polyvinylidene difluoride (PVD) 
membrane (Hybond-P, Amersham Bioscicences). The transfer and immunoblot processes, 
were performed according to the suppliers manual and are now briefly described. On 
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completion of SDS-PAGE, the stacking gel was removed and the resolving gel was marked 
by making a small cut in one corner and the dimension of gel measured with a ruler. A sheet 
of Hybond-P membrane was cut to the size of the gel and wet in 100 % methanol for 10 s for 
activation, washed in distilled water for 5 min and then equilibrated in transfer buffer for at 
least 10 min. Several sheets of Whatman paper were also cut to exactly the same size as the 
polyacrylamide gel and also soaked in transfer solution. Immediately after polyacrylamide 
was prepared it was also soaked in protein transfer buffer (appendix) for 10-20 min. After 
equilibration a transfer “sandwich” was assembled by placing the Hybond-P membrane in 
close contact with the gel (ensuring no bubbles were present) and then placing 6 sheets of 
absorbent Whatman paper on each side. The “sandwich” (soaked in transfer buffer) was 
fastened into an electroblotting cassette and placed inside a vertical electroblotting tank (TE22 
Mighty small tank transfer, Hoeffer, San Francisco, USA) filled with transfer buffer, ensuring 
that the gel was facing the negative electrode. After transfer, carried out for 1 h at 300mA 
with cooling, the Hybond-P membrane containing the transferred proteins was removed from 
the cassette, rinsed in PBS (appendix), wet in 100% methanol and washed for 5 min in 
distilled water before incubation in skimmed milk blocking solution (see appendix) overnight 
at 4 ºC with constant agitation. 
 
Immunoblotting and detection with a chromogen 
For immunoblotting the blocked membrane was then washed in 1x PBS for 10 min to remove 
excess blocking solution and incubated with rabbit anti-seabream TTR sera (optimized 
dilution of 1:10 000) for 2h at room temperature. Excess antisera was removed by washing 
membrane 3 x 5 min in PBS/Tween 20 washing solution (appendix) prior to addition of the 
secondary antibody (anti-rabbit IgG-peroxidase anti-peroxidase 1:5000). Membranes were 
incubated with the secondary antisera at room temperature for 1 h and washed 2 x 10 min in 
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washing solution prior to development with a freshly prepared 3,3’-diaminobenzidine (DAB) 
solution (0.04 %w/v) containing 0.003 % H2O2 and also 0.02 %(w/v) nickel chloride to 
intensify the signal. This step was carried out in the dark with agitation until appropriate 
signal intensity was attained and the color reaction was stopped by transferring the membrane 
to water.  
 
Immunoblotting and detection by chemiluminescence  
Detection by chemiluminescence was performed using the kit ECL Plus Western Blotting 
Detection System (Amersham Biosciences). Basic steps in the protocol were done according 
to the supplier’s instructions and after optimization the procedure was the following: 
The blocked membrane was rinsed in 1x PBS with two changes to remove excess blocking 
solution and incubated with rabbit anti-seabream TTR sera (optimized dilution of 1:10 000) 
for 1 h at room temperature. Excess antisera was removed by washing membrane with excess 
(4 ml/cm2) PBS/Tween 20 washing solution (see appendix) followed by another 3 x 5 min 
washes prior to addition of the secondary antibody ECL anti-rabbit IgG horseradish 
peroxidase linked, from donkey (1:100 000 dilution, Amersham Biosciences). Membranes 
were incubated with the secondary antisera at room temperature for 1 h and rinsed twice in 
washing solution prior to a 15 min wash in excess (4 ml/cm2) wash buffer followed by 
another 3 x 5 min washes. For detection reagents A and B supplied in the kit, previously 
equilibrated at room temperature for some minutes, were mixed with the proportion 40:1 
respectively to allow a final volume of 0.1 ml/cm2 of membrane. The membrane was placed 
in a sheet of clingfilm (after removing excess wash buffer) with protein side up. The mix 
detection reagent was evenly distributed on the membrane surface and incubated at room 
temperature for 5 min. Excess reagent was carefully drained by holding membrane corner 
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against an absorbent tissue. The membrane was then placed inside a transparent plastic sheet, 
removing any air bubbles and transferred to an X-ray film cassette protein side up. In the dark 
room an autoradiography film (Hyperfilm ECL, amersham biosciences) was placed on top of 
the membrane, exposed for 15 s. The film was developed (Kodac fixer and developer, Sigma 
Aldrich) and based on its appearance exposed for more time if needed (estimated time could 
usually go from 1 min to 1 h) until the desired band intensity and clean background was 
achieved.  
 
Ligand binding assay 
Development of sbrTTR [125I]-T3 binding assay was preceded by a long period of 
optimization in which trials were carried out in order to establish the assay buffer 
(concentration and pH), the sbrTTR protein concentration, incubation time and temperature, 
tubes, assays volume and separation method. Several methods were tested to achieve an 
efficient separation of free and bound phase: by gel filtration as previously described for 
human TTR (Almeida and Saraiva, 1996; Hamers et al., 2006; Lans et al., 1993) using 1ml 
Biogel P-6PG columns, using charcoal as adsorbent and finally the PEG method utilised with 
amphibian TTR (Yamauchi et al., 1993). The latter method was found to be most suitable for 
the sbTTR binding assay but had to be optimized. The optimal sbTTR protein concentration 
used in the assay was determined by titration. Several concentrations of sbrTTRWT (0.05, 
0.15, 0.25 and 0.5 µg) were incubated with 0.1 nM [125I]-T3 in the presence or absence of an 
excess of 10 µM unlabeled T3 (to assess non-specific binding) to determine binding 
percentages. A concentration per tube of sbTTR of 50 ng was found to be sufficient to permit 
a working binding percentage of at least 10 %.  
As for incubation times and temperature; a range of temperatures, on ice, 4 ºC, room 
temperature (24 ºC) and 37 ºC were tested using 30 min, 1, 2, 4 hours and overnight 
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incubation. It was observed that 2 h on ice gave maximal binding and that longer incubation 
did not increase the amount of hormone bound. It was also found that the use of glass tubes 
was essential to allow proper binding conditions and with polystyrene or polypropylene 
plastic tubes the assay was not feasible. The use of double distilled rather than single distilled 
or deionised water was also a required condition as has previously been shown (Chang et al., 
1999).  
The overall best working conditions were selected to achieve the final assay protocol which is 
subsequently described and which was most like the assay condition proposed by (Yamauchi 
et al., 1993) for bullfrog TTR and also applied to other species (Ishihara et al., 2003) such as 
the fish, masu salmon (Yamauchi et al., 1999).  
For competitive binding studies, sbrTTR (50ng per tube) was incubated in 200µL TCN buffer 
(see appendix) containing tracer 0.1nM [125I]-T3 in the presence of increasing concentrations 
of unlabeled ligand (0-10 µM) for 2 h on ice. Separation of free and sbrTTR bound [125I]-T3 
was carried out on ice by adding to assay tubes 25 µL of 125 µg/ml bovine γ-globulin and 250 
µL of 25 % (w/v) and PEG 6000 containing 0.2 M ZnCl2 in TCN buffer (Yamauchi et al., 
1993). The mixture was immediately centrifuged at 1500 g for 10 min at 4 ºC and the 
resulting pellet washed with 1ml of 12.5 % (w/v) PEG 6000 containing 0.1 M ZnCl2 and 
counted in a gamma counter (Wizard, Pharmacia-LKB). Non-specific [125I]-T3 binding to 
rsbTTR was determined by incubating with an excess of unlabeled T3 (10µM). Binding assays 
were carried out in duplicate and repeated on at least three different occasions. The data 
obtained was analysed using One-way analysis of variance (ANOVA). If statistically 
significant differences (considered at P<0.05) were detected between treatments, a Tukey 
(HSD) multiple comparison test was applied. All the statistical analysis was performed using 
Sigma Stat software version 3 (SPSS).  
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Thyroid hormone radioimmunoassay 
Thyroid hormone (T3 and T4) plasma concentrations were measured using a specific and 
reproducible radioimmunoassay (RIA). Briefly, plasma samples were diluted (1/10) in 
phosphate buffer (0.01M pH 7.60), heat extracted (1h 30 min at 70ºC) then centrifuged for 5 
min, at 4ºC and 3000 rpm. The total assay volume was 300µl and was composed of 100µl of 
standard or diluted plasma (15 µl of 1/10 diluted plasma in 85 µl buffer), 100 µl of anti T4 
sera (1:8000, ~3% cross-reactivity with T3; T2652 - Sigma-Aldrich, Madrid, Spain) or anti T3 
sera (1:15000, <0.01% cross-reactivity with T4; T2777 - Sigma-Aldrich) and 100 µl of tracer 
([125I]-T4 and [125I]-T3, respectively). Assays were incubated overnight at 4ºC and separated 
by adding a secondary antibody (100 µl; diluted 1:10 in 0.01% (w/v) rabbit IgG; Sigma- 
Aldrich) to all tubes with the exception of those used to determine total counts. Tubes were 
mixed and incubated for a further 20 min at room temperature, after which 300 µl of an ice-
cold PEG solution (7.5 % w/v PEG 8000; Merck) in assay buffer was added, and the tubes 
were centrifuged for 10 min, 1500g at 4ºC. The supernatants were decanted, and the pellets 
were counted in a gamma counter (Wizard, Pharmacia-LKB). 
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Abstract 
 
Thyroid hormone binding proteins (THBP) are poorly characterized in fish and in the present 
study thyroid hormone (TH) binding by piscine Transthyretin (TTR) was determined, as was 
its ability to form fibrils. Piscine TTR, in common with mammalian TTR is a homotetrameric 
protein with two identical, highly conserved TH binding sites. However, piscine TTR has a 
longer N-terminus and the latter has been proposed to influence TH binding affinity between 
species and may also influence tetramer stability. In order to investigate this matter, wild type 
sea bream recombinant TTR (sbrTTRWT) plus two recombinant N-terminal mutants 
(sbrTTRM6 and M12, in which the first 6 and 12 amino acids respectively were removed) 
were produced and purified. Binding of [I125]-T3 to sbrTTRWT and mutants was confirmed by 
native polyacrylamide gel electrophoresis followed by autoradiography. Ligand binding 
studies revealed that both T3 and T4 bind sbrTTRWT with similar affinities (Kds of 10.6 ± 1.7 
nM and 9.8 ± 0.97 nM, respectively) and that the mutation sbrTTRM12 had no significant 
effect on T3 and T4 binding affinity. However, on removal of the 6 N-terminal amino acids 
(sbrTTRM6), poor affinity for T4 was found (Kd = 252.3 ± 15.8 nM) suggesting that the N-
terminus does influence the binding characteristics of sbTTR. The latter mutation was also 
found to inhibit amyloid fibril formation in vitro under acidic conditions as shown by 
fluorometric measurements using the fluorescent dye thioflavine. Such studies also suggested 
that sbrTTRWT is more resistant to acid-mediated fibril formation than the human TTR.  
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Introduction 
Transthyretin (TTR) is one of several thyroid hormone binding proteins (THBP) which 
transport thyroid hormones thyroxine (T4) and triiodothyronine (T3) in the circulation of 
vertebrates. This protein is synthesized and secreted mainly by the liver and its functionally 
active form is a tetramer, the central core of which is proposed to transport one or two 
molecules of thyroid hormones (THs) (Blake et al., 1978; Schreiber and Richardson, 1997; 
Wojtczak et al., 1996). Subsequently TTR was also identified in the choroid plexus of 
mammals where it is proposed to play an important role in the transport of T4 across the blood 
brain barrier (Blay et al., 1993; Hamberger et al., 1990; Harms et al., 1991; Schreiber et al., 
1990).  
TTR has now been identified in most vertebrate groups; it is present in placental mammals, 
Australian and American marsupials, birds, reptiles, amphibians and fish (Dickson et al., 
1985; Duan et al., 1991; Duan et al., 1995; Larsson et al., 1985; Mita et al., 1984; Prapunpoj 
et al., 2002; Prapunpoj et al., 2000; Richardson et al., 1994; Richardson et al., 1997; Santos 
and Power, 1996; Santos and Power, 1999; Yamauchi et al., 1993; Yamauchi et al., 1999). 
The distribution of TTR in blood, liver and the choroid plexus of representative species of 
these groups are variable, making it difficult to establish a consensual model for the evolution 
of this gene. For example, TTR is present principally in the liver and to a lesser extent in the 
brain and other tissue of teleost fish (Power et al., 2000a; Santos and Power, 1996; Santos and 
Power, 1999) but in turtles (Trachemys scripta) it is expressed principally in the choroid 
plexus (Richardson et al., 1997). Moreover, some metatherian (marsupial) species contain 
TTR in the blood stream, whereas others do not (Richardson et al., 1994). In addition to 
differences in tissue distribution of TTR between species, differences in the thyroid hormone 
binding properties of the protein have also been observed.  
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The TTR tetramer is a highly stable protein, however dissociation and misfolding of this 
protein can lead to its conversion into insoluble amyloid structures that can deposit 
extracellularly. This process is associated with severe amyloid disease in humans: familial 
amyloid polyneuropathy (FAP) and senile systemic amyloidosis (SSA) (reviewed in (Benson 
and Uemichi, 1996; Ingenbleek and Young, 1994; Schreiber and Richardson, 1997; Sipe, 
1992). Tetramer dissociation seems to be the critical step in misfolding and in vitro studies 
have shown that the TTR tetramer can form fibrils under acidic conditions at 37 ºC 
(Hammarstrom et al., 2001; Lai et al., 1996). 
The resolution of the crystal structure of human, chicken and rat TTR has revealed that the 
functional tetramer contains two structurally identical binding sites in the central channel 
(Blake et al., 1974; Hamilton et al., 1993; Sunde et al., 1996; Wojtczak, 1997; Wojtczak et al., 
1992). The amino acids that are thought to be involved in T4 binding in the central channel of 
TTR appear to have been conserved between mammals and lower vertebrates. However, 
binding studies of plasma TTR with radiolabelled T4 and T3 have established that mammalian 
TTR has the highest affinity for T4 while avian TTR preferentially binds T3 (Chang et al., 
1999). Similar preferences for T3 were found for crocodile (Prapunpoj et al., 2002) and 
amphibians (Prapunpoj et al., 2000; Yamauchi et al., 1993). The molecular basis for the 
different affinity of mammalian and lower vertebrate TTR for the thyroid hormones remains 
to be established but it has been proposed that changes in the N-terminus of the protein may 
be an important factor. This region is the least conserved between species and in birds, 
reptiles or amphibians it is longer, having three additional amino acids, and is more 
hydrophobic than mammalian TTR (Aldred et al., 1997).  
The identification of TTR in teleost fish is relatively recent, the protein was isolated and the 
N-terminus sequenced from juvenile Masu salmon (Onchorhynchus masou) plasma 
(Yamauchi et al., 1999) and a full-length cDNA for seabream TTR was isolated from the liver 
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of juvenile seabream (Santos and Power, 1996; Santos and Power, 1999). Binding studies 
with Masu salmon TTR revealed that it preferentially binds T3 (Yamauchi et al., 1999). The 
crystal structure of sea bream TTR has been determined and showed that the overall topology 
of seabream TTR is conserved (Eneqvist et al., 2004; Folli et al., 2003). The thyroid hormone 
binding site is also highly conserved, although Ser 117 (human sequence) is substituted by 
Thr in sea bream TTR (Folli et al., 2003). This substitution however is unlikely to affect TH 
binding according to the predicted structure of TTR in complex with L-thyroxine (Wojtczak 
et al., 2001). Despite conservation of TTR structure between sea bream and other vertebrates, 
the surface potential, most noticeably in the thyroid hormone-binding site is more negative in 
the sea bream and the N-terminus of the protein is longer (Power et al., 2000a). 
As a first step to understanding the basis for the differing hormone affinities between fish and 
mammalian TTR, wild type and N-terminal mutant sea bream TTRs were produced. Ligand-
binding studies were carried out in order to characterise the TH:TTR interactions. Also, the 
consequences of the N-terminal mutations for acid-mediated TTR fibril formation were 
assessed. Such studies may help to elucidate the regions of the molecule which are of 
importance in TTR TH binding preference and tetramer stability.   
 
 
Materials and Methods 
Cloning of sea bream TTRWT and mutants 
A construct corresponding to mature sea bream TTRWT (sbTTRWT) or TTR mutants in 
which the first 12 (sbTTRM12) or first 6 N-terminal amino acids (sbTTRM6) were omitted, 
were amplified by PCR using the full-length sea bream TTR cDNA in pBuescript SK(+) as 
the template (Santos and Power, 1999). sbrTTRWT vector pET 24d(+) “construction” was 
supplied by Therese Eneqvist (Umea University) containing the protein encoding gene 
(lacking the signal sequence). Recombinant sbTTRWT (sbrTTRWT) and mutants proteins 
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were produced by PCR with specific primers (table 1). The primers used to amplify mutant 
TTRs were designed to introduce a restriction enzyme site 5’ NheI flanking the vector’s N-
terminal methionine and a BamH I 3’cleavage site following the C-terminal stop codon. PCR 
reaction was as described in chapter 2 in a final 25 µl reaction volume. Thermocycle used was 
of 94 ºC for 3 min, followed by 35 cycles of 94 ºC for 40 s (denaturing), 69 or 67 ºC (optimal 
annealing temperature determined for sbrTTRM6 and M12 respectively) for 60 s and 72 ºC 
for 60 s followed by a elongation step of 5 min at 72 ºC. The PCR reaction products were 
firstly subcloned into pGEM-T Easy vector (Promega, VWR, Portugal) and transformed into 
XL1B E. coli for easier manipulation to achieve the desired mutation (see chapter 2). Final 
insert sequence was ligated using T4 DNA ligase Ready-To-Go kit (Amersham Biosciences, 
UK) into pET 24b(+) vector (Novagen, Germany) which had been cut with the appropriate 
restriction enzymes to generate compatible ends (see chapter 2). The recombinant vector was 
used to transform (Hanahan, 1983) E. coli BL21DE3 pLySs (Novagen) which were then 
plated on LB agar plates containing 30 µg.ml-1 kanamycin and 34 µg.ml-1 cloramphenicol. 
Plasmid DNA was isolated from the bacterial culture using the alkaline lysis method 
(Birnboim and Doly, 1979) and the appropriateness of constructs confirmed by restriction 
digest and DNA sequencing (Macrogen, Korea). 
 
Table 1. Primers used for amplification of sbrTTRWT, M12 and M6.  
 
 
Primers (5’→ 3’) 
 Forward Reverse 
sbrTTRWT TTT TTC ATG ACC CCC ACC CCC ACG TTT CGA GCT CAC TCG TGT ACG CTG GAG 
sbrTTRM12 GCT AGC TGT CCT CTG ATG GTA AAA ATC C GGA TCC TCA CTC GTG TAC GCT GGA GAC 
sbrTTRM6 GCT AGC GGA GGC TCA GAC ACC AGG TG GGA TCC TCA CTC GTG TAC GCT GGA GAC 
 
Bold and underlined sequences represent the restriction enzyme sites for Nhe I and BamHI, respectively, 
introduced for correct insertion in the expression vector. 
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Production of sea bream recombinant TTRWT and mutants 
Recombinant protein expression was carried out in E. coli strain BL21DE3pLysS transformed 
with the appropriate expression vector constructs (pET24d(+)/sbTTRWT, 
pET24b(+)/sbTTRM6 or pET24b(+)/sbTTRM12) as described in chapter 2. After expression, 
the protein extract (~8 ml) containing wild type or mutant sbrTTRs was purified in native 
conditions using the preparative continuous-elution electrophoresis system (Model 491Prep 
Cell, Bio-Rad laboratories) and further concentrated, dialyzed and quantified as described in 
detail in chapter 2.  Purified sbrTTRWT was used to raise a polyclonal sbTTR antibody and 
the proteins were analysed by SDS-PAGE, native PAGE and western blot using colorimetric 
detection as described in chapter 2. 
 
 [125I]-T3 binding to sbrTTRWT and mutants by native PAGE 
In order to analyze the thyroid hormone binding ability of sbrTTRWT, M6 and M12, the 
purified proteins were incubated on ice for 1 h with [125I]-T3, as T3 was previously indicated 
to strongly bind fish TTR (Santos and Power, 1999; Yamauchi et al., 1999). A parallel 
reaction with [125I]-T4 (0.01 µCi) and a human plasma (1.5µl) sample which contain albumin 
(67 kDa) that binds T4 was also conducted. The samples were then separated by 
electrophoresis on a 12.5 % native glycine-acetate gel at 60 mA in glycine-acetate 1 x running 
buffer (see appendix). Samples contained 25 µl protein, plus 5 µl of 50 % glycerol and 5 µl of 
glycine-acetate 5 x glycine-acetate running buffer (see appendix) and finally 1 µl of labeled 
hormone (0.01 µCi). The resulting gel was dried under vacuum for one hour at 60-80 ºC 
(Drygel.jr se540, Hoeffer Scientific Instruments, UK) and exposed for 48 h at -80 ºC to 
Kodak BioMax MS film in a cassette containing an intensifying screen.  
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THs binding to sbrTTR WT and mutants by [125I]-T3 binding assay 
sbrTTR binding assays were developed using the wild type protein as described in chapter 2. 
In order to titrate protein concentration, several concentrations of sbrTTRWT (0.05, 0.15, 
0.25 and 0.5 µg) were tested. Binding to TTRs was analysed by competition binding assay as 
described in chapter 2 followed by scatchard analysis to determine the dissociation constants 
of T3 and T4 binding to sbrTTRWT, M6 and M12. Scatchard plots were derived form 
displacement curves using the softwear Kell-Radlig (Biosoft, UK). The existence of 
significant differences in the IC50 and Kd values obtained was determined by One Way 
Analysis of Variance (ANOVA) and multiple comparison procedures Tukey (HSD) test. 
Differences were considered statistically significant at p<0.05. All the statistical analysis was 
performed using Sigma Stat software version 3 (SPSS).  
 
SbrTTRWT and mutants fibril formation under acidic conditions 
Production of fibrils by sbrTTR was assessed at several different pH values: pH 7 (control), 
pH 5.5, pH 4.5 and pH 3.5 using previously described methods (Colon and Kelly, 1992; 
Hammarstrom et al., 2001; Lai et al., 1996). Briefly, sbrTTR samples (WT and mutants) were 
diluted to a concentration of 0.1-0.2 mg/ml which is close to the mammalian physiological 
average in blood (0.2mg/ml). Acetate buffers used for dilution (NaOAC 50 mM, KCl 100 
mM) were prepared and NaOH or HCl used to obtain the desired pH. Samples were incubated 
at 37 ºC for 72h and fibrils were collected by centrifugation at 14000 g for 30 min. The 
resulting pellet was carefully resuspended in 1 ml of a buffer solution with Thioflavine T 
(ThT) (Tris 50 mM, 100 mM KCl, ThT 10 µM) prepared immediately before use. To quantify 
the fibril aggregates in solution, fluorescence measurements were recorded in a Fluoromax 3 
spectrofluorometer (Jobin Yvon, Horiba) using a 1 cm path length quartz cell. Excitation and 
emission slit width was of 5 nm. The excitation wavelength was set at 450 nm and the 
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emission spectrum recorded between 450-600 nm. Emission at 482 nm is characteristic of 
ThT bound to amyloid fibrils and is proportional to the quantity in solution (Naiki et al., 
1989). The final spectrum was obtained after subtraction of the ThT baseline spectrum and 
dividing by the exact concentration of each protein.  The existence of significant differences 
between samples was assessed by Two Way ANOVA and multiple comparisons analysis 
(Holm-Sidak method) using Sigma Stat software version 3 (SPSS). Differences were 
considered statistically significant at p<0.05. 
 
 
Results 
Expression and purification of sea bream recombinant TTRWT and mutants 
Sequencing of TTR expression vector constructs confirmed that sbrTTRWT and the two 
mutants sbrTTRM6 and sbrTTRM12 were successfully ligated into vectors and were in 
frame. Optimization studies of recombinant protein expression with sbrTTRWT revealed that 
a 0.2 mM IPTG concentration and 3 h incubation post-induction at 30 ºC were appropriate 
conditions. Recombinant protein expression was carried out in E. coli BL21DE3pLysS strain 
and production of protein was analysed using denaturing SDS-PAGE 15% followed by 
western blotting (not shown). A single immunoreactive protein was identified in bacterial 
lysates with rabbit sbrTTR antiserum. Bacteria (BL21DE3pLysS) transformed with the 
expression vector pET 24b(+) without a sbTTRWT insert and vector pET24b(+)/sbTTRWT 
but without IPTG induction were used as controls and did not express the protein. The same 
expression conditions were used for production of the mutant proteins sbrTTRM6 and 
sbrTTRM12. Analysis of purified proteins by denaturing SDS-PAGE (15% polyacrylamide) 
revealed that the monomeric sbrTTRs were similar to the predicted molecular weight of 12, 
13 and 14 KDa for sbrTTRM12, sbrTTRM6 and sbrTTRWT respectively (fig. 1A). The 
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functional form of TTR is a tetramer and analysis of the purified recombinant proteins was 
also carried out by native PAGE (10% polyacrylamide) followed by silver staining. Single 
bands correspondent to sbrTTRM12, M6 and WT were detected (fig.1B) and  both 
monomeric and native WT and mutant TTRs were immunoreactive with sbTTRWT antisera 
as revealed by western blot (fig. 1C and D respectively). 
 
 
 
 
 
 
 
Figure 1. Analysis of purified sbrTTRWT (WT) and mutants sbrTTRM6 (M6) and sbrTTRM12 (M12). A. SDS-
PAGE 15 % followed by silver staining of purified and concentrated recombinant proteins. Molecular weight 
markers are indicated. B. Analysis of purified and concentrated recombinant protein using Ornstein-Davis 10% 
native PAGE, followed by silver staining. C and D. Western blot analysis of the correspondent protein samples 
in denaturing and native PAGE is shown below the correspondent figure. The samples were transferred to a 
PVDF membrane and immunostained using a primary antisera raised in rabbit against sbrTTRWT (1:10000) and 
a secondary antisera against rabbit Ig conjugated to PAP (1:5000). Colour development was carried out using 
3,3’-diaminobenzidine (DAB).  
 
Analysis of sbrTTRWT and mutants binding to [125 I]-T3 by native PAGE 
The native PAGE autoradiographic patterns after 48 h exposure are shown on fig. 2. After 
pre-incubation of TTR with labeled [125I]-T3, different gel migration patterns were detected 
for the labeled hormone. [125I]-T3 alone migrated close to the electrophoretic front, [125I]-T3 
bound to WT and both mutant TTRs had a retarded migration and migrated in a position 
similar to the one found for the proteins in the native gel (fig.1). The results indicate that wild 
type and both mutant TTRs bind [125I]-T3 in the solid phase assay.   
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Figure 2. Analysis of [125I]-T3 binding to sbrTTR by native glycine-acetate gel electrophoresis. Purified 
recombinant sbrTTRWT, M6 and M12 were incubated at 0 ºC for 2 h with labeled [125I]-T3 before run on the gel. 
The gel was dried and autoradiographed with 48 h exposure at -80 ºC. As indicated, first lane shows human 
plasma incubated with [125I]-T4 and human serum albumin (HSA) is indicated; Second lane shows [125I]-T3 
pattern in the absence of TTR; the other lanes, as indicated, correspond to sbrTTRWT, M6 an M12 incubated 
with [125I]-T3. 
 
THs binding to sbrTTRWT and mutants by [125I]-T3 binding assay  
In order to establish the optimal concentration of protein for sbrTTR binding assays, four 
different concentrations of sbrTTRWT were tested. [125I]T3 binding was found to increase up 
to a protein concentration of 0.10 µg/tube, after which only a modest increase was observed 
(fig. 3A). A concentration of recombinant protein of 0.05 µg/tube was found efficient and was 
used thereafter for all binding assays with wild type and mutant sbrTTR. The competitive 
binding assays revealed that [125I]-T3 binding to sbrTTRWT was displaced both by increasing 
unlabeled T3 and T4 with similar IC50 values (fig. 3B and table 2). Also, Kd values found for 
both thyroid hormones (fig. 4A and B and table 2) binding to sbrTTRWT were not 
significantly different (p>0.05). These results suggest sbTTRWT has a similar binding 
affinity for T3 and T4, in contrast to previous studies with piscine TTR which suggest it has a 
higher affinity for T3 than T4 (Santos and Power, 1999; Yamauchi et al., 1999).   
 
[125I]-T3 
+ 
M12 
HSA 
 
[125I]-T4 
+ 
 human 
 plasma 
 
[125I]T3 
 
[125I]-T3 
+ 
WT 
 
[125I]-T3 
+ 
M6 
CHAPTER 3                                                                                                    Transthyretin hormone binding and fibril formation 
   
 91 
   
sbrTTRWT (ng/tube)
0 100 200 300 400 500 600
%
 
[12
5 I
] B
o
u
n
d 
T 3
0
5
10
15
20
25
T3 / T4 (Log M)
-10 -9 -8 -7 -6 -5 -4
B
o
u
n
d 
(%
 
o
f c
o
n
tr
o
l)
0
20
40
60
80
100
120
T3
T4
T3 Log (M)
-10 -9 -8 -7 -6 -5 -4
B
o
u
n
d 
(%
 
o
f c
o
n
tr
o
l)
0
20
40
60
80
100
120
WT
M12
M6
T4 Log (M)
-10 -9 -8 -7 -6 -5 -4
B
o
u
n
d 
(%
 
o
f c
o
n
tr
o
l)
0
20
40
60
80
100
120
WT
M12
M6
A B
C D
 
 
Figure 3. Ligand binding studies of sbrTTRWT (WT), sbrTTRM12 (M12) and sbrTTRM6 (M6). All data 
represented are the mean±SE of duplicate determinations and each assay was independently repeated three or 
more times. A. Purified sbrTTRWT was incubated at several different concentrations (0-0.5µg) with 0.1nM [125I] 
T3 in the absence or presence of 10 µM unlabeled T3 (for determination of non-specific binding) at 0ºC for 2 h to 
determine the best working concentartion. B. Competitive inhibition of [125I]T3 binding to sbrTTRWT at 
50ng/200 µL final volume by increasing concentrations of unlabeled T3 and T4 (0-10 µM). C. Competitive 
inhibition of [125I]T3 binding to sbrTTRWT, M12 and M6 by increasing concentrations of cold T3 ranging from 0 
to 10µM. D. Competitive inhibition of [125I]T3 binding to sbrTTRWT, M12 and M6 by increasing concentrations 
of cold T4 ranging from 0 to 10 µM. Data for competition assays is represented as percentage of control (absence 
of competitor). 
 
In order to test the effect of N-terminal deletions on the binding affinity of sbrTTR to THs, 
parallel competition binding experiments were performed with the three proteins, sbrTTRWT, 
sbrTTRM6 and sbrTTRM12 as previously described (see methods). Binding of [125I]-T3 to 
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WT and mutant sbrTTRs was inhibited by unlabeled T3 in a similar way for each of the 
proteins tested as shown by the almost overlapping competition curves and close IC50 values  
(fig. 3C and table 2). This result seems to suggest that truncation of the N-terminal region of 
sbrTTR has no major influence on T3 binding affinity. Specific binding of the proteins to T4 
was also determined and no significant difference was found in the IC50 value of both in 
sbrTTRWT and sbrTTRM12 (fig. 3D and table 2).  However, a significantly (p<0.001) higher 
IC50 value (622 ± 98.9 nM) was obtained for T4 binding to the mutant sbrTTRM6 when 
compared to sbrTTRWT and sbrTTRM12. In agreement with the preceding results, Scatchard 
analysis revealed close Kd values for sbrTTRWT and sbrTTRM12 binding to both T3 and T4 
and for sbrTTRM6 binding to T3 (see fig. 4 C, D, E and table 2). However, again a 
significantly (p<0.001) higher dissociation constant of 252.3 ± 15.8 was found for sbrTTRM6 
binding to the hormone T4.  
  
Table 2. Summary of IC50 and Kd values for sbrTTRWT, M12 and M6 binding to THs. Values are presented as 
mean ± SE for the sbrTTRWT (n = 7 for IC50 and n=5 for Kd) and mutants (n = 3). One way ANOVA and 
multiple comparison Tukey test were used for comparison of all values for each parameter determined (IC50 or 
Kd). Only T4 binding to mutant sbrTTRM6 was found to be different either between IC50 or Kd values 
(*p<0.001). 
 
 
Overall the results seem to indicate that N-terminal truncation does not affect the affinity of 
sbrTTR for triiodothyronine (T3). Although the same cannot be said about its binding to 
thyroxin (T4), in which intriguingly, removal of the first 6 N-terminal amino acids of sbrTTR 
IC50 values  Kd values 
 
sbrTTRWT sbrTTRM12 sbrTTRM6  sbrTTRWT sbrTTRM12 sbrTTRM6 
T3 19.6±3,3nM 17.9±3.2 nM 21±1.9 nM  10.6±1.7nM 13.5±3,4M 8.47 ± 0.4 nM 
T4 18.3±1.5nM 21.8±4.0 nM 622*±98.9nM  9.8 ±0.97nM 17.9±4,2M 252.3*±15,8nM 
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caused a great loss of affinity (approximately 25 x lower), while removal of the first 12 amino 
acids caused no significant change (p>0.05) in binding affinity compared to sbTTRWT.  
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Figure 4. Scatchard analysis of sbrTTRWT and mutants binding to THs. Plots represent sbrTTRWT (WT), 
sbrTTRM12 (M12) and sbrTTRM6 (M6) binding to T3 (A, C and E) and T4 (B, D and F) respectively. Each plot 
was estimated from displacement curves using the softwear Kell-Radlig (Biosoft) and Kd values determined are 
the mean of three or more independent determinations carried out in duplicate in each assay.  
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Amyloid fibril formation by sea bream recombinant TTRWT and mutants 
Human TTR WT was previously shown to form fibrils after prolonged incubation at 37 ºC 
and low pH (Colon and Kelly, 1992). In the present study sbrTTRWT and N-terminal mutants 
were analysed for their ability to form fibrils in acidic conditions. The amount of fibril 
formation at increasingly acidic pH was monitored by fluorescence measurements in the 
presence of the dye Thioflavine T. As emission at 482 nm is characteristic of ThT bound to 
fibrils, fluorescence spectrum were recorded between 450-600 nm. The maximum emission 
intensity found for each protein at each pH was related to that obtained for the sbrTTRWT at 
pH 3.5 (maximum value found) which was taken as 100%. The final result is depicted in fig. 
5 as a bar graph and shows that sbrTTRWT, in common with human TTR, also has the ability 
to form fibrils in acidic conditions in vitro. However, the extent of fibril formation only 
increases dramatically at pH 3.5 (p<0.001 when compared to pH 7), whereas for the human 
protein, maximum fibrillation was found to occur at pH 4.4. As for the mutant proteins, 
sbrTTRM12 showed significant amyloidogenic properties at an even higher pH of 4.5 with no 
further increase at pH3.5. Interestingly, for the mutant sbrTTRM6 no significant acid-induced 
fibril increase was found (p>0.05) even at pH 3.5 (p<0.001) when compared to the WT at the 
same pH. sbrTTRM6 appears to have lost its amyloidogenic properties in acidic conditions. 
The result seem to indicate that removal of the first 12 N-terminal amino acids slightly 
decreases sbTTR stability, as fibrils start to form at less acidic conditions when compared to 
the WT (pH 4.5). However, removal of only the first 6 N-terminal amino acids seems to 
completely inhibit amyloid fibril formation in vitro under acidic conditions.   
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Figure 5.  Comparison of sbrTTRWT, M6 and M12 fibril formation after partial acid denaturation at the 
indicated pHs. Fibril production at each pH was determined by fluorescence emission at 482nm in the presence 
of the dye Thioflavine T. The highest emission intensity obtained for sbrTTRWT at pH 3.5 was considered as 
100% and all the other measurements were determined relative to it. Multiple comparison statistical analysis 
between all the samples revealed significant (*) increase in fibril formation only for sbrTTRWT at pH 3.5 and at 
both pH 4.5 and 3.5 for the mutant M12. As for the mutant M6 no significant increase in fibril formation was 
found between the different pHs. At pH3.5 and pH4.5, M6 ability to produce fibrils was residual when compared 
to the WT (p<0.001) and M12 (p<0.001) respectively.     
 
 
Discussion 
Evolution of TTR binding affinity for THs 
Over the last few years, TTR cDNA and amino acids sequences have been described for a 
number of representatives of different phylogenetic groups. Several studies concerning TTR 
affinity for the thyroid hormones T3 and T4 seem to indicate that during evolution TTR 
progressively lost its higher affinity for T3 in lower vertebrates and became a T4 binder in 
eutherian mammals, (reviewed in Power et al. (2000a)). This evolution is consistent with 
physiologically advantageous adaptations regarding THs transport in which T4 acts as a 
precursor hormone liberated from the thyroid gland and conversion to T3 occurs in a tissue-
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specific manner being regulated by deiodinases. Also, the strong affinity of TTR for T4 
counteracts the easy permeation of THs into the intracellular compartment as a consequence 
of their lypophilic character. This notion has gained support from studies of T3 and T4 affinity 
for TTR in reptiles (Achen et al., 1993; Prapunpoj et al., 2002), amphibians and fish (Eneqvist 
et al., 2003; Santos and Power, 1999; Yamauchi et al., 1993; Yamauchi et al., 1999). 
However, values reported so far to describe affinities between TTRs and THs are very 
variable between studies even for the same proteins, probably as a consequence of assay 
methods and protein origin (serum or recombinant). For instance, Eneqvist, Lundberg et al in 
2003 (Eneqvist et al., 2003) report that sea bream recombinant TTR has a stronger affinity for 
T3 in a dot-blot analysis, although in the same assay no binding of T3 to human recombinant 
TTR was detected. This may suggest that TH binding to recombinant TTRs may be weaker 
than native TTR in serum. Also the characteristics of these solid-phase methods which 
involve protein binding to membranes may affect protein conformation and in this way TH 
binding. Sea bream recombinant TTR, has been indicated to bind preferentially T3 but only on 
qualitative solid phase gel assays (Santos and Power, 1999). In other fish species, values for 
TTR:TH affinity have been reported for masu salmon serum TTR (Yamauchi et al., 1999) 
which had 3 times higher affinity for T3 than T4. In the present study, in contrast with 
previous studies, we report that sbTTR has similar affinity for T3 and T4 in a liquid phase 
competitive binding assay.   
Comparison of TTR sequences from representative species reveals a high degree of 
conservation between eutherians, marsupials, birds and lizards. However, sequence identity of 
TTR from those species and amphibian and fish is lower (Power et al., 2000a). Also, 
comparative studies of the three-dimensional structure determined for human, rat, chicken and 
sea bream TTR, revealed a highly conserved tetrameric structure but a surface potential, 
especially at the TH binding site, much more negative in chicken and sea bream (Power et al., 
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2000a). Moreover, the difference in affinity of T3 and T4 binding to masu salmon TTR, was 
not as great as observed with other species, such as bullfrog where a 360 times greater affinity 
was found for T3 than T4 (Yamauchi et al., 1993). Such observations taken together with the 
data presented here for sbrTTR, suggest that fish TTR has a similar affinity for both THs. It 
would appear that although from amphibians onwards TTR evolved from a T3 to a T4 binder 
by a Neo-Darwinism mechanism of evolution, in fish an alternative evolutionary process may 
have occurred. Nonetheless further studies of TTR:TH binding are needed from representative 
of the main classes of fish which are the most numerous and diverse vertebrates (Helfman et 
al., 1997). Moreover, studies of ancient species (hagfish and lamprey) close to the divergence 
of the fishes from the lineage giving rise to tetrapods will be necessary to establish the TH 
binding characteristics of TTR in common ancestral vertebrates. The differing hormone 
affinity of TTR in modern teleosts compared to other vertebrates raises interesting questions 
about the functional significance of this change.  
 
Role of the N-terminal region on sea bream TTR binding  
Multiple amino acid sequence alignments of monomeric TTR from several species show a 
high degree of conservation for this protein. More specifically, it reveals that the amino acids 
predicted to be involved in the TH binding channel are almost 100% conserved during 
evolution, suggesting that TH binding is probably the most important function of the protein. 
However the N-terminal region of the polypeptide seems to be the most variable region 
showing progressive changes in length and hydropathy from fish to mammals. This segment 
is shorter and more hydrophilic in eutherians becoming longer and more hydrophobic in 
marsupials (with two additional amino acids), and in birds, reptile and amphibian (with three 
additional amino acids). These changes could be explained by splice site shifts of intron 1 as 
previously proposed (Aldred et al., 1997), but their effect on protein function is not yet clear. 
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A shorter and more hydrophilic tail seems to be coincident with an increase in affinity for T4. 
Moreover, the fact that in the tetrameric structure, this region is thought to be situated at the 
entrance of the binding channel suggests that its size could influence TH access to the binding 
sites. These observations led to the hypothesis that the length and hydrophilic nature of the N-
terminus are important for TH binding properties of TTR.  
So far, binding studies involving recombinant chimeric xenopus/crocodile TTR and recently 
with human/crocodile TTR provided experimental evidence that this region influences TH 
binding affinity of TTR (Prapunpoj et al., 2006; Prapunpoj et al., 2002). In order to shed more 
light on this matter, in the present study, two mutated sbrTTRs were produced, in which the 
first 6 (sbrTTRM6) and 12 (sbrTTRM12) amino acids were removed from the N-terminal 
region of the protein. The sbrTTRM12 mutant maintained TH binding characteristics close to 
sbrTTRWT, while the sbrTTRM6 mutant had approximately 25 times lower affinity for T4 
but not for T3. This curious result could indicate that the size of the N-terminus is not directly 
related to the access of THs to the binding site as has been suggested (Power et al., 2000a) but 
that hormone binding is probably most affected by the properties of the amino acids in this 
region. This influence could be due directly to the amino acids located at the extremity of the 
molecule, or because of the overall charge or conformation acquired by this region and 
possible interactions established with the binding channel.  
Analysis of the hydrophobicity profile of sbTTR N-terminal sequence using Protscale tool at 
http://www.expasy.ch/tools/protscale.html and according to the amino acid scale by Kyte & 
Doolittle shows that hydrophobicity increases towards the inside of the N-terminal sequence 
of sbTTR monomer. Therefore, the N-terminus of sbrTTRM12 is more hydrophobic than in 
sbrTTRM6 and even more than sbrTTRWT. In light of these observations our results do not 
support the notion that increased hydrophilicity is associated with a higher affinity for T4 and 
suggest that other factors must be taken in considerations when analysing the binding 
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properties of TTR. Nonetheless the N-terminal region does appear to be important for 
determining hormone affinity possibly through its interaction with the binding channel. In the 
electron density map of sbTTR, unidentified electron density was found in the centre of the 
channel which could correspond to N-terminal residues of the protein (Eneqvist et al., 2004). 
Structural studies also show that there are several amino acid substitutions in the hydrophobic 
core of piscine TTR compared to the human protein and that residue Val14 (close to the N-
terminus) can affect the position of the otherwise conserved residues. Furthermore, Lys15, 
seems to play a crucial role in hormone binding to the protein. Together with Glu54, this 
residue is located at the entrance of the channel and interacts strongly with THs (Eneqvist et 
al., 2004). Such evidence suggests that amino acids located close to N-terminus can strongly 
influence the surrounding environment and thus affect hormone binding to the protein. 
Therefore it is not surprising that some amino acid modifications can cause strong affinity 
differences while at the same time other modifications have no effect. In conclusion, the 
results of the present study indicate that the N-terminal region plays an important role on the 
ability of TTR to bind THs. However, the results do not necessarily correlate with the binding 
evolution to T4, or with the size of the N-terminus but with an overall combination of specific 
amino acid properties. 
 
N-terminal region and sea bream recombinantTTR tetramer stability 
It is known that human TTR can form amyloid fibrils in acidic conditions. In vitro studies 
have shown that TTR forms fibrils upon incubation at low pH at 37 ºC (Colon and Kelly, 
1992). However, at physiological concentrations and pH it retains its native structure. TTR 
amyloid begins to form only when tetramers dissociate into their monomeric intermediates 
that self assemble into fibrils (Damas et al., 1996; Hammarstrom et al., 2002; Lai et al., 1996; 
Quintas et al., 1999). Thus, the consensual approach to prevent amylodogenesis relies on 
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stabilization of the tetrameric native conformation. Several studies have shown that the 
binding of many small molecules including the natural ligand T4 to TTR’s central channel 
favours tetramer fold stability reducing fibril formation (Adamski-Werner et al., 2004; 
Klabunde et al., 2000; Miroy et al., 1996; Morais-de-Sa et al., 2004; Purkey et al., 2001). So 
far, no particular region of the TTR molecule has been associated with its amyloidogenic 
properties, although previous findings strongly relate fibril formation with the central thyroid 
hormone-binding channel stability. In the present study we suggest that changes in the N-
terminal region of the protein monomer can affect sbTTR affinity for THs by interfering with 
the properties of the binding channel. In this way, such changes might also affect tetramer 
stability and consequent fibril formation.  
Fluorimetric measurements were used to compare the extent of fibril formation at low pH for 
sbrTTRWT and the two N-terminal mutants sbrTTRM12 and sbrTTRM6. Interestingly, the 
mutant sbrTTRM6 that lost affinity for the hormone T4 seemed to be more stable and did not 
form fibrils at a pH as low as 3.5. Again, charge or conformational changes imposed by N-
terminal amino acids are likely to be involved. One could speculate that the electrostatic or 
structural characteristics of sbrTTRM6 N-terminal residues may, by interacting with the 
binding region, strengthen the tetramer stability preventing its dissociation and amyloidosis. 
The greater resistance of sbrTTR to fibril formation found in the present study compared to 
previous studies of the human protein (Eneqvist et al., 2003; Lai et al., 1996) makes further 
comparative analysis concerning TTR stability of great interest. Moreover, the possibility of 
relating a specific region with protein fibril formation may offer a means by which to combat 
this process, and it will be of importance to investigate this further. 
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Abstract 
 
Transthyretin (TTR) is a thyroid hormone binding protein (THBP) which in its tetrameric 
form transports thyroid hormones (THs), thyroxine (T4) and triiodothyronine (T3) in the blood 
of vertebrates. The principal site of production of TTR is the liver but in the sea bream TTR 
mRNA is also present in the heart, intestine and brain. The regulation of TTR is unstudied in 
fish and the normal circulating level of this THBP is unknown. The aim of the present study 
was to establish factors which regulate TTR production in fish. As a first step a number of 
tools were generated; sea bream recombinant TTR (sbrTTR) and specific sbrTTR antisera 
which were used to establish an ELISA (enzyme-linked immunosorbent assay) for measuring 
TTR plasma levels. Subsequently, an experiment was conducted to determine the influence of 
THs on TTR production. Circulating physiological levels of TTR in sea bream determined by 
ELISA are approximately 3.8 µg.ml-1. Administration of T3 and T4 to sea bream significantly 
increased (p<0.001 and p<0.005, respectively) the concentration of circulating TTR (~11.5 
µg.ml-1) in relation to control fish, but did not change gene transcription in the liver. 
Methimazol an antithyroid agent, failed to significantly reduce circulating TH below control 
levels but significantly increased (p<0.005) plasma TTR levels (approximately 10.8 µg.ml-1) 
and decreased (p<0.05) transcription in the liver. Future studies will aim to elucidate in more 
detail these regulatory pathways. 
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Introduction 
Transthyretin (TTR) is one of the binding proteins that convey thyroid hormones (THs) in the 
bloodstream. This role is shared with a number of other proteins and lipoproteins, although 
thyroxine binding globulin (TBG), and serum albumin are the other major serum proteins 
implicated in vertebrates (Bartalena, 1990; Langsteger, 1997; Schussler, 2000). In humans, 
TTR plasma concentrations (~300 mg/l) largely exceeds that of total THs (0.05-0.12 mg/l) 
and less than 1% is involved in hormone transport raising questions about other potential 
functions (Robbins J., 1986). In vertebrates, TTR also plays an important role in retinol 
transport as it also binds retinol-binding protein (RBP) (Kanai et al., 1968; Peterson, 1971; 
van Jaarsveld et al., 1973) and both proteins are secreted by the liver in the same ratio 
remaining closely bound in plasma (Ingenbleek and Bernstein, 1999). Although TTR is 
principally a secretory product of the liver (Schreiber, 1987) it is also highly expressed in the 
choroid plexus of the brain in some vertebrates (Harms et al., 1991) and this has led to the 
formulation of several models for its evolution. 
In mammals, TTR is an acute phase protein and serum levels are abruptly depressed in 
response to inflammation or infection and it has also been extensively characterised as a 
marker of malnutrition or stress (Brugler et al., 2002; Ingenbleek and Bernstein, 1999; 
Ingenbleek et al., 1972; Ingenbleek and Young, 1994; Ingenbleek and Young, 2002). In fact 
although the response of TTR to a number of different physiological or experimental 
conditions has been characterised, relatively little is known about the way in which endocrine 
factors and in particular, THs, regulate TTR synthesis. Studies using thyroidectomized rats, 
suggest low susceptibility of TTR to thyroid status and point to the involvement of regulatory 
pituitary factors on TTR´s production (Franklyn et al., 1989; Vranckx et al., 1994). Similar 
studies involving other vertebrates are scarce or non-existent.  
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TTR has been identified in teleost fish and shown to bind THs (Kawakami et al., 2006; Santos 
and Power, 1999; Yamauchi et al., 1999) suggesting it also behaves as a thyroid hormone 
binding protein (THBP) in these vertebrates, although its function as a RBP binder, remains 
unclear (Berni et al., 1992; Folli et al., 2003; Zapponi et al., 1992). Physiological factors 
which affect TTR production in fish are largely unstudied, although estradiol (Funkenstein et 
al., 2000) and food restriction (Power et al., 2000b) down regulate liver TTR mRNA 
expression. An increase in E2 levels during the reproductive cycle is usually coincident with a 
reduction in TH plasma concentrations and it is also well established that food shortage 
causes down regulation of the hypothalamus-pituitary-thyroid axis resulting in reduction in 
circulating THs (Eales and Himick, 1988; Scott-Thomas et al., 1992). Taken together the 
preceding observations appear to indicate that reduction of TTR gene expression in fish is 
coincident with situations in which THs are depleted, suggesting THs may directly or 
indirectly regulate plasma TTR.  
The objective of the present study therefore was to establish if TH levels can directly control 
TTR expression and secretion into the circulation. In this context, sea bream recombinant 
TTR was produced, specific antisera were generated and an ELISA for measurement of 
plasma TTR was established. The effect of in vivo treatment with T3, T4 and Methimazol 
(MMI, an antithyroid drug) on total plasma protein, TTR hepatic expression and TTR plasma 
concentrations was assessed in sea bream.  
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Materials and Methods 
Animals and Experiments 
Blood samples used for Western blot and establishment of ELISA were collected from 
“stock” sea bream of different ages (6 months, 1.5 years and 3 years) maintained in 1000 l 
open sea water circuits at ambient temperature and salinity for the Algarve, Portugal. Fish 
were fed daily (3-5 % total fish weight) on commercial ration (PROVIMI, Portugal). Blood 
was removed from the caudal vessel of anaesthetised fish (2-phenoxyethanol, 1:1000 v/v; 
Sigma-Aldrich) using a heparinised syringe. Samples were immediately centrifuged at 1000 g 
for 10 min at 4 ºC and plasma separated and frozen in liquid nitrogen.  
Twenty four sea bream were weighed (mean + SD: 43.43 g ± 7.89 g) and the length measured 
(Mean + SD: 13.61 cm ± 0.70 cm) and then randomly assigned to four groups representing 
three different treatments and the control; each group contained six fish. Fish were maintained 
in conical tanks of 250 l with a through flow (250 l/h) of well-aerated seawater under natural 
photoperiod (14 light:10 dark), salinity (38.28 ± 0.25 %) and water temperature (24.54 ± 1.45 
ºC) for summer in the Algarve. Fish were acclimatised to the experimental tanks for one week 
prior to the start of the experiments. After this period, MMI and hormones T4 and T3 (1 
mg/Kg wet weight) were administered by intraperitoneal injection to fish using coconut oil as 
a vehicle. Control fish received injections of coconut oil alone. All fish were fed with 
commercial diets at the rate of 3 % of total fish weight per tank per day with commercial dry 
pellets (sea bream ration, PROVIMI, Portugal), both during the acclimatisation (1 week) and 
experimental periods (10 days). No mortality was registered during the experiment. At the 
end of the experiment fish were anaesthetised with 2-phenoxyethanol (1:1000 v/v; Sigma-
Aldrich) and blood samples collected as described above. Weight (g) and length (cm) were 
measured and fish were killed by decapitation and a sample of liver taken and frozen in liquid 
nitrogen.  
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Maintenance and manipulation of fish was conducted in accordance with the Guidelines of 
the European Union Council (86/609/EU). 
 
Production of recombinant TTR from sea bream 
Sea bream TTR cDNA (Santos and Power, 1999) subcloned in the vector pET24d(+) 
(Promega) was used to produce sea bream recombinant TTR (sbrTTR) in competent E. coli 
BL21DE3pLysS by IPTG (0.2 mM) induction and further isolated and concentrated. All these 
procedures are given in detail in the general methods section (chapter 2). 
 
Production and characterisation of sbrTTR polyclonal antibodies 
The pure protein was used to raise polyclonal sbrTTR antibodies (see chapter 2). The 
obtained antiserum and a pre-immune serum sample were tested by western blot with 
colorimetric detection as described in chapter 2. Briefly, pure sbrTTR samples were 
fractionated by SDS-PAGE (15%). Duplicate gels were run and one was stained with 
Commassie blue and the other was transferred to hydrophobic polyvinylidene difluoride 
(PVD) membranes fo immunoblotting. Membranes were incubated with three different 
dilutions (1:1000, 1:5000 and 1:10000 in 1x PBS) of rabbit anti-seabream TTR sera for 2h at 
room temperature washed and further incubated with secondary antibody (anti-rabbit IgG-
peroxidase anti-peroxidase 1:5000) prior to colorimetric detection. The same methodology 
was used for the detection of TTR in sea bream plasma. Samples of plasma were collected 
(see Animals and Experiments section) and 8 µl of 1:10 dilutions were loaded on a 15% SDS-
PAGE and further transferred for western blot analysis. 
 
Development of sbrTTR ELISA 
In order to quantify TTR an indirect antigen competitive ELISA method was established 
using the sbrTTR and specific antisera. A range of assay optimisation procedures were carried 
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out including assessment of assay buffers; the coating concentration of TTR (10-100ng/well); 
titration of primary (1:10000-1:160000) and secondary antisera (1:2000-1:60000) to give a 
maximal optical density (OD490nm) of 1 and a background of 0.05-0.08 (OD490nm); assay 
incubation times and washing conditions. ELISA was carried out in triplicate for standard and 
samples in 96-well plates (Nunc, Apogent, Denmark) using the optimised procedure. In brief, 
wells were coated overnight at 4ºC with 10ng/200µl/well sbrTTR dissolved in bicarbonate 
buffer (50 mM NaHCO3 and 50 mM  Na2HCO3 to give a final pH of 9.6) containing 0.1% 
sodium azide, washed 2 x 5 min with PBS/Tween-20 (0.1% v/v). Anti-sbrTTR (1:10000 
dilution) was added to the plate along with either standard protein (3.125- 400 ng/well) or 
samples (200 µl/well) and incubated for 2 h at 37ºC. Excess reagent was removed by washing 
3 x 10 min with PBS/Tween-20 before adding anti-rabbit IgG Peroxidase conjugate (200 
µl/well, 1:4000 dilution, Sigma-Aldrich) and incubating for 1 h at 37ºC. Excess reagents were 
eliminated by washing 3 x 10 min with PBS/Tween-20. Colour was developed with OPD (o-
phenylenediamine dihydrochloride, Sigma-Aldrich, 200 µl/well) for 10 min in the dark at 
room temperature. The reaction was stopped by adding 50 µl/well 2M H2SO4 and absorbance 
read at 490nm in a microtitre plate reader (Biorad, Benchmark). Standard curve, non-specific 
binding and maximal binding was determined in all assays. ELISA validation included 
verification of parallelism between samples and the standard curve, the recovery rate of 
standards added to the assay and the intra-assay and inter-assay variation. Plasma samples 
were diluted 1:10 and 1:20 prior to ELISA. 
 
Condition factor 
The condition factor (K) of the fish before and after the treatments was determined as follows: 
100 x W x L –3, where W stands for body weight (g) and L for length (cm). 
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Total plasma protein  
Total protein concentration in plasma samples was determined using the Lowry Method 
(Lowry et al., 1951), and a bovine serum albumin (BSA) standard curve and measuring 
absorbance at 745 nm. 
 
Radioimmunoassay (RIA) 
Thyroid hormone (T3 and T4) plasma concentrations were measured using a specific and 
reproducible radioimmunoassay (RIA). Briefly, plasma samples were diluted (1/10) in 
phosphate buffer (0.01 M pH 7.6), heat extracted (1h 30 min at 70 ºC) then centrifuged for 5 
min at 4 ºC and 1500 g. The total assay volume was 300 µl and was composed of 100 µl of 
standard or diluted plasma (15 µl of 1/10 diluted plasma in 85 µl buffer), 100 µl of anti T4 
sera (1:8000, ~3 % cross-reactivity with T3; T2652 - Sigma-Aldrich, Madrid, Spain) or anti T3 
sera (1:15000, <0.01% cross-reactivity with T4; T2777 Sigma-Aldrich) and 100 µl of tracer 
([125I]-T4 and [125I]-T3, respectively). Assays were incubated overnight at 4 ºC and separated 
by adding a secondary antibody (100 µl; diluted 1:10 in 0.01% (w/v) rabbit IgG; Sigma-
Aldrich) to all tubes with the exception of those used to determine total counts. Tubes were 
mixed and incubated for a further 20 min at room temperature, after which 300 µ1 of an ice-
cold PEG solution (7.5 % w/v PEG 8000; Merck) in assay buffer was added, and the tubes 
were centrifuged for 10 min, 1500 g at 4 ºC. The supernatants were decanted, and the pellets 
were counted in a gamma counter (Wizard, Pharmacia-LKB). 
  
Northern blot 
Total RNA was extracted from livers using TRI reagent (Sigma-Aldrich) and following the 
protocol provided. The quantity and quality of extracted RNA was assessed by spectroscopy 
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(Pharmacia Biotech Ultraspec 3000) by determining absorbance at A260nm and the ratio, 
A260/A280, respectively. 
Seabream TTR and β-actin probes were produced by PCR using specific primers (TTR 
forward primer: 5’ AAT CCT GGA CGC AGT GAA AGG G 3’; reverse primer: 5’ AGC 
AGC AGA GCC AAG GTG TAG TGA 3’; β-actin forward primer: 5’ GGC CGC GAC CTC 
ACA GAC TAC 3’; reverse primer: 5’ ACC GAG GAA GGA TGG CTG GAA 3’) and the 
recombinant plasmids as template (Santos & Power, 1999; Santos et al, 1997). The 
thermocycle consisted of 3 min at 94 ºC, followed by 30 cycles of 94 ºC for 1 min; 60 ºC for 1 
min and 72 ºC for 1 min (TTR) or 45 s (β-actin) and a final 5 min at  72 ºC. PCR probes were 
isolated using GFX PCR DNA and Gel Band Purification Kit (Amersham Biotech). These 
probes were labelled with [α-32P]dCTP (Redivue [32P]dCTP, Amersham Biotech) using a 
Random Prime Labelling System (Amersham Biotech). Equivalent quantities of liver total 
RNA (30 µg) were denatured and fractionated on a 5.5% formaldehyde/1.5% agarose gel, 
using 1x MOPS (Sigma) as running buffer. Fractionated RNA was then transferred to nylon 
membranes (Amersham Hybond-XL) by capillary transfer, using 10x SSC as transfer buffer 
and fixed by UV crosslinking. Membranes were pre-hybridized for 2 hours in Church-Gilbert 
solution at 60ºC and then hybridized overnight in Church Gilbert solution containing sea 
bream [α-32P]dCTP labelled TTR or β-actin. Subsequently, high stringency washes were 
carried out and membranes were exposed to intensifying screens (Bio-Rad) for 3 hours and 
analysed using a phosphoimager (FX Pro Plus System, Bio-Rad). Hybridisation with sea 
bream β-actin served to normalize RNA loaded in each sample.  
 
Statistics 
All data was analysed using One-way analysis of variance (ANOVA) followed by Tukey 
(HSD) multiple comparison test when statistically significant differences were detected 
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between treatments. All the statistical analysis was performed using Sigma Stat software 
version 3 (SPSS, Chicago, IL, USA). Differences were considered statistically significant at 
p<0.05.  
 
 
Results 
Production of sbr TTRWT 
SbrTTR was successfully produced by IPTG (2 mM) induction of E. coli BL21 pLysS 
containing pET24d-sbTTR. Continuous elution native electrophoresis resulted in isolation of 
pure sbrTTR as assessed by the presence of a single band of the expected size for the 
monomer (14 KDa) using analytical SDS-PAGE 15% (Fig. 1A).  
 
Production of sbrTTR  polyclonal antibodies and western blot analysis  
 
A specific high titer polyclonal sbrTTR antiserum was successfully produced. The sbrTTR 
antiserum at a dilution of 1:10 000 was utilized in western blot and cross-reacted with both 
the monomer and dimer of the sbrTTR (fig. 1B-III). Pre-immune serum included as a negative 
control failed to detect sbrTTR in western blot (fig. 1B-IV). Western blot was also used to 
assess whether the specific antiserum (1:10 000 dilution) cross-reacted and detected sea 
bream TTR present in plasma, an essential characteristic for its use in ELISA. Analysis by 
SDS-PAGE (fig. 1C) and western blot (fig. 1D) of plasma samples from sea bream at 
different stages of development, juvenile (6 months), adult (1.5 years) and mature adult (3.5 
years) revealed a single highly specific band of an appropriate size for the TTR monomer in 
all samples (fig. 1D). Although similar protein loading occurred for each of the plasma 
samples analyzed, TTR immunoreactivity increased with fish age, suggesting the 
concentration of plasma TTR differs with age. Moreover, analytical electrophoresis under 
non-denaturing conditions followed by western blot revealed a single band corresponding to 
the native TTR tetramer (results not shown).  
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Figure 1. A- SDS-PAGE analysis of purified sbrTTR. B- Western blot analysis of sbrTTR using different 
dilutions of sbrTTR antisera for optimisation, lane I= 1:100, lane II= 1:5000, lane III= 1:10000. Strong bands of 
the expected size for monomeric (14 KDa) and dimeric (28 KDa) sbrTTR were detected. Lane IV - immunoblot 
carried out with pre-immune serum failed to detect sbrTTR. C- SDS-PAGE and D- Western blot analysis of 
plasma samples from sea bream at different development stages: 1 and 1’- juvenile, 2 and 2’- young adult, 3 and 
3’-mature adult. The same protein concentration for each sample was loaded on the gel. Western blot revealed a 
single band for each sample showing that the anti sbrTTR antisera also cross-reacts with plasma TTR in a 
specific manner. Band intensity was stronger in older fish, suggesting they have higher concentrations of 
circulating TTR.   
 
sbrTTR specific ELISA 
A simple, reliable and reproducible indirect competitive ELISA was developed using sbrTTR 
as the standard and a rabbit polyclonal antisera raised against the recombinant protein. The 
coating concentration of TTR was 10 ng/well and antiserum against sbrTTR was used at a 
dilution of 1:10 000 which gave a maximal OD490nm of 1 and non-specific background of 
0.05-0.08 at OD490nm. This assay had a mean EC50 (mid-range of the assay), calculated as the 
amount of sbrTTR that gives 50 % of the maximal OD of 0.5± 0.015 µg/well (n=4). The 
lower limit of detection (sensitivity of the assay) was 12.5ng of TTR/well. The sbrTTR 
ELISA had a negligible cross-reactivity (<0.001 %) with other plasma proteins over the 
normal working range of the assay 3.125- 400 ng of sbrTTR/well.  
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The optimal method for fitting the standard curve was the log-logit method, and only the 
linear region of the curve was used for assessment of sea bream TTR in samples. Linear and 
logarithmic curve fitting methods were found to either over or under-estimate the 
concentration of a standard of sbrTTR introduced in the assay. 
Sea bream plasma dilution samples gave good parallelism with the standard curve (fig. 2). No 
non-specific binding effects were found with fish plasma and recovery was 100 ± 19 % (n=9). 
The inter and intra-assay variance were 3 % (n=4) and 5 % (n=6), respectively. The overall 
results from the validation studies indicated that the ELISA developed can be used to 
accurately quantify circulating sea bream TTR.  
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Standard curve of sbrTTR ELISA and dilution curve of plasma sample. Note the dilution curve of 
plasma is parallel to the standard. 
 
THs and MMI administration 
 
There are few studies available in fish documenting how thyroid hormone implants alter 
plasma hormone levels, so this was the first factor evaluated to ensure the treatment utilised 
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(hormone concentration and treatment duration) was adequate. The concentration of plasma 
T3 and T4 in control fish was 35.4 and 36.3 ng/ml respectively, which is in accordance with 
previously reported values for sea bream (Power et al., 2000b). Fish which received a T4 
implant had a significantly higher (p<0.001) plasma T4 concentration than fish treated with T3, 
MMI or control fish (fig. 3A and table 1). In fish treated with T3 a significant increase 
(p<0.01) in circulating T4 over control and MMI fish was also found (fig. 3A and table 1) and 
probably reflects cross-reaction of anti T4 sera with the elevated plasma T3 in the samples. T3 
implants were also effective and caused a significant increase (p<0.001) in total circulating 
T3, over that of control, T4 or MMI treated fish (fig. 3B and table 1).  
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Figure 3. A- Concentration of thyroxine (T4, ng/ml) measured by RIA in plasma collected from each 
experimental group of sea bream: C - control implanted with coconut oil alone, MMI - methimazole, T4 – 
thyroxine, T3 - triiodothyronine. Statistical analysis denote a significant increase (p<0.001) in plasma T4 for the 
T4 implanted group (b) compared to all other groups. A small but significant increase in T4 concentration was 
also verified for the T3 (c) treated group (p<0.01) compared to the control group. B- Concentration of 
triiodothyronine (T3, ng/ml) in plasma from sea bream implanted with MMI, T4, T3 or coconut oil alone (C). T3 
(b’) plasma
 
levels were significantly elevated (p<0.001) compared to all other groups in the T3 injected group. 
Data corresponds to the mean ± SE (n=5 or 6/group).  
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Treatment with the antithyroid agent MMI, which acts through inhibition of thyroid 
peroxidase (TPO) in the thyroid follicle in mammals (Engler et al., 1982), was expected to 
suppress TH levels, however did not significantly change plasma THs compared to control 
fish during the experiment.  
 
Condition factor (K) 
The condition factor (Fulton, 1902) of sea bream at the start and end of the experiment was 
determined. This metric, which gives a general idea of fish physiological well-being was 
unaffected by the short term treatment with THs as no significant differences were found 
between treatment groups and the control (fig. 4A). It seems therefore, that hormonal 
treatment and also the inevitable stress caused by manipulation/injection did not have a 
marked physiological effect that might lead to misinterpretation of the results.  
 
Total protein 
Total plasma protein measurements using the Lowry method did not reveal a significant 
difference in protein concentration between fish subjected to different hormone treatments 
(fig. 4B and table 1). This indicates that increased levels of THs do not cause a significant 
alteration in the concentration of total plasma protein in sea bream. 
 
Plasma TTR concentration 
This is the first time that circulating TTR has been quantified in fish. The concentration of 
plasma TTR in control sea bream was 3.8 µg/ml (table 1). The percentage of total plasma 
protein (~40 mg/ml) which correspond to TTR in sea bream was 0.009 % (n=3). Treatment of 
sea bream with T4, T3 and MMI caused a significant increase (p<0.001 for T3 and p<0.005 for 
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T4 and MMI) in circulating TTR levels compared to the control fish which were given 
coconut oil implants alone (fig. 4C and table 1).  
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Figure 4.  A- Change in condition factor (K= 100 x W x L –3) of the fishes before and 10 days after being 
submitted to the treatments: C – control with coconut oil implant, MMI – methimazol, T4 – thyroxine, T3 - 
triiodothyronine.  No significant alteration in K was found between fish receiving hormone/blocker implants and 
control fish (p> 0.05). B- Total plasma protein concentration measured in the fishes at the end of the experiment. 
No changes in protein levels were observed between any of the treatment groups or the control fish (p> 0.05). C- 
Plasma transthyretin (TTR) levels for each group (same as previous) by the end of the experiment. Significant 
differences were found between the treatment groups, T4 (p<0.005), T3 (p<0.001), methimazole (p<0.005), and 
the control fish. No significant differences (p>0.05) were found in plasma TTR concentrations in T4, T3 and 
MMI treated fish. Error bars refer to standard error (SE).   
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Table 1- Concentration of total plasma protein, circulating THs and TTR in each of the experimental groups. 
Values are given as the mean ± SE. Number of samples analysed are indicated in brackets 
 
 
Hepatic TTR mRNA transcription 
The results of sea bream TTR hepatic mRNA exposed to [α-32P]dCTP labelled TTR or β-
actin autoradiography (Fig.5 A) and relative quantification of sea bream TTR hepatic 
expression carried out after radiometric analysis are shown in fig. 5 A and B, respectively. T4 
and T3 treatment did not change hepatic TTR expression in relation to control fish. However, 
there was a statistically significant (p<0.05) reduction in TTR expression in fish injected with 
MMI compared to all other groups. 
 
  
 
 
 
 
 
 
Fgure 5 – A- Autoradiographic pattern of the Northern blot of sea bream TTR hepatic mRNA from the different 
experimental groups exposed to [α-32P]dCTP labelled TTR. B- Comparison of sea bream TTR hepatic 
expression (TTR/β-actin ratio) between different treatments: MMI (n=5), T4 (n=5), T3 (n=6) and control (n=6). 
All data was obtained by radiometric analysis. Results are expressed as mean ± SEM and were analysed by One-
way ANOVA followed by Tukey test, using SigmaStat software. Statistically significant differences were 
observed between MMI and all other groups (p < 0.05).  
 
Treatment 
T4 
(ng/ml) 
T3 
(ng/ml) 
Total 
(mg/ml) 
TTR 
(µg/ml) 
T4 1324.1±150.2 (6)       85.9±17.4 (6) 41.2±2.3 (6)           11.5±2.0 (3) 
T3 145.2±18.3 (6)     901.0±196.2 (5) 42.7±1.6 (6) 11.9±0.8 (6) 
MMI  56.0±12.8 (5)       62.7±12.7 (5) 43.7±2.6 (5) 10.8±1.3 (3) 
Control 36.3 ± 11.9 (6)          35.4±5.0 (6) 42.8±1.8 (6)    3.8±0.05(3) 
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Discussion 
 
TTR is known to be involved in TH transport and metabolic processes related to the thyroid 
axis in fish (Kawakami et al., 2006; Power et al., 2000b; Santos and Power, 1999; Yamauchi 
et al., 1999). However, studies concerning the direct action of THs on TTR production in fish 
are inexistent and the present study focused on this issue. One barrier to studying the 
influence of different physiological factors on TTR in fish is the lack of tools with which to 
measure it. For this reason in the present study a recombinant TTR protein from a teleost fish, 
sea bream, was produced, purified and used to raise specific antisera against the protein. A 
sensitive and specific ELISA was developed for sea bream TTR and used to measure 
circulating levels for the first time in a teleost fish. A concentration of  3.8 µg/ml of plasma 
TTR in juvenile sea bream (table 1, control group) was found which is approximately 100 
times lower than the reported concentrations for human plasma TTR (0.2-0.3 mg/ml) 
determined by different immunological methods (Ingenbleek and De Visscher, 1979; Ritchie 
et al., 1999; Sachs and Bernstein, 1986) including ELISA (Purkey et al., 2001) which is the 
method of choice for clinical analysis. The low percentage of total plasma protein which 
corresponds to TTR in sea bream (~0.009 %) was unsurprising as albumin is the principal 
protein in blood and is far more abundant than other plasma proteins in all the species studied 
so far.  
The concentration of plasma THs in control fish detected by specific radioimmunoassay was 
coherent with values previously reported for sea bream using a similar assay (Power et al., 
2000b). Very similar concentrations of T3 and T4 (35.4 ± 5.0 and 36.3 ± 11.9 ng/ml, 
respectively) were found in sea bream plasma, which contrasts with the situation in humans 
where plasma T4 (50-120 ng/ml) is markedly higher than T3 (0.95-1.90 ng/ml). The 
concentration of TTR in humans is 1000 times higher than the concentration of plasma THs 
so that the ratio of TH:TTR (approximately 85 ng/ml:250 µg/ml) in humans is much lower 
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than the ratio of TH:TTR (approximately 35.8 ng/ml:3.8 µg/ml:) in fish. The biological 
significance of this difference will require further study but may be related to a number of 
factors such as; differences in the abundance and affinity of other plasma THBP in these 
species; the TH:TTR affinity (Chang et al., 1999; Yamauchi et al., 1999) and also the 
possibility that TTR evolved to acquire different and wider functions in mammals, such as 
RBP transport (Kanai et al., 1968; Peterson, 1971; van Jaarsveld et al., 1973). For example, 
the affinity of TTR is greatest for T4 in mammals, while in masu salmon it has greatest 
affinity for T3 (Yamauchi et al., 1999) and in sea bream it has similar affinity for both T3 and 
T4 (Morgado et al., 2006). Only 1 % of circulating human TTR is involved in TH transport in 
humans (Robbins J., 1986), in fish the proportion of THs which circulate bound to TTR is 
unknown, as is its relative importance as a THBP and it also remains to be established if 
piscine TTR also transports RBP (Folli et al., 2003).  
TH implants were highly effective in increasing T4 and T3 plasma levels after 10 days of 
treatment. The administration of T4 did not cause a significant change in the concentration of 
plasma T3 in sea bream, although in rainbow trout (Fok and Eales, 1984) and rabbitfish 
(Ayson and Lam, 1993) it does, possibly as a consequence of increased conversion of T4 by 
5´-monodeiodination. In fact in teleosts this is the main process responsible for the production 
of T3 (Eales and Deborah, 1989; Eales and Shostak, 1985) and this enzyme activity has been 
found in many species of fish (Leatherland, 1990). In sea bream with increased levels of 
either T3 or T4 there was a significant, approximately 3 fold, increase in circulating levels of 
TTR, although hepatic transcription was unchanged. This result shows that in this species an 
increase in plasma THs (several days) is enough to alter circulating levels of TTR probably by 
changing the rate of secretion and indicates a potential regulatory mechanism. Previous 
findings in vertebrates indicate a negative thyroid control over TTR production and 
physiological alterations caused by food deprivation (Eales, 1988) or inflammation (Dickson 
CHAPTER 4  Transthyretin regulation in fish 
 
 
120 
et al., 1982; Ritchie et al., 1999) which cause a reduction in THs are also accompanied by a 
reduction in plasma TTR. The present study supports previous observations in vertebrates that 
the thyroid exerts control over TTR, but in contrast to mammals, in fish the regulation is 
positive.  
The results of the present study appear to support the theory of “free TH cellular uptake” 
(Ekins et al., 1982; Mendel, 1989) which proposes that free circulating hormone and not 
protein-bound hormone is available for entry into cells. THs are lipophilic and can rapidly 
diffuse into tissues and for this reason binding to transport proteins plays an important role in 
homeostasis of plasma THs. As TTR is a TH transporter in fish (Kawakami et al., 2006; 
Santos and Power, 1999; Yamauchi et al., 1999), it regulates free plasma levels of THs and in 
this way is involved in regulation of the thyroid axis. The increased concentrations of 
circulating TTR observed in the present study should help to restrain the acute increase in free 
THs levels induced by treatments.  
Both T3 and T4 treatments caused a similar increase in circulating TTR in sea bream 
presumably to maintain a similar bound/free hormone ratio. The results of the present study 
and those from previous studies in fish, in which measurable T3 circulates in plasma (Eales 
and Brown, 1993; Power et al., 2000b) raises the intriguing possibility that in fish the more 
effective hormone transport system found in mammals in which T4 acts as a precursor of the 
active hormone T3 has not fully developed. The differences in evolution of the thyroid axis 
between fish and tetrapods may be more fully elucidated by a better understanding of the 
function of deiodinase processing in TH target tissues and the rest of the thyroid axis in fish. 
None of the treatments caused a significant change in plasma total protein compared to the 
control fish despite the increased levels of TTR. This is not surprising as in control fish TTR 
corresponds to only ~0.009% of total plasma protein and the 3-fold increase in treated fish 
would not be detectable with the Lowry assay. No broad fluctuations in any other plasma 
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proteins levels were found though it has previously been suggested in mammals that the 
THBP system might act through differential control of these proteins and that any imbalance 
of the system would be compensated by a change in another element (Schreiber, 2002a). In 
fish albumin (Babin, 1992) and TTR (Santos and Power, 1999) are the only THBPs identified 
so far as thyroxin binding globulin (TBG) has yet to be identified. Far more studies will be 
required of the THBPs in fish in order to characterise how they interact and are regulated and 
their relative importance in homeostasis of the thyroid axis in fish.  
Unexpectedly, MMI a known thyroid axis disrupter in mammals did not appear to block the 
production of THs in sea bream. In general, inhibitory effects on larval teleost development of 
antithyroid agents such as, propylthiouracil, thiouracil and thiourea which in common with 
MMI are thionamides have been reported (Dales and Hoar, 1954; Honma and Murakawa, 
1957; Woodhead, 1966). MMI has been found to interfere with zebrafish development 
(Osama and Klaus, 2003). In fish, post larvae goitrogen interference with TH levels has not 
been found (Liu and Chan, 2002) and may indicate that thyroid axis regulation in adult fish 
permit them to overcome the effect of MMI. The significant increase in plasma TTR levels in 
sea bream coupled to a reduction in liver TTR gene expression caused by MMI treatments 
may be caused by the toxicity of this goitrogen (Crane et al., 2006). It will be of interest to 
establish if in common with mammals, TTR in fish acts as an acute response protein 
(Ingenbleek and Bernstein, 1999). 
In conclusion, the concentration of TTR in fish plasma is reported for the first time using a 
specific ELISA.  It would appear that THs regulate hepatic TTR secretion but not gene 
transcription, although it was not possible to establish in the present study if this was a direct 
or indirect effect. Moreover, it remains to be established at what level this regulation occurs 
and the pathways therein involved. That THs failed to influence the total concentration of 
plasma proteins of which albumin, another THBP, is a significant proportion suggests 
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differential regulation of their production may occur. That MMI failed to act as an antithyroid 
agent in sea bream was unexpected and clearly merits further investigation.  
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Abstract 
 
A number of chemicals released into the environment share structural similarity to the thyroid 
hormones (THs), thyroxine (T4) and triiodothyronine (T3) and it is thought that they may 
interfere with the thyroid axis and behave as endocrine disruptors (EDs). One of the ways by 
which such environmental contaminants may disrupt the TH axis is by binding to TH 
transporter proteins. Transthyretin (TTR) is one of the thyroid hormone binding proteins 
responsible for TH transport in the blood. TTR forms a stable tetramer that binds both T4 and 
T3 and in fish it is principally synthesized in the liver but is also produced by the brain and 
intestine. In the present study, we investigate the ability of some chemicals arising from 
pharmaceutical, industrial or agricultural production and classified as EDs, to compete with 
[I125]-T3 for sea bream recombinant TTR (sbrTTR). Ioxinyl, a common herbicide and several 
polybrominated diphenyl ethers (BDEs) were strong inhibitors of [I125]-T3 binding to TTR and 
some showed even greater affinity than the natural ligand T3. The TTR competitive binding 
assay developed offers a quick and effective tool for preliminary risk assessment of chemicals 
which may disrupt the thyroid axis in teleost fish inhabiting vulnerable aquatic environments.  
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Introduction  
Environmental contamination by endocrine disruptors is presently a major issue of concern. 
Such synthetic chemicals can mimic or block hormones interfering with the endocrine system 
and eventually compromising crucial biological processes. The increasing contamination of 
the biosphere with chemicals with potential endocrine disrupting effects can become a serious 
threat to human and wildlife populations.  
Thyroid hormones (THs) are known to play a crucial role in many metabolic processes and 
are essential for normal growth, differentiation and development of vertebrates (Hadley, 
1996). Their importance in early life stages is well established in mammals and in amphibians 
THs are crucial for metamorphosis (Shi et al., 1996). In fish THs are implicated in 
reproduction and appear to be important in the regulation of development. High 
concentrations are present in fish eggs and increased levels are reported during 
metamorphosis or during the larval-juvenile transition (for review see Leatherland, 1994; 
Power et al., 2001; Yamano, 2005). In light of this evidence, disruption of the thyroid axis 
may seriously compromise normal development, differentiation, growth or reproduction in 
many vertebrates (Boas et al., 2006; Brown et al., 2004).  
The thyroid hormones have a small hydrophobic thyronine nucleus that mediates their action 
by binding to specific nuclear receptors, which act directly on target genes bringing about a 
cellular response (Yen and Chin, 1994). 3, 5, 3’-L-triiodothyronine (T3) is the most active 
hormone and binds with high affinity to nuclear receptors (TRs), while L-thyroxine (T4), 
which is the precursor of T3 binds with low affinity and has few direct actions (Darras et al., 
1998; Hadley, 1996). Almost all THs circulating in the plasma are bound to transporter 
proteins (Larsson et al., 1985) and only free hormones enter cells to elicit a response (Ekins et 
al., 1982; Mendel, 1989). The balance of free to bound THs in the plasma depends on plasma 
proteins, although the importance of this interaction is not entirely understood. 
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In vertebrates, thyroid hormone-binding proteins (THBPs) include transthyretin (TTR), 
thyroxine-binding globulin (TBG) and albumin (ALB). Transthyretin in its tetrameric form 
transports THs and is the major plasma TH carrier in rodents and the main THBP in 
cerebrospinal fluid of both rodents and humans (Schreiber and Richardson, 1997). In small 
eutherians and lower vertebrates both albumin and transthyretin seem to be important for TH 
transport (Power et al., 2000a). However, in tadpoles and fish, TTR is proposed to be the 
major TH carrier protein (Yamauchi et al., 1993; Yamauchi et al., 1999) and is reported to 
have higher affinity for T3 than T4 in birds, reptiles and amphibians (Chang et al., 1999; 
Yamauchi et al., 1993; Yamauchi et al., 2000). The TH affinity of TTR in teleost fish is less 
clear cut and in some species it is reported to have higher affinity for T3 (Yamauchi et al., 
1999), although sbrTTR binds T3 and T4 with similar affinities (Morgado et al., 2006). 
A number of chemicals released into the environment share structural similarity with THs 
(fig.1) and may behave as endocrine disrupting chemicals (EDCs) if they substitute THs and 
disrupt the thyroid axis. Many of these chemicals, usually benzenic halogenated compounds, 
arising from either the industrial, medical or agricultural sector have been reported to interact 
strongly with plasma THBPs, especially TTR in vertebrates (Brouwer et al., 1999; Cheek et 
al., 1999; Ingbar, 1958; Ishihara et al., 2003a; Ishihara et al., 2003b; Lans et al., 1993; 
Rickenbacher et al., 1986; Yamauchi et al., 2000). Other compounds structurally even closer 
to THs are the brominated flame retardants (BFRs), extensively used in electronic and plastic 
materials. These organohalogenic chemicals are produced as commercial mixtures that 
include a wide variety of bromine-containing derivatives, like the polybrominated diphenyl 
ethers (PBDE) or tetrabromobisphenol A (TBBPA), and many of them are found as persistent 
pollutants in the environment with bioaccumulating potencies. 
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Figure 1. Structure of thyroid hormones and several chemicals (potential endocrine disruptors) tested for their 
capacity to compete with sbrTTR-[125I]-T3 binding in the in vitro assay. 
 
 In the past few years BFRs have been associated with endocrine disruption (Darnerud et al., 
2001; Hamers et al., 2006) and many of them were found to mimic THs (Kitamura et al., 
2002; Zhou et al., 2002) and bind human TTR in vitro (Hamers et al., 2006; Meerts et al., 
2000).  
The binding and transport of exogenous compounds by THBPs might be expected to affect 
TH balance as they may be preferentially taken up by cells leading to thyroid axis disruption. 
The aquatic environment and organisms such as fish are constantly threatened by pollution 
resulting from human activity and a previous study has shown that EDCs can bind to TTR in 
masu salmon (Ishihara et al., 2003b). The large number of chemicals released into the aquatic 
environment (from industrial residues, land run-offs and acid rains) and the desire of society 
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to minimize the use of animals for testing highlights the need for quick robust and cheap 
predictive in vitro assays.   
In the present study a competitive binding assay was developed and the effect of putative 
EDCs of agricultural, medical and industrial origin on [I125]-T3 binding to sbrTTR was 
assessed. Teleost fish are frequently used as sentinel organisms for aquatic ecosystem 
contamination and the present in vitro assay with teleost TTR should be a more adequate risk 
assessment tool than equivalent assays with mammalian TTR.  
 
 
Materials and Methods 
Reagents 
Labeled [125I]-T3 (114 MBq µg-1) was purchased from Amersham Biosciences (UK). 
Unlabeled T3, T4, ioxynil and 4-nonylphenol were obtained from Sigma-Aldrich (Madrid, 
Spain). Pentachlorophenol, Diethystilbestrol, Biphenyl and Bisphenol A were acquired from 
Cymit Química, S.L. (Barcelona, Spain). A suite of BFRs were purchased or synthesised 
(table 1). Hormones and all the compounds tested as EDCs were dissolved in 
dimethylsulfoxide (DMSO) to a concentration of 2 mM or 2.5 nM and then diluted in the 
assay buffer; the concentration of DMSO in assays was always less than 1% (v/v). Control 
experiments were carried out with DMSO alone in the same concentration range as used for 
assays with EDCs, in order to assess if it influenced [125I]-T3 binding to sbrTTR. None of the 
concentrations of DMSO tested influenced binding.   
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    Table 1. Source of the brominated flame retardants (BFRs) tested for sbrTTR binding ability 
  
 
 
 
 
 
 
 
 
 
 
 
Production and isolation of sbrTTR 
Recombinant protein expression was carried out in E. coli strain BL21DE3pLysS transformed 
with the expression vector construct pET24d(+)/sbTTRWT by IPTG (0.2 mM) induction as 
described in chapter 2. After cell lysis the protein extract was analysis on SDS-PAGE and 
further purified, concentrated, dialyzed and submitted to western blot with colorimetric 
detection with specific anti-sbrTTR antisera. All these procedures are given in detail in the 
general methods section (chapter 2). 
  
Analysis of [125I]-T3 binding by sbrTTR using native PAGE 
To establish if the purified sbrTTR was able to bind ligand it was incubated on ice for 2 h 
with [125I]-T3 (0.01 µCi); a parallel reactions with [125I]-T4 (0.01 µCi) and a human plasma 
sample (1.5 µl) which contain albumin (67 kDa) that binds T4 was also conducted. 
Subsequently, binding reactions were subject to electrophoresis on 12.5 % native glycine-
acetate gels run at a constant current (60 mA) in glycine-acetate 1 x running buffer (see 
BFRs Acquired from 
BDE-28, BDE-47,  BDE-49,  BDE-99,  BDE-100,  BDE-153,  
BDE-155,  BDE-169,  BDE-181,  BDE-183,  BDE-190,  
BDE-206,  BDE-209, 6-OHBDE-47 
                       Stockholm University 
        (Dr. Göran Marsh and Dr. Ake Bergman) 
BDE-19,  BDE-38,  BDE-39,  BDE 127,  BDE 185 Accu Standard 
Pentamix Great Lakes Chemical Corporation 
TBBPA, 246TBP Aldrich 
HBCD Dead Sea Bromine group 
αHBCD, βHBCD, γHBCD Cambrige Isotope Laboratories 
 
TBBPADBPE 
 
Broomchemie BV Terneuzen 
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appendix). The gel was then dried under vacuum for one hour at 60-80 ºC (Drygel.jr se540, 
Hoeffer Scientific Instruments, UK) and exposed for 48 h at -80 ºC to Kodak BioMax MS 
film in a cassette containing an intensifying screen.  
 
[125I]-T3 Competitive Binding assay 
For competitive binding studies, sbrTTR (50 ng per tube) was incubated in 200µl TCN buffer 
(see appendix) containing tracer 0.1 nM [125I]-T3 in the presence of increasing concentrations 
of unlabeled ligand T3, or EDCs (0-10 µM) for 2 h on ice. Separation of free and sbrTTR 
bound [125I]-T3 was carried out as described in chapter 2- Ligand binding assay section. 
Assays were done in duplicate and each chemical was tested on at least three different 
occasions. Results were analysed using One-way analysis of variance (ANOVA). If 
statistically significant differences were detected between treatments, a Tukey (HSD) multiple 
comparison test was applied. All the statistical analysis was performed using Sigma Stat 
software version 3 (SPSS). Differences were considered statistically significant at p<0.05.  
 
 
Results 
Production of pure sbrTTR and [125I]-T3 binding in native PAGE 
sbrTTR for use in binding assays was obtained after expression optimization under 0.2 mM 
IPTG induction of recombinant E. coli BL21DE3pLysS at 30 ºC (fig. 2A-a). The sbrTTR was 
purified from bacterial extracts by continuous-elution native electrophoresis and a single band 
of the expected size for the monomer (14 kDa) was identified analytical SDS-PAGE 15% 
(reducing conditions); no additional proteins were detected even though the extremely 
sensitive silver staining method was used (fig.2 A-b). Western blot of the purified protein 
using specific sbrTTR antisera revealed a single immunoreactive protein of the expected size 
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(fig. 2A-c). Concentration of total protein in the sbrTTR purified sample (4 ml final volume), 
determined using the molar extinction coefficient at 280 nm and was found to be 0.25 mg/ml. 
Nondenaturing PAGE of the binding reactions of human plasma incubated with [125I]-T4 or 
sbrTTR with [125I]-T3 gave a single intense band respectively after autoradiography and had a 
different migration pattern from labelled hormone alone (fig. 2B); the [125I]-T3 bound to 
sbrTTR could be displaced by excess unlabelled hormone (not shown). The recombinant 
sbrTTR was found to migrate slightly faster than human plasma albumin (67 kDa) with a 
pattern typically described for tetrameric TTR in most other species (Chang et al., 1999; 
Kabat et al., 1942); TTR is not visible in the human plasma sample as it is found in blood in 
much lower concentrations than albumin.  
 
 
 
 
 
 
 
 
Figure 2. A - Analysis of sbrTTR production and purification. a) SDS-PAGE of protein extracts prepared from 
recombinant bacteria after induction with IPTG; previously purified sbrTTR sample was used as a marker for 
comparison (first lane) b) sbrTTR purified and analysed by SDS-PAGE (15%) followed by silver staining, or by 
c) western blot with specific anti-sbrTTR sera. B – PAGE under native conditions of ligand-binding experiments 
with human plasma and sbrTTR
 
incubated respectively with [125I]-T4 or [125I]-T3. A single intense band of d) 
human albumin (approx. 67 KDa) + [125I]-T4 and g) sbrTTR + [125I]-T3 were identified after autoradiography. A 
single band migrating with the “electrophoretic front” was detected for e) [125I]-T3 and f) [125I]-T4.  
 
 
 
HSA
17 KDa
11 KDa
C+        a       b          c
sbrTTR
A B
d      e             f             g   
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Effect of EDCs on [125I]-T3 binding to sbrTTR 
Competitive binding experiments with the pure recombinant protein using [125I]-T3 revealed 
that binding to sbrTTR was displaced by increasing concentrations of unlabeled T3 and T4. 
Moreover, both T3 and T4 displaced [125I]-T3 from TTR with similar efficiency (p>0.05) and 
had IC50 values of 23.8 ± 5.4 nM and 20.9 ± 3.7 nM, respectively (fig. 3 and tables 2 and 3). 
In competitive binding assays with putative EDCs, [125I]-T3 binding to sbrTTR was displaced 
by increasing concentrations of a number of the tested chemicals.  
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Figure 3. Competitive inhibition curves of [125I]-T3 binding to sbrTTR by EDCs. SbrTTR was incubated for 2 h 
on ice with 0.1 nM [125I]-T3 in the presence of the following compounds: A- (●) T3, (○) T4, (▼) 
pentachlorophenol, (∆) DES, (■) ioxynil. B- (●) T3, (○) T4, (▼) Bisphenol A, (∆) Biphenyl, (■) 4-nonylphenol. 
C- (●) T3, (○) T4, (▼) BDE-47, (∆) BDE-49 and (■) TBBPA. Total binding is shown as a percentage of the 
control and each value is the mean of two duplicates.  
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The brominated flame retardants, TBBPA and BDE-49, 47 and 99, were the most potent 
inhibitors of [125I]-T3 binding to sbrTTR with IC50 values significantly lower (p<0.05 for 
BDE-47 and 99; p<0.001 for TBBPA and BDE-49) than the natural ligand T3 and T4 (fig. 3C 
and table 3). Ioxynil, a common herbicide (fig. 3B and table 2), and a panel of several other 
BFRs, mostly BDEs but also pentamix and 246TBP (table 3) were also strong competitors for 
[125I]-T3 binding to sbrTTR and their IC50 values did not differ significantly (p>0.05) from 
that of THs, suggesting they have similar affinity for the protein (tables 2 and 3). 6OH-BDE-
47 was a moderate competitor that could displace [125I]-T3 binding to sbrTTR although with a 
significantly higher (p<0.001) IC50 value (700.6 ± 40.4 nM) than THs (table 3). 
Pentachlorophenol, Diethylstilbestrol (DES) and 4- Nonylphenol were poor competitors 
showing much higher IC50 values (table 2) than T3 and T4 (p<0.001). Bisphenol A and 
Biphenyl and many of the BFRs tested did not show binding to sbrTTR as assessed by their 
inability to displace [125I]-T3 binding to the protein. The rank order of hormone and chemicals 
binding to sbrTTR is described in tables 2 and 3.  
 
Table 2. sbrTTR binding ability to THs and several putative EDCs. The IC50 values are indicated in rank order of 
binding affinity expressed as mean ± S.E. (n = 4 for THs and ioxynil and n = 3 for the tested chemicals). The IC50 
of T3 and T4 binding to sbrTTR was not significantly different (p>0.05). 
Chemicals IC50 (nM) 
T4 20.9 ± 3.7 
T3 23.8 ± 5.4 
Ioxynil 38.9 ± 4.9 
Pentachlorophenol *     2480 ± 1023 
Diethystilbestrol *    4849 ± 1841 
4-Nonylphenol *      17035 ± 6865 
Bisphenol A - 
Biphenyl - 
 
                                            
*significantly different from THs binding (p<0.001)                                        
                             - no effect  
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Table 3.  IC50 values of THs and Brominated flame retardants (BFRs) tested for T3-sbrTTR competing capacity 
expressed as mean ± S.E. (n=3) in rank order of binding affinity. The IC50 of T3 and T4 binding to sbrTTR was not 
significantly different (p>0.05).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Significantly different than THs binding with p<0.05 
**Significantly different than THs binding with p<0.001 
- no effect 
 
 
Discussion 
Many hydroxylated compounds, like PCBs, have been shown to have endocrine disrupting 
activity on the thyroid axis and TTR binding abilities in mammals, birds, amphibians and fish 
(Brouwer et al., 1998; Brown et al., 2004; Ishihara et al., 2003a; Ishihara et al., 2003b; 
Yamauchi et al., 2000). In the present study, different compounds frequently found as 
environmental pollutants and some of which have previously been reported to bind human 
TTR in vitro were tested for their ability to interfere with [125I]-T3 binding to sbrTTR (table 
BFRs IC50 (nM)  BFRs IC50 (nM) 
T4 20.9 ± 3.7  BDE 153 [2,2’,4,4’,5,5’] - 
T3 23.8 ± 5.4  BDE 127 [3,3’,4,5,5’] - 
BDE49 [2,2’,4,5’]** 0.5 ± 0.3  BDE 155 [2,2’,4,4’,6,6’] - 
TBBPA** 2.1 ± 0.3  BDE 169 [3,3’,4,4’5,5’] - 
BDE 47 [2,2’,4,4’]* 5.25 ± 0.7  BDE 181 [2,2’,3,4,4’,5,6] - 
BDE 99 [2,2’,4,4’,5]* 6.7 ± 2.4  BDE 183 [2,2’,3,4,4’,5’,6] - 
Pentamix 8.3 ± 4.5  BDE 185 [2,2’,3,4,5,5’,6] - 
BDE 39 [3,4’,5] 9.5 ± 2.4  BDE 190 [2,3,3’,4,4’,5,6] - 
BDE 28 [2,4,4’] 14.9 ± 10.8  BDE 206 [2,2’,3,3’,4,4’,5,5’,6] - 
246TBP 30.0 ± 13.6  BDE 209 [2,2’,3,3’,4,4’,5,5’,6,6’] - 
BDE 19 [2,2’,6] 43.9 ± 17.8  TBBPADBPE - 
BDE 100 [2,2’,4,4’,6] 55.5 ± 28.9  HBCD - 
BDE 38 [3,4,5] 65.1 ± 24.3  αHBCD - 
60HBDE47** 700.6 ± 40.4  βHBCD - 
   γHBCD - 
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1). Bisphenol A and 4-Nonylphenol are widely used in the plasticizers industry and have been 
found as contaminants mainly in aquatic environments. Pentachlorophenol, Biphenyl, ioxynil, 
common pesticides, and DES a synthetic estrogen are also identified environmental 
contaminants. BFRs are also recognized as persistent contaminants and a large panel of such 
chemicals was tested in the present study. 
This is the first time that the disruptive potential of the aforementioned compounds has been 
tested with a piscine TTR and results indicate that the competitive binding assay developed 
may be a useful indicator of potential thyroid axis disrupting compounds. The use of an in 
vitro TTR binding assay as a screening method for detection of EDCs in environmental waste 
water was previously suggested using avian and amphibian plasma TTRs (Yamauchi et al., 
2003). Also, systematic in vitro screening for TTR-binding potency of BFRs was recently 
performed using human TTR (Hamers et al., 2006). Here we propose that the use of a piscine 
TTR assay may be more appropriate for determination of TTR-binding potency of BFRs or 
other EDs in fish, which are frequently used as sentinel species for assessment of 
environmental quality. Such an idea acquires greater significance when the TH binding 
characteristics of piscine and other vertebrate TTRs is considered (Yamauchi et al., 1999). 
Despite the high amino acid conservation of TTR’s binding channel between different 
organisms, in terrestrial vertebrates the protein has a significantly greater affinity for T4 than 
for T3 and in fish no significant difference or a slightly greater affinity for T3 has been found 
(Morgado et al., 2006; Yamauchi et al., 1999). 
The present results with sbrTTR underline the relevance of a specific piscine TTR assay as a 
more adequate indicator of hazard for fish exposed to the test chemicals. Moreover, 
comparison of the disrupting potential of the compounds on TH binding to TTR between 
different species reveals significant differences. For example, DES and Pentachlorophenol 
were powerful inhibitors of [125I]-T3 binding to TTR purified from plasma of chicken (IC50: 
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DES 0.4 nM, pentachlorophenol 6 nM), bullfrog (IC50: DES 0.3 nM, pentachlorophenol 45 
nM) (Ishihara et al., 2003b) and Japanese quail (IC50: DES <0.4 nM, pentachlorophenol 6.3 
nM) (Ishihara et al., 2003a). Similar observations were also made with binding of DES to 
recombinant Rana and Xenopus TTR which had an IC50 of 9 and 400-550 nM respectively 
(Yamauchi et al., 2000). In contrast, sbrTTR showed very poor affinity for DES and 
pentachlorophenol (IC50 = 4.8±1.8 and 2.5±1.0 µM respectively). Bisphenol A was a poor 
inhibitor of TTR-TH binding (IC50 from 1500 nM to 10 µM) for all the above mentioned 
species and it failed to bind to sbrTTR. These observations reinforce the notion of species-
specific differences in TTR binding affinities for EDCs and it is noticeable that avian (chicken 
or quail) TTRs are more susceptible to EDCs than bullfrog TTR. The same kind of 
comparison was also established by Ishihara, et al (2003b) using THBP serum samples 
extracted from human, chicken (plasma and cerebrospinal fluid), bullfrog and masu salmon 
and by determining their relative [125I]-T3 binding inhibition potencies. Bisphenol A, a poor 
EDC binder for other species was found to be a potent inhibitor of [125I]-T3 binding to human 
THBP. TBG is the major THBP in human plasma which has generally greater resistance to 
EDC binding than avian, amphibian or fish plasma in which TTR is the major THBP. Such 
observations indicate that when plasma samples are utilised in binding assays the differing 
affinities encountered may not only be a consequence of TTR affinity but also of the relative 
abundance and importance of other THBP (Brucker-Davis, 1998). 
The affinity of sbrTTR for some compounds like TBBPA, 246-TBP, ioxynil or 
pentachlorophenol is consistent with a proposed structure-activity relationship, in which an 
increase in interaction with TTR is observed for chemicals with hydroxylations in a para 
position, with one but preferably two adjacent halogens and this affinity increases with the 
number of halogen substitutions, especially bromine over chlorine (see fig.1). The latter type 
of structure seems to be required for human TTR binding to hydroxylated PCBs (Lans et al., 
CHAPTER 5  Disruption of sbrTTR binding in vitro 
 
 
138 
1993) and brominated bisphenols (Meerts et al., 2000). This structure-activity relationship 
could also explain the poor binding affinity of sbrTTR for 4-Nonylphenol, Bisphenol A, 
Biphenyl or DES (fig.1).  
We also report extremely strong affinities between sbrTTR and several BDEs, ranging from 
BDE-19 to BDE-100, which include tri, tetra and pentabromodiphenylethers, especially BDE-
49, 47 and BDE-99 with four and five bromine substitutions respectively. Such binding 
ability, however, seems to be lost for BDEs with higher degrees of bromine substitution (table 
3).  
The affinity of BDEs for sbrTTR is quite different from human plasma TTR where very low 
binding affinities for these compounds (IC50 values over 7000 nM) were found (Hamers et al., 
2006). In fact, BDEs have a favourable bromine substitution but lack the characteristic para 
hydroxylation commonly found in strong TTR binders. The results of the present work are 
however in agreement with previous studies using bromophenols and non-hydroxylated 
compounds which showed that strong binding to TTR can occur even in the absence of OH 
group interactions (Ghosh et al., 2000; Rickenbacher et al., 1986). Crystallographic studies 
revealed that the above mentioned bromophenol compounds bind to human TTR in an 
unusual “reversed” mode where the hydroxyl group doesn’t seem to play an important role 
(Ghosh, Meerts et al. 2000) which may explain the unexpected affinities of the none-
hydroxylated BDEs in ligand-binding studies.  
The reason for the different binding affinities of BFRs to human and piscine TTR remains to 
be established but it seems likely that differences in the physicochemical and structural 
properties are important. The crystal structure of sbrTTR is available (Eneqvist et al., 2004; 
Folli et al., 2003) and its structure is well conserved with that established for human, rat or 
chicken. However, the same study reveals that despite amino acid conservation (only one 
substitution) the shape of the TTR hormone binding channel is different when compared to 
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human TTR (Eneqvist et al., 2004). Also the surface potential of sea bream and chicken TTR 
seems to be more negative than the human or rat proteins (Power et al., 2000a). These facts 
could explain discrepancies in binding affinities between such species. Moreover, it is well 
known that the N-terminal amino acid sequence is shorter and more hydrophilic in eutherians, 
and longer and more hydrophobic in birds, reptiles, amphibians and fish (with three additional 
amino acids). The significance of this difference has been widely discussed and it has been 
proposed to strongly influence the TH binding properties of TTR (Morgado et al., 2006; 
Power et al., 2000a; Prapunpoj et al., 2002). In light of the previous findings and since 
chemical and structural aspects of TTR-TH binding are not completely clarified,  conclusions 
that directly relate the chemical structure of sbrTTR to binding affinity are still difficult to 
draw. Although in general diphenyl compounds with halogen substitutions, which most 
resemble the structure of THs, seem to have a greater affinity for this protein. 
In vitro binding assays provide a relatively quick method, which does not imply the use of 
animals, to screen for potential ED effects of chemicals. However, such assays have 
limitations; the poor binding affinity for TTR found for some chemicals does not exclude 
their possible disrupting activity in a direct or indirect way in vivo. For instance, 4-
Nonylphenol, ubiquitous in aquatic environments and reported to alter T4 levels and inhibit 
growth and development in Atlantic salmon (Fairchild et al., 1999) had a poor in vitro TTR 
binding affinity in the present study. The latter may indicate that many more mechanisms 
other than TTR-binding can lead to thyroid-axis disruption. For example, EDCs may act by 
binding to other THBP and bioaccumulation and metabolism may also modulate their effects. 
It has previously been observed that some metabolites of EDCs become even stronger TTR 
binders than the original compounds (Brouwer and van den Berg, 1986). A similar situation 
may occur in the environment if EDCs interact with other natural or synthetic chemicals and 
generate by-products with a stronger endocrine disrupting activity. For example, Yamauchi et 
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al (2003), reported that although Bisphenol A and Nonylphenol show poor binding affinity 
for chicken and bullfrog TTRs, their respective chlorinated derivatives can be powerful 
binding inhibitors with affinity increasing with their degree of chlorination (Yamauchi et al., 
2003). This means that a poor effect detected in TTR binding assays in vitro does not exclude 
potential harmful effects of compounds in vivo.  
Many questions are still unanswered concerning the biological significance of EDCs 
interfering with the thyroid axis. In vitro assays or short term exposure may give a measure of 
hazard but do not reflect the in vivo situation. Moreover, data about the concentration of 
EDCs in aquatic environments is scanty and generally relates to wastewater treatment plant 
discharges and industrial residues. However, due to the high production volumes (mid-1990s 
was 600000 metric tonnes) and use of PBDEs  (de Boer et al., 2003; Manchester-Neesvig et 
al., 2001; North, 2004; Oberg et al., 2002) reports of their concentration in river water 
samples, marine biota and biosolids exist (Akutsu et al., 2001; Anderson and MacRae, 2006; 
Ikonomou et al., 2002; Lacorte et al., 2003; Manchester-Neesvig et al., 2001).The most 
commonly detected contaminants are penta-BDE congeners, components of one of the major 
commercial mixtures Bromkal 70-5DE which include BDE-47, 99 and 100, strong sbrTTR 
binders in the present study. For example, effluent concentrations of up to 10.5 and 11.2 ng/l 
have been reported for BDE-47 and 99 respectively in the USA (North, 2004) and in 
Penobscot River (Main, USA) values of up to 50.0 ng/l were measured (Anderson and 
MacRae, 2006). Moreover, as BDEs are highly lipophylic they readily bioaccumulate and 
BDE-47 and 99 concentrations of 10000 ng/g lipid, and BDE-100 at 2000-3000 ng/g lipid 
have been measured in small mouth bass in Penobscot river. Bioaccumulation of a range of 
other BDE congeners have been reported in a number of fish species in North America and 
northern Europe where concentrations tend to be lower (for review see Anderson and 
MacRae, 2006). The levels of environmental contamination and bioaccumulation of BDEs 
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suggest that in fish these chemicals may reach values at which they can efficiently out-
compete TH binding to TTR and disrupt this aspect of the TH axis.   
Further experiments are required to clarify the biological consequences of EDC binding to 
TTR. Nevertheless, plasma proteins, and particularly TTR because of its role in TH transport 
and delivery are very likely to strongly influence EDC action in vertebrates. Therefore, the 
use of preliminary methods to detect putative EDCs based on TTR binding seems to be a 
pertinent choice and of particular interest for aquatic habitats when using a teleost fish TTR.  
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Abstract 
 
Chemicals contaminating the environment are thought to cause disruption of the thyroid 
system in vertebrates. Endocrine disrupting chemicals (EDCs) may act at several levels in the 
thyroid axis, synthesis, transport and metabolism of thyroid hormones (THs). Several putative 
EDCs have a strong affinity in vitro for Transthyretin (TTR), one of the thyroid hormone 
binding proteins (THBPs), although how they behave in vivo is unknown. In vitro analysis 
reveals that ioxynil and diethylstilbestrol (DES) strongly bind sea bream TTR and in the 
present study the aim was to establish how they influence the thyroid axis in vivo. DES, 
ioxynil (1mg/kg fish) and propilthyouracil (PTU, 1 and 10 mg/kg) were administered in the 
diet to sea bream juveniles (n=14/treatment) for 21 days. Ioxynil slightly increased (p<0.05) 
total protein plasma levels and fish were euthyroid (p>0.05) and quantitative PCR analysis 
revealed that TSH expression was down-regulated in the brain (p<0.001) and pituitary 
(p<0.005). Deiodinases DII and DIII expression was strongly down-regulated in the brain 
(p<0.001) but not in the pituitary or the liver (only determined for DII). PTU lowest dose and 
DES treatment down-regulated TRβ expression in the pituitary. TTR plasma levels remain to 
be quantified but hepatic expression was up-regulated by PTU lowest dose (p<0.05) and 
unaltered by the other treatments. The histology of the thyroid in PTU (1mg/kg fish) group 
was indicative of low TH production. It appears that the in vitro TTR-binders ioxynil and 
DES strongly influence peripheral deiodination although the thyroid axis appears to maintain 
TH homeostasis in the fish. Further analysis of thyroid histology and TTR plasma levels are 
required to better understand the action of ioxynil and DES.  
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Introduction 
Disruption of the endocrine system by xenobiotic compounds is consistently reported in 
humans and wild life species and is a matter of concern worldwide. In particular, disruption of 
the thyroid system, which has had relatively little attention, is now increasingly reported in 
vertebrates (for review see Boas et al., 2006; Brown et al., 2004; Colborn, 2002). Since 
thyroid hormones (THs) are crucial for many biological processes (Hadley, 1996) thyroid 
disruption can seriously compromise normal development of exposed species. In fish THs are 
thought to be very important in reproduction and regulation of development (Power et al., 
2001; Yamano, 2005). A great variety of natural or synthetic chemicals from different classes 
or sources (e.g. all sorts of pesticides, industrial by-products or pharmaceutical drugs) are 
thought to exert an acute affect at different levels of the thyroid cascade. It is consensual that 
endocrine disrupting chemicals (EDCs) act by interfering with TH synthesis, cellular uptake 
or metabolism, at the level of TH receptors (TRs) and also with TH transport by binding to 
thyroid hormone binding proteins (THBP) (Boas et al., 2006; DeVito et al., 1999). The TH 
transport system in particular may be quite susceptible to EDCs as many chemicals are 
structurally related to THs and may bind THBPs and disturb homeostasis of TH levels or even 
cellular uptake (Divino and Schussler, 1990). In fact many in vitro studies report that TTR, 
one of the THBPs in vertebrates, has strong affinity for a great number of putative EDCs in 
human, birds and amphibians (Cheek et al., 1999; Hamers et al., 2006; Ishihara et al., 2003a; 
Ishihara et al., 2003b; Kudo and Yamauchi, 2005; Meerts et al., 2000; Yamauchi et al., 2003). 
In particular in fish, where TTR is the major THBP its binding to EDCs could have greater 
consequences to normal  thyroid status. In the present thesis (chapter 5) an in vitro sea bream 
recombinant TTR (sbrTTR) binding assay was developed and a number of chemicals shown 
to bind the protein more strongly than THs. However, the possible in vivo binding of EDCs 
and the consequences of exposure to such compounds in fish are completely unexplored. In 
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fact, although many environmental chemicals have been shown to influence the thyroid 
cascade in more than 40 teleost species (Brown et al., 2004) in vivo, mechanisms of thyroid 
disruption are unclear and have never been explored from the TH transport endpoint 
perspective.  
Two compounds, diethylstilbestrol (DES, a synthetic nonsteroidal estrogen) and ioxynil (a 
hydroxybenzonitrile herbicide) which bind strongly to sbrTTR in vitro (chapter 5) were tested 
in vivo. Ioxynil in particular was found to bind sbrTTR with very high affinity. Previous 
studies by Ishihara et al. (2003a; 2003b) also report DES and ioxynil amongst the strongest 
binders in vitro to serum protein extracts from humans, chicken, bullfrog and masu salmon. 
Therefore, in the present study the effect of exposure to two putative EDCs, DES and ioxynil 
on sea bream thyroid status was assessed. In parallel, the consequence of exposure to 
propilthyouracil (PTU) a known anti-thyroid drug were also analysed as a positive control of 
TH inhibition. A multi-parameter assessment of the thyroid axis was used to identify at what 
level disruption occurs. For this reason total plasma protein, circulating TH concentrations 
and transcript abundance of TTR, TSH, deiodinases and TRβ were carried out in different 
tissue.  
The current study should help establish the effect of EDCs on fish thyroid status and also 
provide useful data on the potential toxicity of the tested compounds. This is important 
information as fish are frequently used as sentinels for pollution in aquatic ecosystems and the 
physiological importance of THs means that disruption of this axis may threaten their 
survival. 
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Methods 
Animals and experiment conditions 
Juvenile sea bream were obtained from TIMAR (Tavira, Portugal) and maintained in 1000 l 
open sea water circuits at the experimental station Ramalhete Marine Station (Faro, Portugal) 
at normal ambient temperature and salinity for the Algarve, Portugal in September. Fish of 
approximately similar sizes were chosen for the experiments and transferred to glass tanks of 
65 L at a density of 14 or 12 fish per tank. All experimental tanks were in closed circuit, each 
with its own water pump and a second submersible aeration/filtration device (Duetto, 
Aquarium Systems) to improve oxygen circulation and water quality. A 12 h light/dark 
photoperiod was maintained with daybreak set at 07.00h. Water temperature was 20-21 ºC 
during the experiment and salinity 36 parts per thousand. Fish where allowed to adapt to 
experimental conditions for 2 weeks prior to experiments and were fed twice daily (1.5 % 
total fish weight per tank per day) with a commercial sea bream diet (Dourasoja size 2 mm). 
Every 3 days 1/3 of the tank water was substituted and water pumps and filters washed. 
Before starting the experiment, fish in each group were weighed (g) and length (snout to tail 
bifurcation) measured and mean body weight ± S.E. and mean body length ± S.E determined. 
Experimental groups and tanks were labelled with the treatment and dose as follows: PTU1-1 
mg/kg fish (n=14; 11.6 ± 0.8 g and 8.7 ± 0.2 cm), PTU10-10 mg/fish kg (n=14; 9.9 ± 0.7 g 
and 8.3 ± 0.2 cm), DES-1 mg/fish kg (n=14; 11.3 ± 0.8 g and 8.6 ± 0.2 cm), Ioxynil-1 mg/fish 
kg (n=14; 10.9 ± 0.7 g and 8.6 ± 0.2 cm) and a C-control tank (n=12; 9.1 ± 0.6 g and 8.1 ± 0.2 
cm). Treatment with PTU, an antithyroid drug know to inhibit TH synthesis, was used as a 
positive control. The concentration of each tested dose (1 mg/kg fish or 10 mg/kg fish) 
corresponds to the cumulative exposure of fish to the test chemicals at the end of the 
experiment. Experiments were carried out for 21 days and the estimated daily exposure to 
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chemicals was 0.05 and 0.5 mg/kg fish/day. Maintenance and manipulation of fish was 
conducted in accordance with the Guidelines of the European Union Council (86/609/EU). 
 
Preparation and administration of the chemicals 
Food was chosen as the vehicle for administration of the chemicals and treated food was 
prepared weekly (to avoid oxidation) and stored at 4 oC in the dark. Commercial sea bream 
pellets were sprayed with the appropriate concentration of chemical solution and fed at the 
desired dose to the fish. To prepare the solution of chemicals they were dissolved in DMSO to 
give a stock solution of 10 mM which was diluted in ethanol to the appropriate concentration 
and used to treat the food (maximum concentration <1 % DMSO). The food given to control 
fish was treated with vehicle alone (ethanol and <1 % DMSO). Food was evenly coated with 
the chemical solution and left in a fume cupboard until all the ethanol had evaporated. Just 
before feeding the food was sprayed with cod liver oil to increase its palatability.   
 
Sample collection  
After 21 days of treatment fish were anaesthetised in phenoxyethanol (0.1 %; Sigma-Aldrich), 
weight and length measured and a blood sample removed using heparinized syringes. Blood 
was centrifuged at 1000 g for 10 min at 4 ºC and the plasma frozen in liquid nitrogen and 
stored at -20 ºC until analysis. Fish were subsequently killed by decapitation and brain, 
pituitaries and liver collected, frozen in liquid nitrogen and stored at -80 ºC until utilised for 
RNA extraction. Tissue from the insertion of the gill arch into the lower mandible was fixed 
in Bouin-Holland for subsequent thyroid histology. 
 
Sample analysis 
Condition factor (K) was determined using the following formula, K= 100 x W x L–3 (W = 
body weight and L = length) and the fish weight and length recorded at the beginning and end 
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of the experiment. The total protein concentration in plasma was determined using the Lowry 
Method (Lowry et al., 1951) with bovine serum albumin as the standard. Absorbance was 
measured at 745 nm. Plasma THs (T3 and T4) were determined by radioimmunoassay (RIA) 
as described in Chapter 2. TTR in plasma was determined by western blot analysis using the 
ECL system (ECL plus western blotting detection system, Amersham Biosciences) as 
described in chapter 2. For western blot a standard curve was prepared with serial dilutions of 
standardised sea bream recombinant TTR and was always run in parallel to plasma samples 
collected from experiments. TTR was quantified by densitometry using the software Quantity 
One (free trial- Bio-Rad, USA). Time did not permit all experimental samples to be analysed 
and this will be carried out in the future.  
 
RNA extraction and cDNA synthesis 
Total RNA was extracted from liver, pituitary and brain using TRI reagent (Sigma-Aldrich) 
according to the protocol provided. Extracted RNA was resuspended in 20-500 µl DEPC-
treated water and the quantity and quality assessed by electrophoresis of 1 µg RNA in a 1 % 
agarose gel and by spectroscopy (Pharmacia Biotech Ultraspec 3000) at A260 and by 
determining the ratio at A260/A280. Prior to cDNA synthesis RNA was treated with DNase 
using DNA-free Kit (Ambion, UK) following the suppliers instructions. Synthesis of cDNA 
was carried out in a 20 µl final reaction volume using,  0.5 µg of DNase-treated RNA, 1 mM 
of dNTPs mixture, 1 µg of random hexamer primers (pd(N)6, Amersham Biosciences) and 
sterile water (Sigma-Aldrich). The reaction was heated at 65 ºC for 5 min to heat-denature 
RNA and incubated on ice for 5 min before adding the final reaction components: 25 U of 
RNAguard RNase inhibitor (Amersham Biosciences), 40 U of MMLV RT (reverse 
transcriptase) and 1x RT buffer (Invitrogen, Carlsbad, CA, USA). The cDNA synthesis 
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reaction was incubated for 10 min at 25 ºC followed by 50 min at 42 ºC and terminated by 
incubation for 10 min at 72 ºC. 
 
Quantitative real-time RT-PCR 
Real-time RT-PCR reaction was performed using “Taqman” technology and a Bio-Rad 
iCycler iQ system and software (Bior-Rad laboratories). The correct probes and primers (see 
table 1) for each gene analysed (sea bream TSH, deiodinases II and III, TTR and TR-β) were 
designed using the original sea bream sequences using Beacon Designer software (Premier 
Biosoft international). The probes were labelled at the 5’-end with FAM and at the 3’-end 
with TAMRA-6-FAM (Thermo). The optimal concentration of probe and reverse and forward 
primers was established using the following criteria, highest fluorescence, best log fit and 
linear phase and lowest possible cycle number. Primer and probe concentration selected are 
given in table 1. Real time RT-PCR reactions were performed using Eppendorf qPCR 
mastermix in a 25 µl reaction volume and approximately 20 pg of sample cDNA with the 
optimal primer and probe concentrations. The thermocycle utilised was 1.5 min at 95 ºC 
followed by 45 cycles of 15 seconds at 95 ºC followed by 1 minute at 60 ºC.  Quantification 
was carried out using the standard curve method with serial dilutions (1/10 interval from 1 
ng/µl to 1 fg/µl) of cDNA plasmid of the target genes in each experiment. To normalise the 
quantity of each gene, target amplicons obtained per reaction were divided by absolute values 
of 18s rRNA.  
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Table 1. Quantitative RT-PCR primers and Taqman probe sequences and respective optimized concentration 
(below primer sequence) used to analyse sea bream expression of genes: D2, D3, TSH, TRβ and 18S which was 
used as a standard to normalise expression analysis.  
 
 
Histology  
Tissue samples for histology were fixed in Bouin–Holland fixative for one week at room 
temperature with gentle agitation and decalcified in 0.5 M Ethylene diamine-tetracetic acid 
(EDTA; USB Corporation) pH 8.0. Samples were then washed in water to remove excess 
fixative and placed in 70 % ethanol, dehydrated in a graded series of ethanol (70 % →100 %) 
and  embedded in paraffin using an automated tissue processor (LeicaTP1020, Leica). Serial 
saggital sections (5 µm) of embedded tissues were cut and mounted on glass slides coated 
with 3-Aminopropyltriethoxysilane (APES; Sigma-Aldrich). Standard Haematoxylin-Eosin 
coloration was performed on dewaxed and rehydrated sections at an interval of 5 sections in 
each larvae to visualize the thyroid gland. Briefly, tissues were immersed in Harris 
Haematoxylin for 30 seconds, washed in tap water and distilled water and immersed in Eosin 
for 30 seconds, washed in distilled water with a few drops of acetic acid and then tap water. 
Gene Sequence Forward Primer qPCR Concentration (nM) 
Sequence Taqman probe 
qPCR Concentration (nM) 
Sequence Reverse Primer 
qPCR Concentration (nM) 
DII 
5’-GGT TGA GGA CTT CAG TGA TG -3’ 
300 
5’-TTA GTG TAC ATT GAT GAG GCT CAC CCA-3’ 
100 
5’-GAA AGA GCA AGA GCC CAT AG-3’ 
900 
DIII 
5’-CTA TCG GCA GGG GAA GAG ATG-3’ 
50 
5’-CGG CGG TGT CCA AAT GGC GAG GG-3’ 
100 
5’-CAC AGG GCT GCA TT TTC AG-3’ 
900 
TSH 
5’-TCG GTG TAC CAA ACC AGT CAG-3’ 
900 
5’-ACC CGT ATC CCG ACC AGA GCA ACT-3’ 
100 
5’-GCG CTA ACA ACAGGA AGA TCA G-3’ 
900 
TTR 
5’-GTC ACT ACA CCT TGG CTC TGC-3’ 
900 
5’-CGT TCT CCT ACA CCA CCA CCG CCG-3’ 
100 
5’-GTC ACT CGT GTA CGC TGG AG-3’ 
900 
TRβ 
5’-CAA AGC TGC TAA TGA AGG TGA CG -3 
300’ 
5’-CCT GCG GAT CGG TGC CTG CC-3’ 
100 
5’-GAA TAA CTC GGT GGA ACA CTC AAC -3’ 
900 
18s 
5’-TCG ATG GTA CTT TCT CTG CCT AC-3’ 
300 
5’-CAC ATC CAA GGA AGG CAG CAG GCG-3’ 
100 
5’-AGT CGG GAG TGG GTA ATT TGC-3’ 
900 
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Stained sections were then dehydrated, cleared and mounted in DePX (Sigma-Aldrich). 
Thyroid tissue morphology was examined and presence or absence of colloid, vacuolation of 
colloid, follicular epithelial folding and size were registered. Morphometrical measurements 
were taken to establish number and size of follicles and the height of thyrocytes and their 
nucleus in 10 follicles per section in 3 individual fish from control and PTU1 treated fish. 
Measurements were always carried out on sections containing the hypohyal of the hyoid arch 
and the hypobranchial of the first branchial arch. Measurements taken from 4 cells located 90º 
from one another within each follicle, using the software ImageJ for digital image analyse. 
The ratio nucleus/cell height was determined. 
 
Statistics 
Unless mentioned, statistical analysis of the data was carried out by one-way analysis of 
variance (ANOVA) followed by Tukey multiple comparison test (HSD) when significant 
differences (considered at p<0.05) were found between treatments. The statistical software 
utilised was Sigma Stat version 3 (SPSS, Chicago, USA).  
 
 
Results 
 
Condition factor (K) 
This parameter is usually used as comparative and theoretical measure of fish physiological 
well-being. Values obtained for condition factor of the fish before and after the treatments in 
each group are represented in fig. 1-A. Data analysis revealed no significant differences 
between treatment groups and the control, or within each group at the start and end of the 
experiment (t-test was used). Indicating fish well being was not seriously affected by the 
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treatments or by the stress derived from experiment conditions and manipulation. No 
mortality was observed during the experiment.   
 
Total protein 
Total protein plasma concentration values found for each of the experimental groups are 
represented in fig. 1-B. Comparison between all treatment groups and the control showed no 
statistically significant differences were found PTU1, PTU10 and DES. However, a slight but 
significant increase on total plasma protein concentration (p<0.05) was found in fish exposed 
to ioxynil.  
 
Total plasma TH levels  
Concentration of T3 and T4 in fish plasma was determined by RIA and results are represented 
in fig. 1-C and D respectively. Data analysis revealed that there were no significant 
differences in T3 or plasma T4 concentrations in experimental and control fish at the end of 
the experiment.  
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Figure 1. A- Changes in condition factor (K=100 x W x L-3) of the fish before and after treatments:  C- control 
group,  PTU1- fish exposed to PTU at 1mg/kg fish,  PTU10- fish exposed to PTU at 10 mg/kg fish, ioxynil- fish 
fed with ioxynil at 1mg/kg fish, DES- fish fed with DES at 1mg/kg fish. No significant alteration was found in K 
between the different groups and the control (p>0.05) at the end of the experiment or within the same group at 
the start and end of the experiment. B- Total plasma protein concentration (mg/ml) measured by Lowry assay in 
each group at the end of the experiment. Only ioxynil (p<0.05) caused a significant increase on total plasma 
protein. C and D- Concentration of plasma (ng/ml) of T3 and T4 levels, respectively, measured by RIA in each 
experimental group. No significant differences in T3 and T4 levels occurred between all the treatments and the 
control at the end of the experiment. Data correspond to mean ± SE (n=14 in A, C and D or n=10 in B) and 
differences were considered significant at p<0.05 (*). 
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Plasma TTR  
An ELISA assay was previously developed (see chapter 5) to measure TTR plasma levels, 
however for technical reasons and because of lack of time the assay could not be used in the 
present study. An alternative technique, western blot coupled to chemiluminescence detection 
was utilised to measure plasma TTR, although only a small number of samples were analysed 
as a consequence of shortage of time. Preliminary analysis suggests that the treatments caused 
a modification in plasma TTR (fig. 2). The same sample volume (4 µl) of plasma from each 
fish was loaded in duplicate on gels for each group (except for PTU10 where only one sample 
was loaded). One principal band was detected by the anti-sbTTR sera. Visual analysis of 
bands intensity suggests a slight increase in TTR levels for ioxynil and PTU10 treated fish, 
and a strong increase in TTR levels for PTU1 group. In fish exposed to DES the strong 
intensity of the bands suggests a major elevation of TTR plasma levels in this group. A better 
quality image of a gel with 5 replicates for each group will allow confirmation and further 
quantification of these preliminary results.   
 
 
 
 
 
 
Figure 2. Western blot analysis with sbrTTR antisera (1:10000 dilution) of plasma samples from sea bream 
exposed to the different ED chemicals. The blot was developed by chemiluminescence and the autoradiograph 
was exposed for 40 min. Plasma from fish treated with vehicle alone C- control group; PTU 1mg/kg fish – 
PTU1; PTU 10mg/kg fish –PTU10; ioxynil 1mg/kg fish -Ioxynil; DES 1mg/kg fish -DES. The same sample 
volume (4 µl) of plasma from each fish was loaded on the gel in duplicate with the exception of PTU10 where 
only one sample was loaded. 
 
C PTU1 PTU10 Ioxynil DES 
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Histology of thyroid follicles  
Histological appearance of thyroid follicles was only analysed for fish exposed to the 
goitrogen PTU at 1mg/ml (group PTU1) as a consequence of shortage of time. Measurements 
of epithelial cell height and ratio nucleus/cell height revealed no significant difference from 
the control. However, the morphology of the follicles in PTU treated fish (fig. 3B) differs 
from that in the control fish (fig. 3A) as the follicle are of a more homogeneous size and 
appear to be flattened and the lumen is small and lacks colloid. The thyroid follicles in control 
fish contain abundant colloid with vacuoles present close to the thyrocyte interface and have a 
typical slightly oval appearance (fig. 3B). The observations in the control fish are 
characteristic of an active gland while those in the PTU treated fish are more typical of 
follicles with reduced activity.  
 
 
 
 
 
 
 
 
 
Figure 3. Haematoxylin and Eosin stained thyroid tissue from, A- control sea bream and B- PTU1 (1mg/kg 
fish). The thyroid follicles in the fish treated with the goitrogen PTU are flattened and contain scarce colloid. 
Amplification scale is indicated.  
 
 
Effect of the different treatments on gene expression 
The effect of the EDCs used on various elements of the sea bream thyroid system in vivo, was 
assessed by analysing target transcripts in different tissues by real-time RT-PCR. Transcript 
number for each gene was normalised by dividing by absolute values of 18s rRNA expression 
and are represented in relative units in fig 4. TSH expression was quantified in the pituitary 
B A 
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and brain and analysis showed that TSH expression levels in pituitary (fig. 4A) were 
significantly lower after exposure to 1mg/ml PTU (p<0.001), ioxynil (p<0.005) and DES 
(p<0.001) compared to control fish. Higher doses of PTU (10mg/ml) did not cause a 
significant decrease in TSH transcript number. All the experimental treatments caused a 
significant down-regulation of TSH expression levels (p<0.05) in the brain (fig. 4B) 
compared to control fish. TRβ transcripts in the pituitary were down-regulated by PTU1 
(p<0.001) and DES (p<0.05) but not by any of the other chemicals tested (fig. 4C). 
Expression of TRβ in the brain and liver was assessed but no transcripts were detected in fish 
treated with EDCs or in the control fish. Deiodinase type I (DI), type II (DII) and type III 
(DIII) transcript abundance was also quantified in the pituitary, brain and liver. It was not 
possible to detect DI transcripts in any of the tissue collected. Deiodinase type II (DII) 
transcript abundance in the pituitary was not significantly altered by EDCs (fig. 4D), but was 
significantly down-regulated in the brain (fig. 4E) by all the chemicals tested (p<0.001). In 
the liver (fig. 4F) treatment with PTU (1mg/kg fish) caused up-regulation in DII expression 
(p<0.005) and no change in DII expression was observed in the other treatment groups 
compared to the control fish. It was not possible to detect DIII transcripts in the pituitary or 
the liver (not shown) but in the brain (fig. 4G) all EDCs tested caused down-regulation in DIII 
transcript number (p<0.001) compared to the brain in control fish.  
A number of previous studies have demonstrated that TTR expression is principally restricted 
to the liver in fish and for this reason only this tissue was analysed (fig. 4H). Treatment with 
PTU (1mg/kg fish) significantly up-regulated TTR expression (p<0.05) compared to control 
fish liver. No significant changes in TTR transcript abundance was observed in other EDCs 
treatment groups compared to the control fish. 
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Figure 4. Quantitative real-time RT-PCR analysis of gene expression in fish exposed to different ED chemicals:  
C- control group, PTU1- PTU treatment 1mg/kg fish, PTU10- PTU treatment 10mg/kg fish, Iox- ioxynil 
treatment 1mg/kg fish, DES- DES treatment 1mg/kg fish. The values obtained for transcript number in the 
different treatments were normalised by dividing by absolute values of 18s rRNA expression values and are 
represented in relative units. Gene transcripts analysed for each treatment group are: TSH in pituitary and brain 
(A and B respectively); TRβ in pituitary (C); deiodinase type II (DII) in pituitary, brain and liver (D, E and F 
respectively); deiodinase type III (DIII) in brain (G); TTR in the liver (H). Data are presented as mean ± SE (n=6 
or 5). Significant differences from corresponding controls are marked with * (p<0.05) and **(p<0.001). 
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Discussion  
 
Endocrine disrupting chemicals affect the thyroid system at different sites and can directly 
interfere with TH synthesis, TH metabolism and TH serum transport. They may also bind to 
TH receptors but data to support this hypothesis is still scarce (DeVito et al., 1999) and it has 
been suggested that TR may be a less important target for EDCs (Cheek et al., 1999; Ishihara 
et al., 2003b; van den Berg, 1990). Alteration in thyroid function is frequently determined by 
measuring TH serum levels as they give a fairly good indication of the central thyroid axis 
activity. The plasma THs act at the pituitary gland to cause positive or negative feedback on 
the release of TSH. A reduction in circulating TH levels leads to positive feedback and an 
increase in TSH secretion by the pituitary and if this is prolonged hypertrophy and 
hyperplasia of the thyroid tissue may occur in order to increase synthesis and release of THs. 
Exogenous EDCs may interfere with the metabolism of THs by modifying deiodinase enzyme 
activity or abundance and in this way modify hormone concentrations in serum and tissue. In 
most vertebrates, including teleosts, there are three types of deiodinases: type I (DI) which is 
found in liver, pituitary, thyroid, etc, which catalyses activation or inactivation of both T4 and 
T3 and their metabolites; type II (DII) which is mainly present in brain although in teleosts the 
liver also has a high activity (Orozco and Valverde-R, 2005) and low levels are also present in 
the CNS and pituitary. This enzyme has an essential role during hypothyroidism as it 
catalyses T3 synthesis and is a major activating enzyme; and type III (DIII) which is present in 
brain and fetal tissue and is the major inactivating enzyme and catalyses the production of 
inactive rT3 and 3,3’T2.  
The EDCs selected in the present study, DES and Ioxynil were chosen because in vitro 
(chapter 5) they had a high affinity for sbrTTR (a major THBP in fish) and might be expected 
to disrupt TH transport. Binding of exogenous chemicals to TTR in vivo may have a twofold 
effect: decrease affective free TH concentrations in plasma and consequently cellular uptake 
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and biological responses but also, displace THs from THBPs altering plasma TH homeostasis 
(Ishihara et al., 2003b). The overall consequence of EDCs binding to TTR may therefore 
results from the combined effect of these two situations. It has been hypothesized that TH 
displacement from THBP increases free TH clearance from plasma and decreases their 
circulatory concentrations (DeVito et al., 1999). It has also been suggested that TTR binding 
can be predictive of interactions with other proteins in thyroid system such as the deiodinases 
(Calvo et al., 1990) but this has never been assessed in fish. 
Ioxynil and DES are chemicals that have high affinity for avian and amphibian TTR in vitro 
(Ishihara et al., 2003a; Ishihara et al., 2003b) and also (particularly ioxynil) sea bream TTR 
(chapter 5). Here we report that after 21 days of exposure to ioxynil (1 mg/kg fish) sea bream 
had slightly increased serum total protein levels. This might reflect an increase in levels of 
albumin or other plasma proteins and represent an acute response to toxicity. Preliminary 
analysis suggest that TTR plasma levels are significantly changed with all of the EDCs 
utilised in the study, although they did not modify TTR gene transcription in the liver (fig. 
4H). Further analysis will be required before firm conclusions can be drawn, however, the 
mismatch between hepatic transcription and secretion is consistent with our previous 
observation (chapter 4) pointing to control of TTR at the level of secretion. 
In fish treated with EDCs, levels of serum total THs were not significantly different from the 
control group in any of the treatments at the end of the experiment. Surprisingly, a highly 
significant down-regulation in TSH transcripts occurred in the brain and pituitary of all the 
experimental fish and may indicate EDCs act directly to influence TSH transcription in the 
brain and pituitary. The histological appearance of the thyroid tissue in fish exposed to PTU 
(1mg/kg fish) was indicative of a gland with reduced activity. It will be important to analyse 
the thyroid tissue in the fish exposed to the other EDCs. The apparently euthyroid status of 
fish despite down-regulation of TSH transcripts in fish treated with EDCs remains to be 
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explained but possible explanations may be the maintenance of normal levels of circulating 
TSH or other compensatory mechanisms which exist in the thyroid axis. Moreover, in the 
present study THs were analysed at a single time point and although initially chemical 
treatment may have disturbed homeostasis by the end of the experiment it may have been re-
established. In favour of this suggestion are the results of previous studies in fish which report 
unaltered TH levels in response to EDCs but with changes in other thyroid axis endpoints 
(Brown et al., 2004).  
All EDCs treatments affected TH metabolism in the brain and both DII and DIII expression 
levels were significantly depressed. In contrast, DII transcription was not affected in the 
pituitary or in liver (except by PTU1). Deiodinase activity is critical for regulation of TH 
tissue concentration and is strongly affected by TH serum concentrations in fish (Eales et al., 
1993; MacLatchy, 1993; Mol et al., 1999; Orozco and Valverde-R, 2005). Tissue specific 
alterations in deiodinase activity have previously been observed in euthyroid fish after 
exposure to EDCs (for review see Brown et al (2004)) and it has been proposed that in fish 
EDCs induced changes in deiodinase activity may represent a compensatory mechanism to 
help preserve the euthyroid state. The modification in deiodinase observed in EDCs 
treatments in the present study fits well with the general notion that in teleost fish peripheral 
deiodination is the primary control mechanism of thyroid function, independent of the 
hypothalamo-pituitary-thyroid axis (Eales and Brown, 1993; Orozco and Valverde-R, 2005; 
Power et al., 2001). The difference in the relative importance of peripheral and central control 
of the TH axis in fish and mammals suggest that fish may have a more robust response to 
chemical disruption.  It will be of interest in the future to assess the consequences of changing 
DII expression in the brain, particularly in relation to THBPs.  
TRβ expression levels in the pituitary were not affected by exposure to ioxynil but treatment 
with DES seems to have caused a slight decrease in the number of receptor transcripts 
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suggesting suppression of TH responsive genes. Curiously, studies by Ishihara et al (2003b) 
also reported DES to be one of two EDCs showing some ability to bind the chicken and 
bullfrog TR ligand binding domain in vitro. Nevertheless, the great majority of studies 
suggest that few chemicals interfere with TRs (Cheek et al., 1999; Ishihara et al., 2003b) and 
there is generally a lack of evidence that EDCs bind to TR (DeVito et al., 1999).  
PTU is a known anti-thyroid agent shown to have both intra- and extra-thyroidal anti-thyroid 
actions. In both animals and humans PTU inhibits many of the peripheral actions of THs and 
slows the peripheral deiodination (see Saberi et al (1975)). In fish PTU is known to have 
inhibitory effects on larval development (Liu and Chan, 2002; Osama and Klaus, 2003; 
Woodhead, 1966) and it has been reported to decrease TH levels in zebrafish (Wester et al., 
2003). Here we tested two different doses of PTU: 1mg/kg fish (PTU1) and 10mg/kg fish 
(PTU10) as a positive control and for comparison to the effects of ioxynil and DES. Although 
unexpectedly none of the treatments altered TH levels at the end of the experiment. In fact, 
overall the effect of both PTU doses was comparable to the effects observed for DES and 
ioxynil on all the parameters studied and the only exception was the significant increase in 
DII and TTR expression in the liver caused by PTU1. The results suggest that neither DES 
nor ioxynil affected thyroid status more than the goitrogen PTU. It is tempting to speculate 
that binding of EDCs to TTR could decrease their cellular uptake and therefore biological 
consequences but much more work will be required to validate this hypothesis. The strong 
depression of deiodinase expression levels by PTU is consistent with its observed action in 
mammals. Again, such a decrease might reflect an effective compensatory peripheral 
mechanism which exists in fish to re-establish TH homeostasis. Analysis of thyroid tissue in 
the present study was only carried out for PTU1 (analysis is ongoing for other samples) and 
was consistent with a slightly less active gland. This is in accordance with the decreased TSH 
expression levels encountered in the pituitary which would lead to a reduction in TH 
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production. The enzyme DI is known to be particularly resistant to PTU in fish (Orozco and 
Valverde-R, 2005) and evaluation of the response of DI to PTU would be of interest but it 
was not possible to detect this enzyme in control or EDCs exposed fish. The fact that the 
lowest PTU (1mg/kg fish) dose was more effective than the higher dose (10mg/kg fish) in 
provoking changes in several elements of the thyroid axis is difficult to explain but may be 
related to the changing toxicity with time and accumulated dose during the experiment. 
Moreover, in general goitrogen effects are poorly understood and studied in all age classes of 
fish and further studies addressing this question are required.  
In the present study two chemicals were selected for their strong TTR binding capacity in 
vitro and their possible in vivo consequences assessed in the sea bream. The chemicals tested 
appeared to have a strong effect on peripheral deiodination and the results suggest that the 
fish thyroid axis may have the ability to overcome disruption and re-establish TH 
homeostasis. The study is however, incomplete and further evaluation of thyroid histology 
and TTR plasma level quantification are currently being undertaken in order to better describe 
the endocrine disrupting effect of the test chemicals. It will be of interest in future to establish 
the relationship between EDCs which bind strongly to TTR in vitro and their in vivo 
consequences. The potential endocrine disrupting capacity of the test chemicals, a pesticide 
(ioxynil) and a synthetic estrogen (DES) is very relevant, as both are present in environmental 
effluents but relatively few studies on their influence on fish thyroid status exist (Brown et al., 
2004).  
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Transthyretin is a well characterised protein in higher vertebrates. It is a plasma protein 
involved in the transport of thyroid hormones and vitamin A. TTR association with severe 
human amyloidopathies is the object of intensive research. The strong affinity of TTR for 
putative endocrine disruptors could compromise thyroid system homeostasis although the 
importance of TTR’s in thyroid axis regulation in not clear. In fish TTR has only recently 
been identified and relatively little is known about its function, regulation and interaction with 
THs and endocrine disruptors and the aim of this thesis was to investigate these questions. A 
recombinant TTR from the teleost sea bream (sbrTTR) was produced using a bacterial 
expression system. This approach was taken in order to generate sufficient quantities of TTR 
for experiments as its purification from fish plasma would be unlikely to generate the 
sufficient amounts. Bacteria expression systems are widely used to purify and characterize 
eukaryotic proteins as they have rapid growth, are easy to transform and induce, they are low 
cost and give high protein yields (Higgins and Hames, 1999). However, the major drawback 
of such systems is their inability to perform post-translational modifications typical of 
eukaryotes and the accumulation of proteins as insoluble inclusion bodies, in most cases due 
to protein misfolding (Sorensen and Mortensen, 2005). These issues were not a drawback for 
recombinant sbTTR production as demonstrated in previous studies of this protein (Eneqvist 
et al., 2004; Eneqvist et al., 2003). Furthermore, as one objective of the thesis was to evaluate 
the influence of the N-terminal on ligand binding the generation of mutant recombinant 
proteins is relatively straight forward. Purification of the recombinant TTR produced using 
native PAGE was sufficient for it to retain TH binding ability (and therefore its native 
conformation). Studies to ascertain protein native structural characteristics are also currently 
being performed using chromatography (HPLC) and circular dichroism (CD).  
The binding affinity of sbrTTR to THs was established using an in vitro competitive binding 
assay and indicate it has a similar affinity for T3 and T4. However current theories suggest that 
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in lower vertebrates TTR was a T3 binder and during evolution became a T4 binder in 
eutherian mammals in association with the proposed evolution of T4 as a pro-hormone 
(Schreiber, 2002a; 2002b). In fish there are few studies of TTR hormone affinity and those 
that exist are qualitative and indicate a slightly higher affinity for T3 (Eneqvist et al., 2003; 
Santos and Power, 1999; Yamauchi et al., 1999). In our studies we developed and optimized a 
specific competitive binding assay for sbrTTR binding to THs which gives consistent and 
reliable results. Interestingly the assay conditions for piscine and human TTR binding assays 
differ significantly and suggest assay conditions are crucial for appropriate binding and may 
explain the very variable Kd obtained by different authors for the same proteins (for example 
see Chang et al (1999)). Further studies on TTR:TH binding from representative of the main 
classes of fish would be of great interest and the fact that TTR cDNA from the lamprey (an 
ancient species) was recently cloned (Manzon et al., 2007) opens interesting perspectives.      
The proposed hypothesis that the length and hydrophilic nature of the N-terminus of TTR is 
important for TH binding properties was also explored. Two sbrTTR mutants were produced 
and it was observed that removal of the first 12 N-terminal (sbrTTRM12) amino acid does not 
alter sbrTTR:TH binding properties but when only the first 6 amino acids (sbrTTRM6) are 
removed the protein losses affinity for T4. Therefore, the N-terminus which is thought to be 
placed at the entrance of the binding channel, appears to influence TTR:THs binding affinity 
and this was also reported by Prapunpoj et al (2006; 2002). It appears that the length per si of 
TTR may not be important but rather the physicochemical properties of the amino acid 
residues in this region. Possible interactions of the N-terminal residues with other residues at 
the binding site or even possible changes in conformation induced in these regions could be at 
the origin of the observed affinity changes. It is also noticeable that changes in affinity were 
only found for T4 and this agrees with the observation of Prapunpoj et al (2006) who suggest 
the N-terminus exerts greater influence on the affinity of T4 then that of T3. 
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Fluorimetric measurements of sbrTTR in acidic conditions in order to evaluate fibril 
formation revealed that the mutant lacking the first 6 N-terminal amino acids (M6) which lost 
affinity for T4 also failed to form amyloid fibrils. It is known that fibril formation can be 
prevented by stabilizing TTR tetramer at the binding site (Colon and Kelly, 1992; Miroy et 
al., 1996) and we therefore hypothesise that the M6 mutation either by interaction of local 
residues or conformational changes stabilized the tetramer. The work reported in the thesis 
presents for the first time the assessment of fibril formation by piscine TTR using 
spectroscopy and indicated that sbrTTR seems to be more resistant to this process compared 
to the human protein as was also suggested by Eneqvist et al (2003). The results about TTR 
stability are of considerable interest and open new perspectives and highlight the potential 
utility of comparative analysis in understanding TTR stability.  
In the present work for the first time TTR levels in fish plasma were measured using a 
sensitive and specific ELISA assay developed for sea bream TTR. Using the assay it was 
possible to establish that TH:TTR ratio in fish is much higher than in humans and this may be 
related to species specific differences in THBP abundance and affinities or to a broader action 
TTR in humans beyond TH transport (e.g., RBP-retinol transport). Our experiments also 
indicate that THs appear to be involved in the regulation of plasma TTR levels, probably by 
changing its rate of secretion. As TTR appears to be the main THBP in fish it may have a 
fundamental role in regulating homeostasis of free levels of THs and when hormone levels 
increase it probably counteracts partitioning of free THs into cells. This is the first time that 
the regulation of TTR by THs has been considered in fish and in general many more studies 
are required to explore regulatory mechanisms in fish but also in other vertebrates. In contrast 
to mammals in which free T3 levels are very low in fish plasma they are frequently similar to 
T4 levels (Eales and Brown, 1993; Power et al., 2000b) and it is tempting to speculate that the 
progressive loss of affinity of TTR for T3 during vertebrate evolution is associated with the 
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establishment of T4 as a pro-hormone. Further comparative studies relating TH levels and 
TTR affinity in vertebrates and a better understanding of deiodinases system and the thyroid 
axis in fish would be of great interest.  
The importance of TTR in TH transport in fish raises a number of questions about how it is 
affected by environmental chemicals which disrupt endocrine systems in humans and wild 
life. The majority of studies of endocrine disruptors are in the context of the reproductive 
system; however there is increasing evidence from animal and in vitro studies that the thyroid 
axis is also vulnerable to endocrine disruption. Thyroid hormone transport is an important 
endpoint of the thyroid cascade and a number of recent studies have indicated that TTR from 
vertebrates has high affinity for many exogenous chemicals (Cheek et al., 1999; Hamers et al., 
2006; Ishihara et al., 2003a; Ishihara et al., 2003b; Lans et al., 1993; Rickenbacher et al., 
1986; Yamauchi et al., 2000). In the context of the differing affinity of piscine TTR for THs 
and the frequent reports of water contamination by EDCs an in vitro study of a panel of 
putative EDCs was conducted using the competitive binding assay developed for sbrTTR. 
Chemicals from different sources (industrial, pharmaceutical and agricultural) and classes 
reported as environmental pollutants in aquatic environments (Anderson and MacRae, 2006; 
Brown et al., 2004), some of which accumulate (Akutsu et al., 2001; Manchester-Neesvig et 
al., 2001) or cause thyroid disruption in fish and other species were selected (Brown et al., 
2004; Brucker-Davis, 1998). Some of the tested chemicals bound sbrTTR with similar or 
higher affinity than T3. The use of sbrTTR as opposed to plasma (Ishihara et al., 2003b) in 
competitive binding assays allows the specific effect of EDCs on TTR to be established and 
avoids possible non-specific effects. The pattern of binding preferences of sbrTTR for EDCs 
was quite distinct from that of TTR from other vertebrates (Hamers et al., 2006; Ishihara et 
al., 2003a; Ishihara et al., 2003b) and are coherent with the different TH affinity found for this 
protein in fish (chapter 3). As piscine TTR seems to have quite distinct binding properties 
CHAPTER 7  General Discussion 
 171 
from other vertebrates it is proposed that the developed piscine competitive binding assay 
represents a specific tool to assess potential thyroid axis disrupting by EDCs in fish. As fish 
are frequently used as sentinel species for quality of aquatic environments this would be a 
more accurate tool than previously proposed methods using TTR from different species 
(Yamauchi et al., 2003). Moreover, it would permit new chemicals to be tested for affinity to 
sbrTTR and provide indication of potential disruptive effects and ability to stabilize the native 
tetramer and inhibit fibril formation as previously proposed (Maia et al., 2005; Miroy et al., 
1996; Morais-de-Sa et al., 2004).  The in vitro binding assay can only be a preliminary risk 
assessment tool as poor/high binding affinity found for compounds in vitro does not directly 
indicate disrupting activity in the more complex in vivo system.  
The identification of several chemicals with high affinity for sbrTTR in vitro led to the next 
study which was to try and relate this character to in vivo consequences. Brominated flame 
retardants like the tetrabromodiphenylether BDE-49 or tetrabromobisphenol A (TBBPA) 
which showed remarkable affinity to sbrTTR (chapter 5) or the commercial Bromkal 70-5DE 
which include BDE-47, 99 and 100, strong sbrTTR binders were not selected, as such flame 
retardants have been banned in USA and Europe (De Wit, 2000; Kucher and Purvis, 2004) 
and are not available in sufficient quantities. Instead ioxynil (herbicide, (Geiger et al., 1990)) 
and DES (synthetic estrogen, (Wenzel, 1995)) which bind to sbrTTR and TTR from other 
species (Ishihara et al., 2003a; Ishihara et al., 2003b) and are readily available were used in 
vivo. Such EDCs and their conjugated metabolites are found in wastewater or activated 
sludge. The chemicals are practically insoluble in water and therefore in the bioassays 
conducted they were administered via the diet rather than in tank water. Moreover, natural 
exposure of fish to EDCs through diet has commonly been reported in the literature (Brown et 
al., 2004; Brown et al., 2002; Coimbra et al., 2005) and is less invasive or stressful than 
administration through injection. No literature is available about the typical exposure levels 
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for the EDCs tested and the dose selected (1mg/kg fish accumulative dose over 21 days) 
reflected that reported for other EDCs (Brown et al., 2004; Coimbra et al., 2005).  
No strong conclusion can be drawn from the study as it was not possible to complete sample 
analysis prior to the conclusion of this thesis, but it is clear that the administered chemicals 
influenced the thyroid axis. An interesting observation was that although TH levels were 
normal peripheral deiodination decreased (as assessed by reduction in deiodinase transcripts) 
supporting suggestions that in fish peripheral deiodination may control thyroid function rather 
than the hypothalamo-pituitary-thyroid axis (Eales and Brown, 1993; Orozco and Valverde-R, 
2005; Power et al., 2001). The overall effect of PTU on the thyroid axis was greater than the 
EDCs and may indicate their binding to TTR may protect cells from their effects, although 
more studies will be required to test this hypothesis. Future studies of TTR plasma levels in 
fish exposed to EDCs will be crucial as will quantification/detection of TTR expression in the 
brain where the most significant changes in TSH and deiodinases gene expression were 
identified. It is not yet clear if in fish TTR regulates TH uptake into the brain (Santos et al., 
2002; Schreiber, 2002b) but if it does changes in its expression caused by EDCs might 
explain the changes in TSH and deiodinases in this organ. Further studies will be required to 
establish if correlations exist between TTR binding to EDCs in vitro and their effect in vivo in 
fish.   
The work reported in this thesis gives important insights into thyroid hormone transport in 
fish and their regulation, TTR structure/function evolution and amyloid properties and the 
ability and consequences of TTR binding to putative EDCs. In addition to attaining the 
objectives initially proposed a number of new and interesting questions arose from the results 
of the work. The tools developed will be important for future studies aimed at understanding 
the role of THBP in fish and other vertebrates and factors which determine binding affinity 
and stability of TTR. The TTR binding assay could be used to identify new molecules with 
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the ability to bind and stabilize the native tetramer and inhibit fibril formation. Moreover, the 
preliminary studies on endocrine disruption and the possible role of TTR indicate that this 
will be a fruitful area of research and emphasizes the need for future studies and should 
provide insights into the thyroid axis in fish.  
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Solutions used in agarose gel electrophoresis 
 
6x DNA loading buffer 
40 % (w/v) sacarose, 0.25% (w/v) bromophenol blue in stH2O. Store at 4ºC. 
 
10x TBE (Tris-Borate-EDTA) buffer 
108 g of Trizma base  
55 g of boric acid 
40 ml of 0.5 M EDTA pH 8.0 
Add dH2O to 800 ml, mix until it dissolves, check the pH and if necessary adjust to 8.3 with 
boric acid. Add dH2O to 1 L and autoclave.   
 
 
Solutions used in plasmid DNA purification by Alkaline Lysis 
 
GTE (Glucose-Tris-EDTA) buffer 
50 mM glucose, 25 mM Tris-HCl pH 8.0, 10 mM EDTA pH 8.0. Autoclave. 
 
3M KAc  
60 ml of 5M potassium acetate (KAc)  
11.5 ml of glacial acetic acid 
Add dH2O to a final volume of 100 ml and autoclave. 
 
 
Solutions used for SDS-PAGE and Native PAGE 
 
2x SDS sample buffer 
100 mM Tris-HCl pH 6.8, 200 mM DDT, 4%(w/v) SDS, 0.2%(w/v) bromophenol blue, 
20%(v/v) glycerol. 
 
1.5 M Tris, pH 8.8 
Dissolve 36.2 g of Tris-base (Merck) in 150 ml ddH2O, adjust pH to 8.8 with concentrated 
HCl and add ddH2O to 200 ml. 
 
1 M Tris, pH 6.8 
Dissolve 12.1 g of Tris-base (Merck) in 75 ml ddH2O, adjust pH to 6.8 with concentrated HCl 
and add ddH2O to 100 ml. 
 
5x Tris-Glycine running buffer  
25mM M Tris-HCl, 250mM glycine buffer, 0.1%SDS pH 8.8 
Dissolve 15.1g of Tris base (Merck) and 94g of glycine in 900ml ddH2O. Add 50 ml of 
10%(w/v) SDS and ddH2O to a final volume of 1L.  
To make 1x running buffer, dilute 1:5 with ddH2O. 
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Stacking and resolving gel for SDS-PAGE 
 
 
Reagents Stacking Gel 
(Total volume = 4 mL) 
Resolving Gel 
(Total volume = 10 mL) 
Polyacrylamide percentage 5% 15% 
ddH2O 2.92 ml 3.55ml 
40%Acrylamide:Bisacrylamide 0.5 ml 3.75ml 
Tris-HCl buffer 0.5 ml of 1M Tris-HCl pH6.8 
2.5 ml of 1.5M Tris-HCl 
pH8.8 
10% SDS 0.04 ml 0.1ml 
10% Ammonium Persulfate (APS) 0.04 ml 0.1ml 
TEMED 
(N,N,N’,N’-Tetramethylethylenediamine) 0.004 ml 0.004 ml 
 
For the resolving gel: combine water, acrylamide, Tris-HCl buffer and SDS. Add freshly 
prepared 10% (w/v) APS and TEMED, mix well and pour solution into the gel sandwich 
(plates assembled with 0.75-1.5 mm spacers), leaving sufficient space at the top for the 
stacking gel. Gently overlay with dH2O and allow to polymerize for 30 min.  
Pour off aqueous layer, prepare stacking gel as above and pour into the gel sandwich. 
Immediately insert comb and allow polymerising for 30 min. 
 
Coomassie blue staining solution 
0.25% (w/v) Coomassie brilliant blue, 10% (v/v) glacial acetic acid, 45% (v/v) methanol. 
 
Destain solution 
10% (v/v) glacial acetic acid, 10%(v/v) methanol. 
 
Silver nitrate staining solutions 
 
Staining solution: 21ml of NaOH 0.36%, 1.4ml of NH4OH 29.5%, 4ml of a 0.2 g/ml AgNO3 
solution. Add the AgNO3  to the solution drop by drop with vigorous agitation. Adjust the 
final volume to 100ml with MillQ H2O 
 
Developing solution: 0.5 ml of 1% (v/v) citric acid (C6H8O7), 0.05 ml of formaldehyde 38% 
and MilliQ H2O to 100ml 
 
Stop solution: 100ml of 1% acetic acid in MilliQ H2O 
 
Glycine-acetate 1X running buffer 
Glycine 0.2M; Sodium Acetate 0.12 M 
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Glycine-acetate gel 12.5% 
 
Reagents Gel (Total volume = 4 mL) 
Polyacrylamide percentage 12.5% 
ddH2O 8.37 ml 
40%Acrylamide:Bisacrylamide 4.7 ml 
Gly-Acet 5x buffer 3.04 ml 
10% Ammonium Persulfate (APS) 0.375ml 
TEMED (N,N,N’,N’-
Tetramethylethylenediamine) 0.015 ml 
 
 
Solution for Western blot 
 
Blocking solution  
10% (w/v) dried skimmed milk; 0.1% (v/v) Tween-20 in 1x phosphate buffered saline, PBS 
 
DAB substract solution  
0.04% (w/v) 3,3-diaminobenzidine (DAB, Sigma), 0.02 %(w/v) nickel chloride, 
0.0025%(v/v) hydrogen peroxide in 1x PBS 
 
10x PBS (Phosphate Buffered Saline) 
80 g of NaCl (Sigma) 
2 g of KCl 
14.4 g of Na2HPO4  
2.4 g of KH2PO4  
Add ddH2O to 1 L and adjust pH to 7.4 with concentrated HCl. 
To make a 1x PBS dilution, dilute 1:10 with ddH2O. 
 
Washing solution PBST (PBS-Tween) 
PBS 1x with 0.05% (v/v) Tween-20 
 
Western Transfer buffer 
Dissolve 3.03g of Tris base (Merck) and 28.8 g of glycine in 800 ml ddH2O. Add 100 ml of 
methanol, 5 ml of 20% SDS and ddH2O to 1 L. Store at 4ºC until use.  
 
 
Prep cell preparative SDS-PAGE 
 
Resolving gel: (internal diameter 28mm with 3.6 cm2 surface area, 20mL): 15% 
polyacrylamide in 0.375 M Tris-HCl, pH 8.8. 
Stacking gel: (same as resolving, 10mL) -  4% polyacrylamide in 0.125 M Tris-HCl, pH 6.8.  
Sample buffer: 0.06 M Tris-HCl pH 6.8; 0.025% bromophenol blue; 2% SDS, 10% glycerol  
Running buffer:  0.025 M Tris-HCl, 0.192M glycine buffer, pH 8.3  
Running time: approximately 10h 
Sample volume: ~1.2 ml 
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Gel preparation: 
Reagents Stacking Gel 
(Total volume = 10 mL) 
Resolving Gel 
(Total volume = 20 mL) 
Polyacrylamide percentage 4% 15% 
ddH2O 6.43 ml 7.4ml 
40%Acrylamide:Bisacrylamide* 1 ml 7.5ml 
Tris-HCl buffer 2.5ml of 0.5M Tris-HCl pH6.8† 
5ml of 1.5M Tris pH 
8.8‡ 
10% Ammonium Persulfate (APS) 0.05 ml 0.05 ml 
TEMED 
(N,N,N’,N’-Tetramethylethylenediamine) 0.01ml 0.005ml 
 
* PlusOne ReadySol IEF acrylamide solution with 3% bisacrylamide (Amersham Biosciences) 
†0.5 M Tris, pH 6.8: 6.05 g of Tris-base (Merck) in 75 ml ddH2O, adjust pH to 6.8 with concentrated HCl and 
add ddH2O to 100 ml. ‡1.5 M Tris, pH 8.8: 36.2 g of Tris-base (Merck) in 150 ml ddH2O, adjust pH to 8.8 with concentrated HCl and 
add ddH2O to 200 ml. 
Degas gels for approximately 30 minutes before adding APS and TEMED 
 
 
Prep cell preparative large scale Native-PAGE 
 
Resolving gel - (internal diameter 37mm with 8.2 cm2 surface area, 60mL): 10% 
polyacrylamide in 0.375 M Tris-HCl, pH 8.8.  
Stacking gel (same as resolving, 20mL) was of 4% polyacrylamde in 0.125 M Tris-HCl, pH 
6.8.  
Sample buffer - 0.0625 M Tris-HCl pH 6.8; 0.025% bromophenol blue; 10% glycerol 
Running buffer:  0.025 M Tris-HCl, 0.192M glycine buffer, pH 8.3  
Running time: approximately 7h 
Sample volume: ~8 ml 
 
Gel preparation: 
Reagents Stacking Gel 
(Total volume = 20 mL) 
Resolving Gel 
(Total volume = 60mL) 
Polyacrylamide percentage 4% 10% 
ddH2O 12.86 ml 29.94ml 
40%Acrylamide:Bisacrylamide 2 ml 14,94ml 
Tris-HCl buffer 5ml of 0.5M Tris-HCl pH6.8† 
15ml of 1.5M Tris pH 
8.8‡ 
10% Ammonium Persulfate (APS) 0.1 ml 0.150 ml 
TEMED 
(N,N,N’,N’-Tetramethylethylenediamine) 0.02ml 0.015ml 
 
  † ‡
 see the upper table 
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Solutions for the binding assay 
 
TCN buffer 
20mM Tris/HCl, pH 7.5, 93mM NaCl, 1mM CaCl2 and 1mM MgCl2 in ddH20 
 
bovine γ-globulin  
125µg/ml  
 
Separating solution 
25% (w/v) and PEG 6000 containing 0.2M ZnCl2 in TCN buffer 
 
Washing solution 
12.5% (w/v) PEG 6000 containing 0.1M ZnCl2 in TCN buffer 
 
 
Culture media 
 
LB (Luria-Bertani) broth 
Dissolve 1 LB broth tablet (Sigma) / 50 ml dH2O and autoclave. Final composition for 1 liter: 
5 g NaCl, 10 g tryptone, 5 g yeast extract. For LB broth with antibiotics, add antibiotic to the 
desired concentration (see below) after autoclaving and store at 4ºC. 
 
LB agar plates 
Dissolve 1 LB agar tablet (Sigma) / 50 ml dH2O, autoclave, allow to cool to 55ºC and pour 
into Petri dishes. Final composition for 1 litre: 5 g NaCl, 10 g tryptone, 5 g yeast extract, 15 g 
agar. For selective agar plates, add antibiotic, IPTG or X-Gal to the desired concentration 
before pouring into petri dishes. 
 
 
Antibiotics, IPTG and X-Gal: 
Ampicillin   Stock 50 mg/ml Used at 80-100 µg/ml 
Chloramphenicol  Stock 34 mg/ml Used at 34 µg/ml 
Kanamycin  Stock 50 mg/ml Used at 50 µg/ml  
IPTG   Stock 0.5M  Used at 0.5 mM 
X-Gal    Stock 80 mg/ml Used at 80 µg/ml 
 
 
Primers (5’→ 3’) 
 
sbTTRWT 
fw   TTT TTC ATG ACC CCC ACC CCC ACG 
rv    TTT CGA GCT CAC TCG TGT ACG CTG GAG 
 
sbTTRM12 
fw GCT AGC TGT CCT CTG ATG GTA AAA ATC C 
rv   GGA TCC TCA CTC GTG TAC GCT GGA GAC 
 
sbTTRM6 
fw   GCT AGC GGA GGC TCA GAC ACC AGG TG 
rv    GGA TCC TCA CTC GTG TAC GCT GGA GAC 
